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ABSTRACT 
 
 
DCs are central to fetal defences and it was postulated that phenotypic changes on CBDCs in 
response to infectious/stressor stimuli could identify compromised fetuses. 
Investigations were performed on whole blood using monoclonal antibody labelling and flow 
cytometry. Functional studies included endocytosis of Dextran particles and MLR.   
Both plasmacytoid (HLA-DR+CD11c-) and myeloid (HLA-DR+CD11c+) DCs were identified in 
CB. Additionally CB contained a DC subset with a HLA-DR+CD11c-CD45intermediate(inm) 
phenotype. This population expressed lower levels of CD45 and HLA-DR and did not express 
plasmacytoid (CD123, BDCA2, and CD45RA) or myeloid (CD33 and CD13) markers. All 
subsets exhibited endocytosis and unlabelled CBDCs exhibited lymphocytic stimulatory 
capacity.  
Both myeloid and plasmacytoid CBDC subsets showed no change with gestation. The CD11c-
CD45inm subset decreased with increasing gestation representing 31.33% of total DCs in preterm, 
21.26% in term CB and 1.54% in adult PB. CD11c-CD45inm DC numbers expressing CD40, 
CD86 and production of IL-12 increased significantly with stressors. The myeloid and the 
plasmacytoid subsets showed no upregulation of CD40 and CD86 with stressors. The myeloid 
subset decreased while the plasmacytoid subset increased IL-12 production with stressors.  
Neutrophilic activation markers of CD11b and CD16 showed significant correlation with the 
stressed CB samples which exhibited proinflammatory DC responses, thus validating the clinical 
classification. 
These data indicate that CB contains plasmacytoid and myeloid DC populations as seen in adult 
PB. Additionally this study has identified a hitherto unreported CBDC subset with an immature 
phenotype, exhibiting endocytosis and phenotypically distinct from plasmacytoid DCs. Of the 
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three subsets, only the CD11c-CD45inm subset showed a costimulatory response to stressors 
suggesting this subset to be the most kinetic; changing with advancing gestation as well as 
exposure to stressors. Thus investigating phenotypic changes on CBDC subsets, especially on the 
CD11c-CD45inm subset, could serve to identify fetuses exposed to stressor stimuli and at risk of 
adverse sequelae. 
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INTRODUCTION 
 
Evolution over the millennia has equipped the human body with a multifaceted defence system 
effective against assault by external pathogens.  The immune system protects the host from 
pathogens as well as distinguishes self antigens from foreign antigens thus forestalling self 
destruction. These multiple almost contrary functions of the immune system have interesting 
consequences for the development of the fetus whose tissues are essentially a conglomeration of 
maternal antigens recognised as self antigens and paternal antigens normally recognised as 
foreign. The biology of the pregnancy is unique as it supports the co-existence of two 
immunologically diverse hosts. The uterus which harbours the fetus and provides nutrients is 
also the site of a unique immunological phenomenon whereby maternal tolerance to fetal 
antigens is developed, while allowing immunogenic activation to prevent infection. The antigen 
presenting dendritic cell (DC) is the initiator and modulator of the immune response and plays a 
central role in orchestrating both immunogenic and tolerogenic effects. The DC’s unique 
plasticity of function enables the modulation of the fine balance between fetal immune 
competence and immunotolerance, which is determined by the maturation status of the DC. Thus 
the raison d’être for the contrary requirements of the immune system is acceptance of the fetal 
allograft by the maternal immune system while providing protection from a hostile pathogen 
filled micro environment.  
The fetal immune system has developed the ability to mount a response to immunogenic stimuli 
from a very early period in the gestation, even though evidence so far points to a reduced ability 
to mount an effective response. Evidence of this reduced response is best available from the 
phenotypic and functional changes on the fetal DCs. Thus it follows that evidence of an 
INTRODUCTION 
 
29 
 
immunogenic response mounted by the fetal DC reflects exposure of that fetal immune system to 
antigenic/pathogenic stimuli. Although occurring in response to infectious threats, release of the 
fetal immune system from the tolerogenic placental control and mounting of an immunogenic 
response has been proven to have wide reaching adverse effects on the pregnancy such as 
preterm labour and delivery and long term fetal neurological and respiratory morbidity.  
Understanding this immunological paradox is essential in identifying the aetiology and 
pathogenesis of such adverse outcomes. The role of this cardinal cell of the immune system, the 
DC, in modulating and mounting an immunogenic fetal response and thereby enabling 
identification of the immunocompromised and at risk fetus is the main focus of this work. 
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1.1     DENDRITIC CELLS 
 
1.1.1   Introduction 
 
DCs are bone marrow derived antigen presenting cells (APC), which are found both in lymphoid 
tissues where they act as initiators of immune responses and in non-lymphoid peripheral tissues 
where they fulfil a sentinel like function both creating and curtailing the immune response 
(Steinman, 1991; Banchereau and Steinman, 1998; Banchereau, et al., 2000). DCs are the 
gatekeepers of the immune system and are widely distributed throughout the body especially at 
portals of pathogen entry. In the immature state DCs actively uptake and process antigen in their 
environment and when stimulated by appropriate cytokine and chemokine signals, mature into 
potent APCs orchestrating an immune response (Hart, 1997). The DC liberates cytokines (Reid, 
et al., 1990; Wan and Bramson, 2001) and chemokines (Cyster, 1999) to summon and co-
ordinate different effector cells of the immune system, including T-cells (Knight, et al., 1982), 
natural killer (NK) cells (Fernandez, et al., 1999), macrophages and monocytes (Steinman, 1991) 
and other DCs (Knight, et al., 1998). DCs play a pivotal role at the interface between innate and 
adaptive immunity as innate pattern recognition pathways trigger DC activation which 
determines the adaptive immune responses (Medzhitov and Janeway, 1999). They are central in 
the ability to discriminate between self and non self antigens and maintain the dual role of 
immune tolerance to self antigens as well as mounting an immune response against foreign 
antigens (Hawiger, et al., 2001; Bonifaz, et al., 2002; Knight, et al., 2002). 
When first observed in the late nineteenth century, DCs were mistaken to be of neural origin due 
to the dendritic like projections displayed by their cytoplasm and described as Langerhan cells by 
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Paul Langerhans. (Langerhans, 1868). The renewal of interest in DC research was initiated with 
the discovery of Birbeck granules in DC cytoplasm with the use of electron microscopy, leading 
to the identification of Langerhans cells in situ (Birbeck, et al., 1961; Zelcikson, 1966; Hoshino, 
et al., 1970).  Almost 100 years passed before the term ‘dendritic cells’ was described by Ralph 
M Steinman and Zanvil A Cohn (Steinman, 1973). The immunological significance of DCs 
emerged only after the discovery of MHC class II antigens on the cell surface (Nagao, et al., 
1976; Rowden, et al., 1977; Stingl, et al., 1978; Tamaki, et al., 1979). More extensive 
knowledge about them was curtailed in the 1970’s due to the low numbers in vivo and ineffective 
generation techniques, they are less than 0.5% of all nucleated cells in adult peripheral blood 
(PB) and cord blood (CB) (Naderi, et al., 2009). The development of methods to isolate and 
generate DC’s from blood and bone marrow precursor cells led to the explosion in the current 
knowledge. Inaba et al showed that rapid production of reasonable numbers of DCs was possible 
in a liquid culture medium with the addition of Granulocyte macrophage colony-stimulating 
factor (GM-CSF) (Inaba, et al., 1992). The use of this method provided DCs with the phenotypic 
and physical characteristics of DCs including mixed leukocyte reaction (MLR) and T cell area 
homing. But GM-CSF stimulates all the systems of myeloid cells including granulocytes and 
macrophages, and also causes DC maturation. Hence methods of freshly isolating DCs from non 
manipulated cultures have been developed (Naderi, et al., 2009). 
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1.1.2   DC phenotypical characteristics 
 
Human DC is identified phenotypically based on their surface expression of major 
histocompatibility complex (MHC) class II protein Human Leukocyte antigen (HLA-DR) and 
lack of expression of lineage associated markers (CD3, CD14, CD16, CD19, CD34 and CD56) 
(Knight, 1984; Reid, 1997; Banchereau, et al., β000). The term ‘lineage’ includes all cells that 
express markers for lymphocytes, granulocytes, monocytes, NK cells and stem cells.  
 
1.1.2.1   Morphology 
 
 
Figure 1.1    Electron micrograph of a human DC   
Scanning (Figure 1.1A) and electron micrograph (Figure 1.1B) of a human DC (Type III) 
exhibiting long ‘veil like’ dendrites giving rise to the classical stellate appearance (from 
Prof S.C Knight and N English, A.P.R.G) 
 
DCs were initially characterised and named on the identification of their multiple cytoplasmic 
processes which give rise to their classical stellate appearance. These cytoplasmic processes or 
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dendrites vary in size, length and number, and distinguish the DC from other mononuclear 
leukocytes (Steinman and Cohan, 1973). Electron microscopy delineates these processes as 
>10µm long and either ‘veil like’ or spiny. Initially DCs were classified as based on the cell 
surface membrane morphology of spiky projections, short bulbous extensions or thin 
cytoplasmic veils corresponding to Type I, II and III respectively (Knight and Stagg, 1993). Live 
DCs viewed by phase contrast microscopy exhibit extension and retraction of these ‘veil like’ 
projections continuously. Similar to mononuclear leukocytes, DCs have an irregular eccentric 
nucleus with heterochromatin arranged along the nuclear envelope. The cytoplasm has prominent 
mitochondria and an abundant number of endosomes (Kleijmeer, et al., 1995; Nijman, et al., 
1995). Two physical properties of DCs were especially useful in carrying out early 
morphological studies. DCs adhere to glass and surface adherence of enriched populations yield 
cultures containing 50% DC preparations amenable to more detail analysis. DCs also have a 
buoyant density of less than 1.082 which is less than that exhibited by 90% of the other nucleated 
cells in spleen and lymph node and can be enriched 7-20 fold by centrifugation. These properties 
were used by Steinman and his colleagues to obtain relatively higher numbers of DCs which 
facilitated more detailed morphological and functional analyses (Steinman and Cohn, 1974).  
 
1.1.2.2  DC classification 
 
DCs are widely distributed in all human tissues and have multiple subsets exhibiting different 
characteristics and fulfilling varied functions. In adults, this classification is based on their sites 
of location as Tissue DCs in nonlymphoid and lymphoid tissues and PB DCs. Additionally DCs 
are classified based on ontogeny, as well as function.  
INTRODUCTION 
 
34 
 
Traditionally the following aspects have been used to identify DC lineages: morphology, 
phagocytic capacity, cell surface markers and antigen processing and presentation. Recent 
studies have established newer criteria that explain the development and functioning of DCs 
more succinctly. These include immune tolerance functions of DCs, identifying committed 
progenitors e.g. monocyte and DC progenitors, common DC progenitor (CDP) and preDCs 
(Onai, et al., 2007; Steinman and Idoyaga, 2010).  
 
1.1.2.2.1 Classification based on phenotypic markers 
 
Phenotypic markers on DCs vary between the steady state and the activated state attained after 
exposure to infectious/inflammatory stimuli. In adults in the non-inflammatory steady state, two 
major subsets of DC have been identified; the conventional/myeloid, usually called cDC or mDC 
and the plasmacytoid/lymphoid (pDC) (Shortman and Liu, 2002; Randolph, et al., 2005; 
Shortman and Naik, 2007; Wu and Liu, β007; Hochrein and O’Keeffe, 2008). cDCs are 
lymphoid resident as well as non lymphoid resident and migratory. DCs that develop after an 
infection or inflammation include the monocyte derived DCs, the tumour necrosis factor 
producing DCs and the inducible nitric oxide synthase expressing DCs (Geissmann, et al., 1998; 
Randolph, et al., 1999; Serbina, et al., 2003; Naik, et al., 2006). 
The Myeloid/Lymphoid nomenclature has been shed in the light of recent new data on DC 
ontogeny (Shortman and Naik, 2007). Historically these two subsets were named based on the 
perceived notion that cDCs originated from a myeloid precursor and the pDC originated from a 
lymphoid progenitor. Recent evidence has revealed that a rigid dichotomy between the subsets 
does not exist as the development of both subsets has been shown from lymphoid as well as 
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myeloid precursor cells (Manz, et al., 2001; Wu, et al., 2001; Shortman and Liu, 2002; Chicha, 
et al., 2004; Shigematsu, et al., 2004). These DC subsets are plastic and can be modulated by 
various antigenic stimuli e.g. bacterial antigens (Bauer, et al., 2001).  
 
1.1.2.2.1.1  Conventional DCs in the human 
 
cDCs are CD11c+/CD123lo/CD45hi, GM-CSF dependent for their generation from precursor cells 
and have a monocytoid appearance. They also exhibit class II MHCbright, CD80+++, CD86+++, 
CD83+, CD13, CD33, CD11b and a high level of HLA-DR.  They express toll like receptor 2 
(TLR2), TLR4 and secrete IL-12. Immature DCs express class II MHC, CD80, and CD86, and 
these increase with maturation. They can be divided into further distinct populations according to 
their expression of BDCA1+ or BDCA3+.  
 
1.1.2.2.1.2 Plasmacytoid DCs in the human 
 
pDCs prior to activation resemble plasma cells morphologically with their round or oval non 
dendritic structure and a well developed endoplasmic reticulum and excentered nucleus. They 
play an important role in antiviral immunity and autoimmunity and are found primarily in blood 
and lymphoid organs. They circulate in blood and are found in the steady state in the bone 
marrow, thymus, lymph nodes, spleen and the liver (Liu, 2005). They secrete interferon-Ȗ (IFN- 
Ȗ)  when exposed to viral or bacterial antigenic stimuli and prime T lymphocytes against viral 
antigens which is their most important function after activation (Asselin-Parurel, et al., 2001; 
Pashenkov, et al., 2002; Yoneyama, et al., 2004). Due to the expression of the transcription 
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factor IRF-7, pDCs can secrete large quantities of IFN-α on exposure to viral nucleic acids 
(Fitzgerald-Bocarsly, et al., 2008).  
pDCs exhibit high levels of CD123 (IL-3 receptor), CD45RA, CD4, CD62L, BDCA-2 (CD303) 
and BDCA-4 (CD304) and are negative for CD11c, CD33 and CD16. They do not stimulate 
naïve T cells, exhibit only low levels of MHC class II molecules and lack most lineage markers 
(Grouard, et al., 1997; Liu, 2005). They also capture and process antigens onto MHC molecules 
less effectively when compared to cDCs (Grouard, et al., 1997).  
 
1.1.2.2.2 Classification based on immunological function 
 
DCs have a dual role and bidirectional interactions between DCs and T cells initiate either an 
immunogenic or a tolerogenic pathway and based on these functions DCs have been classified as 
Immunogenic or Tolerogenic (Steinman and Banchereau, 2007).  
 
1.1.2.2.2.1 Immunogenic DCs 
 
Innate immunity uses a nonclonal set of molecules for recognition and is a phylogenetically 
ancient non specific mechanism of host defence. The adaptive arm is clonally distributed and has 
immunological memory which develops on exposure to specific antigens. DCs as potent APCs 
are the only ones capable of activating resting T cells and initiating innate and adaptive immune 
responses and as part of the innate immune system DCs exhibit high phagocytic activity both in 
the peripheral tissues and in secondary lymphoid organs.  
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Figure 1.2  Dual role of DC in immunity and tolerance (from Quah and O’Neill. (2005). 
Maturation of function in dendritic cells for tolerance and immunity. J. Cell. Mol. Med. 
9(3): 647) 
DC precursors in blood develop from Haemopoietic stem cells (HSC) in the bone marrow. 
Immature DCs in the peripheral tissues develop from these DC precursors and in the steady 
state they take up self antigens, mature and follow a tolerogenic pathway of development. 
Upon exposure to infectious/inflammatory antigens, immature DCs mature and migrate to 
lymph nodes where antigen presentation leads to T cell differentiation 
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1.1.2.2.2.2 Tolerogenic DCs 
 
Modulation of responses to self antigens and tolerance induction are functions central to 
maintaining a healthy immune system, which the DC coordinates effectively.  DCs induce 
peripheral tolerance in the steady state and immature DCs in the secondary lymphoid tissues 
present self antigens (Scheinecker, et al., 2002). Immature DCs in lymphoid organs efficiently 
present and process self antigens to induce and maintain tolerance (Hawiger, et al., 2001; 
Bonifaz, et al., 2002; Lutz and Schuler, 2002). Such presentations lead to ignorance, anergy 
induction or deletion depending on the type of DC, affinity of the T cell receptor (TCR) and the 
level of costimulation on the DC (Diebold, 2008). Various pathways have been described for the 
induction of tolerogenic DCs; including induction of regulatory T cells by exhausted DCs, DC 
maturation with IL-10 or apoptotic cell uptake (De Smedt, et al., 1997).  
 
1.1.2.2.3 Classification based on anatomical location 
 
In adults, DCs have been classified based on their sites of location as Tissue DCs in 
nonlymphoid and lymphoid tissues and PB DCs.  
 
1.1.2.2.3.1 DCs in nonlymphoid tissues 
 
Non lymphoid tissue DCs can be seen distributed in internal organs such as the pancreas and the 
heart and DCs present in filtering sites such as the kidneys and the liver. Interface DCs are 
present at environmental interfaces such as the intestines, lungs and skin which form the primary 
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barriers to infections. Epidermal DCs also called Langherhans cells, express CD1a and play a 
crucial role in maintaining an impermeable barrier to infection.   
 
1.1.2.2.3.2 DCs in lymphoid tissues 
 
DCs on lymphoid tissues are classified as those present in the spleen, lymph nodes, thymus and 
those seen in the mucosa associated lymphoid tissues such as intestinal lymphoid follicles, 
Peyers patches and nasopharyngeal lymphoid follicles. Adaptive immune responses to pathogens 
are initiated in these lymphoid tissues and DCs play a critical role in delivering and presenting 
the antigens to T cells.  
 
1.1.2.2.3.3 Peripheral blood DCs 
 
Both cDC and pDC subsets as discussed above have been identified in adult PB. pDCs account 
for less than 1% of total peripheral blood mononuclear cells (PBMCs). The expressions of 
chemokine receptors on circulating blood cDCs and pDCs are similar but vary in quantity. Upon 
activation, pDCs can produce 100–1000 times more type I IFN than other blood cell types and 
are thus considered the professional type I IFN producing cells.  cDC produce large amounts of 
IL-12, induce Th1 and cytotoxic responses and also secrete type I IFN in response to viruses, but 
less efficiently than pDCs (Schettini and Mukherjee, 2008).  
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1.1.3 DC functional characteristics 
 
Functionally the characteristic feature of a DC is its ability to stimulate a primary lymphocyte 
response to presented antigen (Knight, et al., 1982; Knight, et al., 1983; Villadangos, et al., 
2005). 
 
1.1.3.1 Antigen surveillance and Uptake 
 
DCs patrol the peripheral tissues where they come into contact with pathogenic antigenic 
material, which are recognised by germ line encoded pattern recognition receptors (PRR) on the 
DC. Lymphocyte activation requires the recognition of short peptides associated with MHC class 
I or II molecules on the DC surface. Activation signals lead to increase antigen uptake (West, et 
al., 2004) and upregulation of MHC II molecules synthesis which are preferentially delivered to 
endosomal compartments containing foreign antigens (Blander and Medzhitov, 2006). Large 
antigen fragments are broken down into 10-20 amino acid peptides, loaded onto MHC class II 
molecules and translocated to the cell surface (Cresswell, 1994).  In MHC class I presentation 
ribosomal products are digested by the proteasome into small peptides that are translocated into 
the Endoplasmic Reticulum where they are loaded on MHC class I molecules and are transported 
to the cell surface (Yewdell and Nicchitta, 2006). 
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1.1.3.2 Antigen Processing and Presentation 
 
DCs are the most potent APCs and one DC can stimulate 100 to 3000 T cells. Antigenic proteins 
can be presented by DC in association with either MHC class I molecules or MHC class II 
molecules on the surface of the DC. The presentation of exogenous proteins requires the antigens 
to be first endocytosed by pinocytosis, phagocytosis or receptor-mediated endocytosis (Wilson 
and Villadangos, 2005). The cytosolic pathway is more relevant where exogenous antigen is 
transferred from phagosomes into the cytosol for proteasomal degradation (Kovacsovics-
Bankowski, 1995), while the second pathway involves peptide generation within the phagosome 
(Shen, et al., 2004).  
The phenomenon of cross presentation whereby DCs present exogenous antigens on their MHC I 
molecules also make the DCs function as highly efficient APCs (Wilson, et al., 2004). Cross 
presentation could result in activation as well as induction of tolerance in T cells and two 
pathways for presentation have been described.  DCs are the main cell population that can cross 
present in vivo and this ability makes them crucial in tolerance induction (Heath, et al., 2004). 
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Figure 1.3    Antigen presenting pathways in DCs (from Villadangos and Schnorrer. 
(2007). Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in 
vivo. Nat. Rev. Immunol.7: 548) 
The two main pathways of MHC I and MHC II as well as the mechanism of cross 
presentation is illustrated 
 
1.1.3.3 T Lymphocyte Activation 
 
DCs have the cardinal ability to interact with lymphocytes and other immune cells allowing 
transfer of information regarding foreign antigens invading the body. On arrival in the lymph 
nodes activated mature DC exhibiting MHC-peptide complexes on their surface interact with 
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naïve T cells. The outcome of these interactions are dependent on three DC derived signals: the 
levels of antigen presentation delivered through the TCR by its attachment to the MHC/antigenic 
peptide complex (signal 1), the display of co-stimulatory molecules (e.g. CD80 and CD86) 
which deliver signals through counter receptors on T cells (e.g. CD28) (signal 2) and the 
presence of immunomodulatory factors such as cytokines (signal 3) (Diebold, 2008). After 
activation by DCs, T cells divide and give rise to a clone of effector T cells each specific for the 
same antigen–class II MHC complex. Thus DCs can direct the T cell to eliminate a specific 
pathogen.  
 
1.1.4 DC life cycle 
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Figure 1.4    The life cycle of the DC (from Ueno, et al., (2010). Harnessing human 
dendritic cell subsets for medicine. Immunol Rev. 234: 200)  
Immature DCs in the circulation enter tissues and encounter pathogens directly or 
indirectly to induce cytokine secretion. Cytokines activate eosinophils, macrophages and 
NK cells, and these changes triggers DC migration and maturation. Mature DCs arriving at 
lymphoid organs display peptide-MHC complexes and recruit antigen-specific T 
lymphocytes 
 
1.1.4.1 DC Ontogeny 
 
The origins of DCs remain in relative obscurity despite extensive research. It is accepted that 
DCs are derived from self renewing HSC in the bone marrow giving rise to a series of 
downstream precursor cells that are progressively committed to particular cell lineages.  
 
1.1.4.1.1 Early non committed progenitors  
 
Early progenitors such as the common lymphoid progenitor (CLP) and the common myeloid 
progenitor (CMP) populations have been identified (Akashi, et al., 2000; Kondo, 2003), but both 
these progenitors retain developmental capacity of all DC subsets. Thus the phenotype of the DC 
is not diagnostic of its lineage origin. Downstream from the progenitors the capacity to develop 
into either DC or monocyte is governed by the cytokine milieu (Caux, et al., 1996).  
 
 
INTRODUCTION 
 
45 
 
1.1.4.1.2 Committed/Restricted progenitors 
 
DC committed precursors have been divided into three groups depending on their stage of 
restriction (Merad and Manz, 2009). Data is scarce as to whether these groups overlap and if they 
do so, the level of differentiation at which they overlap. They are: 
 
- Early DC progenitors: These cells are present in the bone marrow and have high 
proliferative capacity expressing CD117 (stem cell factor receptor) with no expression of 
lineage markers. They include macrophage and DC progenitors (Fogg, et al., 2006; 
Waskow, et al., 2008) giving rise to monocytes, macrophages, and DCs; and CDPs and 
pre-DCs giving rise to cDCs and pDCs (Naik, et al., 2007). The developmental lineage 
has been elucidated as follows. HSC differentiate into the CLP and CMP. Both CLPs and 
CMPs are seen exclusively in the bone marrow.  
 
- Late DC progenitors: Successive commitment steps produce macrophage/DC 
progenitors (MDP) which within the bone marrow differentiate into CDP. PB DC 
precursors which generate pDCs and precursors for cDCs (preDCs) are included in this 
group (del Hoyo, et al., 2002).  MDPs also give rise to monocytes and macrophages.  
 
- Immediate DC progenitors: These are precursors at a developmental stage just prior to 
the formation of a DC with its characteristic identifiable phenotype. These cells consist of 
nonproliferating monocytes with potential to immediately differentiate into DC on 
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exposure to inflammatory stimuli (Ginhoux, et al., 2006; Landsman, et al., 2007; Varol, 
et al., 2007). 
 
1.1.4.2 Maturation 
 
DCs in the steady state are immunologically ‘immature’ i.e. they have not acquired the capacity 
to prime naïve T cells (Banchereau, et al., 2000). The immature DC exhibits high endocytic 
potential with MHC class II molecule accumulation in endosomal compartments and a low T cell 
activation potential with low surface expression of T cell costimulatory molecules (Villadangos 
and Schnorrer, 2007). In the immature state DCs exhibit high levels of macropinocytosis and 
express endocytic receptors, such as the mannose receptors, DEC-205 and DC-SIGN. Maturation 
is mediated either by host-derived molecules such as CD40 ligand, Tumour necrosis factor 
(TNF-α), IL-1, IL-6, and IFN-α, or from microbial products stimulating TLRs (Cheng, et al., 
2003).  
On contact with an antigenic stimulation DCs exhibit characteristic phenotypic changes known 
as ‘maturation’. The changes include upregulation of MHC class II synthesis, phagocytosis and 
micropinocytosis; higher surface expression of MHC molecules and changes in endosomal 
protease activity (Villadangos, et al., 2005). Physical changes take place including the 
development of characteristic cytoplasmic extensions or “dendrites” and cytoskeletal 
reorganisation. Maturation results in the upregulation of the chemokine receptor CCR7 and 
costimulatory CD80/86 molecules (Sallusto, et al., 1999) and production of IL-12. During 
differentiation CD34 levels are downregulated and expression of HLA-DR is increased 
(Banchereau and Steinman, 1998). Maturing DC down regulate their endocytic capacity, in order 
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to increase the stable expression of MHC II/peptide complexes at the cell surface by preventing 
their reabsorption and degradation (Villadangos, et al., β001). The term ‘maturation’ currently 
indicates the phenotypic changes taking place on the DC and not to any specific change in its 
functional capacity.  
 
1.1.4.3 DC apoptosis 
 
Migrating DCs that reach the lymph nodes have a life expectancy of 2-3 days. The final stage in 
the DC life cycle is apoptosis. Cellular apoptosis is mediated either by T lymphocytes or NK 
cell. Apoptosis triggers signalling pathways resulting in the next wave of DC migrating from 
local tissues into the lymphoid tissues (Parajuli, et al., 1999). 
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1.2 THE FETAL DENDRITIC CELL 
 
1.2.1  Introduction 
 
The paradigm of the fetal immune system is the capacity to mount an immune response as a 
defence against pathogens while preserving tolerance to prevent maternal immune rejection. 
Fetal haemopoiesis initially occurs in the mesoderm of the yolk sac and the extraembryonic 
mesenchymal tissue from very early stages of gestation. Primitive pluripotent human erythroid 
progenitors have been detected in the yolk sac at 3-4 weeks of gestation and can be detected in 
the circulation from 4 weeks of gestation (Holt and Jones, 2000). The liver is the major site of 
haemopoiesis from 5-6 weeks of gestation until term and delivery. MHC Class II+/lineage- cells 
have been identified in the lamina propria of the fetal gut from 11 to 24 wks of gestation, and 
CD83+, putative mature DCs, were detected in lymphoid follicles from 16 wks of gestation 
(Jones, et al., 2001). The fetal and neonatal immune systems are functionally and phenotypically 
different from that of the adult and studies have shown that the neonatal immune system can be 
deficient in its efficacy (Marchant and Newport, 2000). The relative inefficiency of fetal CBDCs 
in the activation of T cells has been shown to be linked to their low cell surface expression of 
MHC and cell adhesion molecules (Hunt, et al., 1994; Petty and Hunt, 1998).  
Neonatal impaired fetal Th1 type adaptive immune responses have been implicated in the 
neonatal increased susceptibility to infections (Klein and Remington, 2001; Adkins, et al., 2004). 
Research has shown that transfer of maternal antibodies though the placenta limits the impaired 
primary antibody responses of the infant to infections by antigen removal. On the contrary T cell 
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responses have been shown to be unaffected by maternal antibodies (Gans, et al., 1999; Siegrist, 
2001; Glezen, 2003; Adkins, et al., 2004). 
Neonatal impaired cytokine secretion in response to infectious stimuli have also been 
demonstrated; namely TNF-α (De Wit, et al., 2003; Levy, 2005), which could result in defective 
Th1 polarisation. The impaired immune activity may be partly due to increased fetal production 
of IL-6 which exhibit Th2 polarising functions by inhibiting neutrophil migration to sites of 
infection (Marchini, et al., 2000; Schultz, et al., 2002) and also leads to low levels of secretory 
IgA (Markel, et al., 2006). Levels of most cytokines have been found to be low in the neonate; 
IL-2, IL-6, IL-4, IL-8, IL-10, IL-12, and IFN-Ȗ (Silver, et al., 2004).  The overall effect is to 
decrease the efficiency of innate immune responses and also cell-mediated immunity.  
Although of decreased efficacy on comparison with the adult immune system, the fetus can 
mount an innate as well as an adaptive immune response. The fetal immune system has the 
capacity to mount an immune response to maternal exogenous antigens; IgM responses to 
maternal immunisation (Gill, et al., 1983) and against congenital rubella (Naot, et al., 1981).  
 
1.2.2 Tolerogenic neonatal immune system 
 
Tolerogenic immune responses in pregnancy are necessary for the development of the foreign 
antigenic reservoir that is the fetus. Multiple evidence points to immune modulations at various 
levels: placental interface and the neonatal immune system. Circulating fetal antigens play a 
crucial role by promoting immune tolerance at the feto-maternal placental interface. Following 
recognition of fetally derived antigens, the immune system initiates a series of protective 
mechanisms. Maternal immune response is biased toward humoral immunity and deviates away 
INTRODUCTION 
 
50 
 
from cell-mediated immunity that could result in miscarriages. Another mechanism is by 
stimulation of maternal lymphocytes to develop progesterone receptors and in the presence of 
progesterone to produce a mediator that inhibits NK activity and protects against miscarriages. 
Fu et al found that decidual NK cells promote immune tolerance by decreasing inflammatory 
Th17 cells via IFN-Ȗ secreted by NK subset. Loss of this NK cell mediated regulatory response 
results in a prominent Th17 response and extensive inflammation leading to recurrent 
spontaneous miscarriages (Fu, et al., 2013). Studies have suggested that persistence of paternal 
antigens in the maternal circulation is important for the establishment and maintenance of a 
paternal antigen specific Treg population which contribute to the immunological tolerance 
(Zenclussen, et al., 2010).  
 
1.2.2.1   Materno-Placental interface 
 
Recent studies have indicated that placental immune modulations at the materno-fetal interface 
down regulate the immune responses to the fetus rather than a shift in the immune system from a 
Th1 to a Th2 bias. Conventional concept was that during pregnancy there was a change in the 
balance of Th1 and Th2 cells which resulted in an increase in the production of Th2 cytokines 
such as IL-3, IL-4, IL-6, and IL-10 and a reduction in Th1 cytokines such as IL-2, IFN-Ȗ, and 
TNF-α (Borzychowski, et al., 2005). Placental immune modulations depend on the stage of the 
pregnancy. Mor et al propose three immunological phases of pregnancy: A proinflammatory first 
trimester characterised by Th1 responses necessary for implantation and placentation, second 
trimester characterised by Th2 responses to mask the fetal antigens and facilitate fetal growth, 
and third trimester proinflammatory responses of Th1 shift to facilitate parturition (Mor, et al., 
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2011).  IL-10 is a potent immunosuppressive cytokine which protects the fetus from rejection by 
suppressing cellular immunity and inducing HLA-G expression in the trophoblast (Moreau, et 
al., 1999; Raghupathy, et al., 2001b). This raises questions about the types of 
immunomodulations at the materno-fetal interface and the cytokines involved, as well as the 
differences in these modulations between normal and abnormal pregnancies. 
DCs play an active part in this tolerogenic immune modulation. Miyazaki et al reported that 
mature CD83+ decidual DCs secrete lower levels of IL-12 when compared to PB DCs and they 
also induce Th2 immune activity (Miyazaki, et al., 2003). Tolerogenic DCs induce regulatory T 
cells and their activity is increased in normal pregnancy (Lutz and Schuler, 2002; Steinman and 
Nussenzweig, 2002). Natural Treg cells are found within the decidua and PB during the 1st and 
2nd trimester (Somerset, et al., 2004) and they secrete IL-10 (Le and Chao, 2007) promoting 
differentiation of tolerogenic DCs.  
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Figure 1.5   Tolerogenic activity of the DC at the feto-maternal interface (from Blois, 
et al., (2007). Dendritic cells: key to fetal tolerance? Biol Reprod. 77(4): 593) 
During normal pregnancy, partial activation of the DC at the materno-fetal interface is 
achieved by tolerogenic stimuli. This results in the production of anti-inflammatory 
cytokines which promote the induction of tolerance at the fetal-maternal interface 
 
1.2.2.2   Fetal immune system 
 
Functional regulatory cells in the thymus and secondary lymphoid organs have been identified in 
the fetus from 14 to 17 weeks of gestation (Cupedo, et al., 2005). Immunologic self-tolerance 
and negative control of immune responses have been shown to be due to a subset of T regulatory 
cells which have the ability to inhibit T-cell proliferation (Van Parijs and Abbas, 1998; 
Sakaguchi, 2004). During delivery Th1 response predominates with increasing IL-12 levels as 
IL-12 has a potent Th1 effect (Wegmann, et al., 1993).  
IL-12 stimulates IFN-Ȗ production and directs T cell responses towards Th1 (Macatonia, et al., 
1995; Goriely, et al., 2001). CBDCs capacity to skew the fetal immune system towards Th2 
could be due to reduced production of IL-12 (Goriely, et al., 2001; Vanden Eijnden, et al., 2006). 
This has been shown to be associated with an increased risk of sepsis in premature infants 
(Lavoie, et al., 2010).  
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1.2.3 Fetal DC characteristics 
 
CBDCs have been identified by cell surface markers as HLA-DR+ and lacking the CD3, CD14, 
CD16, CD19, CDγ4, and CD56 markers. This population represents only about 0∙γ% of CB 
mononuclear cells (Sorg, et al., 1999). Both lymphoid (HLA-DR+ CD11c- CD33-) and myeloid 
(HLA-DR+ CD11c+ CD33+) DCs have been identified in CB. 
 
1.2.3.1     Phenotypic characteristics 
 
The majority of CBDCs shows a lymphoid phenotype resulting in an inverted CD11c+/CD11c- 
ratio of 1:3 with predominant CD11c- DCs, when compared to adult blood DCs (3:1) where 
CD11c+ DCs predominate (Borras, et al., 2001; Naderi, et al., 2009). This could be due to an age 
related, evolving antigen specific immunity as the immature CBDCs matures into DCs with adult 
phenotype.  
Holloway et al reported that CBDCs exhibited higher levels of CD34, a marker of immaturity. 
CD34 is a marker of immaturity on precursor DCs and during differentiation DCs are known to 
down regulate the CD34 expression.  The percentage of DCs expressing CD40, CD86 and CD54 
was significantly lower than adults throughout gestation showing a reduced capacity for 
costimulation and the capacity increases with advancing gestation (Holloway, et al., 2009). 
These observations have been confirmed by various studies showing CBDCs to be more 
immature than adult PB DCs and expressing lower levels of MHC class II, ICAM-1, CD80 and 
CD86 (Hunt, et al., 1994; De Wit, et al., 2003; Encabo, et al., 2007).  
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1.2.3.2     Functional characteristics 
 
Fetal blood DC are immature compared with adult (high CD34, low CD4 and CD83) and 
expressed lower levels of HLA-DR, CD40 and CD86 (Holloway, et al., 2000; Naderi, et al., 
2009). CBDCs display a tendency to express lower levels of the gamma-chain IL-2 receptor, 
CD132 and of the CD86 costimulatory molecule, supporting a higher degree of immaturity as 
compared to adult DCs. (Crespo, et al., 2004). They also exhibit a lower bioactivity and reduced 
frequency of cytokine production as compared to adult cells (Bogunia-Kubik, 2001).  
CBDCs exhibit an immature phenotype, but are still potent stimulators of allogenic CB T cells 
(Pacora, et al., 2002b). The reduced ability of cord DCs to attain a fully mature adult phenotype, 
and to activate naïve CD4+ T cells to produce IFN-Ȗ, suggests that they are intrinsically pre-
programmed against the generation of Th1 immune responses (Langrish, et al., 2002). Naderi et 
al have reported on CBDCs preferential priming of näive T cells towards Th2 population. They 
showed CBDCs to be poor inducers of IFN-Ȗ secretion and poor stimulators of MLR when 
compared to adult PB DCs and displayed decreased expression of HLA-DR and CD86 
molecules. The ratio of lymphoid DCs to myeloid DCs was significantly higher in CB when 
compared to adult PB (Naderi, et al., 2009).  
Regulatory T cells exert an inhibitory effect on CBDCs, the interactions of which result in the 
downregulation of the expression of CD80, CD86 and MHC Class II molecules on DC and also 
converts CBDCs into tolerogenic APCs (Cederbom, et al., 2000; Vendetti, et al., 2000). These 
multiple inhibitory effects on the CBDC result in their functional immaturity and also play an 
important role in maintaining immunological tolerance towards the fetus. 
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1.2.4 Fetal DCs and infection 
 
Fetal biology has been shown to change with the onset of   maternal/intrauterine infection, with a 
rise in IL-8 concentration in CB (Dembinski, et al., 2002), and also increased cytokine in 
gestational membranes suggesting an inflammatory process (Keelan, et al., 1999).  
Fetal DCs have defective functions in their responses to infectious stimuli as evidenced by 
multiple studies, a few examples of which are given below. Research performed by Breitling and 
colleagues in newborn African infants exposed to Plasmodium falciparum in utero has shown 
that CB samples from those exposed to Plasmodium falciparum in utero reveal a Th2 bias as 
opposed to the Th1 bias in Plasmodium falciparum infected placentas (Breitling, et al., 2006). 
Fetal response to cytomegalovirus infection has been shown to be different to the adult where 
infection rarely causes a severe illness. Congenital cytomegalovirus infection leads to severe 
morbidity in 15-20% of infected newborns. Renneson and colleagues found that 88 of the genes 
regulated by cytomegalovirus were differentially regulated between neonatal and adult DC 
leading to lower levels of IL-12 and IFN produced by CBDCs as compared with adult DC 
(Renneson, et al., 2009). Furthermore CBDCs of fetuses with maternal chronic hepatitis B 
infection show lower costimulatory markers, IL-12 production and T lymphocyte stimulatory 
capacity when compared to CBDCs from fetuses of uninfected mothers as well as adult PBDCs 
(Zhang, et al., 2005).  
Low basal expression of costimulatory molecules, altered maturation and defective production of 
cytokines in response to TLR or CD40 signalling and reduced endocytic activity and response to 
TLR agonists of CBDCs may contribute to the deficient functions (Goreily, et al., 2001; 
Langrish, et al., 2002; De Wit, et al., 2003; Crespo, et al., 2004; Wong, et al., 2005; Danis, et al., 
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2008; Naderi, et al., 2009). These recent studies have mostly used DCs which are non-
manipulated and freshly isolated from cord blood and thus provide robust results. Earlier studies 
have used DCs generated from precursors using overnight culture or stimulation using GM-CSF 
and IL-4. Such techniques could themselves cause DC maturation and deviate the results from 
those seen in vivo.   
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1.3  SPONTANEOUS PRETERM LABOUR AND DELIVERY 
 
1.3.1   Introduction 
 
Preterm labour is a clinical syndrome characterised by uterine contractility, cervical ripening, 
and/or membrane rupture occurring before 37 weeks of gestation (Romero, et al., 1994). It is the 
major cause of perinatal mortality and morbidity and infants born before the thirty-seventh week 
of gestation account for approximately 6% to 9% of all births, but 70% of all perinatal deaths and 
half of all long-term neurological morbidity (Gibbs, 2001). Compared with term infants, preterm 
infants have higher rates of cerebral palsy (CP), respiratory distress, hypoglycaemia, jaundice, 
kernicterus, seizures, periventricular leukomalacia (PVL), hospital readmissions and infant 
deaths (Wang, et al., 2004; Escobar, et al., 2006). At least 25% of all preterm deliveries occur in 
mothers with microbial invasion of the amniotic cavity and studies suggest that infection may 
account for 25–40% of preterm birth (Romero, et al., 1992; Goncalves, et al., 2002). Diagnostic 
difficulties abound as only a minority of infected pregnancies exhibit clinical signs of 
chorioamnionitis. Only 12.5% of women with preterm labour and intact membranes with a 
positive amniotic fluid culture have been found to have clinical chorioamnionitis (Romero, et al., 
1989b; Goncalves, et al., 2002). This could be a reflection of the fact that not all 
chorioamnionitis are infection driven. Preterm delivery may occur with intact membranes or with 
PROM. PROM is defined as spontaneous rupture of membranes at less than 37 weeks gestation 
at least one hour before the onset of contractions. One third of all patients who deliver 
prematurely presents with premature labour and intact membranes and one third of preterm 
deliveries presents with PROM.  The remaining preterm deliveries are iatrogenic and due to 
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maternal or fetal indications (Arias and Tomich, 1982). The cause for the majority of preterm 
births is unknown while 30% have a definite diagnosis of infection/inflammation (Challis, 2000). 
 
1.3.1.1 Incidence 
 
Worldwide, there has been a dramatic increase in the incidence of preterm births, more so in the 
developed countries than in the developing countries in the past 20 years (Callaghan, et al., 
2006). Since 1981 there has been a 31% increase in the preterm birth rate in the USA, of which 
two-thirds were late preterm births (34–36 completed weeks of gestation) (Davidoff, et al., 
2006). The systematic review conducted by the World Health Organisation in 2010 found that 
the in 2005, 12.9 million births (9.6% of all births) were preterm. Africa had the highest rate of 
11.9%, followed by North America at 10.6%, while Europe had the lowest rate of 6.2% (Beck, et 
al., 2010). The majority of preterm births seem to occur idiopathically (45-50%), while 30% are 
related to PROM.  
Evidently different risk factors play different etiological roles in different parts of the world. In 
developing countries the major etiological factors are thought to be intrauterine infections (Beck, 
et al., 2010). In developed countries many other factors such as increased obstetric interventions, 
use of assisted reproduction techniques, increased rate of multiple births, increase in maternal 
age and a rise in iatrogenic preterm delivery rates play major roles. Changes in clinical practice 
such as increased use of ultrasound for gestational age estimations and changes in the definitions 
of stillbirth and early neonatal deaths has had an impact (Slattery and Morrison, 2002; Stanton, et 
al., 2006). Iatrogenic preterm deliveries mainly between 34-36 weeks gestation has increased 
due to the increase in preterm induction and preterm caesarean deliveries for fetal and maternal 
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indications. Such iatrogenic causes contribute to 15-20% of preterm deliveries and are on the rise 
mainly in developed countries (Haas, 2006; Pennell, et al., 2007). Norman et al found a 
significant percentage increase in crude rates of medically indicated preterm births in Scotland 
from 1998-2004 (Norman, et al., 2009). While in the United States, iatrogenic preterm birth 
increased from 2.2 to 3.7 per 100 live births between 1995 and 2005 (Lisonkova, et al., 2011). 
Assisted reproductive techniques per se have been shown to increase the risk of preterm delivery 
in on analysis of singleton pregnancies alone as preterm birth rates in multiple and singleton 
pregnancies are different. A significantly increased risk for preterm birth in singleton 
pregnancies was found in pregnancies after IVF [RR of 2.04 (95% CI 1.80–2.32) by Helmerhorst 
et al; OR of 2.0 (95% CI 1.7–2.2) by Jackson et al; RR of 1.98 (95% CI 1.77–2.22) by 
McGovern et al; OR of 1.93 (95% CI 1.36–2.74) by McDonald et al] (Helmerhorst, et al., 2004; 
Jackson, et al., 2004; McGovern, et al., 2004; McDonald, et al., 2005). 
 
1.3.1.2 Clinical and financial impact 
 
In spite of the use of antibiotics (Svare, et al., 1997; King and Flenady, 2002), corticosteroids 
and the use of advanced drugs such as atosiban (Worldwide Atosiban study group, 2001), the 
incidence of preterm birth with its attendant morbidity and costs has not reduced. The short-term 
costs of the neonatal intensive care unit in the UK are approximately £800 a day and annual costs 
are approximately £340,000,000 (Petrou, 2005). The total cost of preterm birth to the public 
sector was estimated to be £2.946 billion (US $4.567 billion), and an inverse relationship was 
identified between gestational age at birth and the average public sector cost per surviving child 
(Mangham, et al., 2009).  
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1.3.1.3 Importance of prevention 
 
Prematurity has significant public health impact due to its maternal, perinatal and neonatal 
morbidity and mortality (Iams, et al., 2008; Rüegger, et al., 2012). Preterm birth is the leading 
cause of neonatal mortality and morbidity accounting for one in five children with mental 
retardation and one in three children with visual impairments (Dammann and Leviton, 2000; 
Wood, et al., 2000; Marlow, et al., 2005; Vohr, et al., 2005). Premature infants have long term 
health risks such as an increased risk for cardiovascular disease and diabetes (Kajantie, et al., 
2010; Poplawska, et al., 2012). These diverse sequelae, especially in the long term impose a 
heavy burden on the health services (Kuban and Leviton, 1994; Petrou, 2005; Kruse, et al., 2009; 
Mangham, et al., 2009). Hence it is important to investigate the biology of prenatal infections, 
which is one of the major causes of premature birth. 
 
1.3.2   Clinical Debility 
 
Severe morbidity, especially respiratory distress syndrome, intraventricular haemorrhage, 
bronchopulmonary dysplasia and necrotising enterocolitis are far more common in preterm 
infants than in term infants. The EPICure Study suggests that almost 50% of babies born at 23-
25 wks gestation will have significant long-term handicap, with a survival of only 35% of 
preterm deliveries less than 25 weeks (Wood, et al., 2000).  
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1.3.2.1 Resultant Morbidity 
 
Retinopathy of prematurity is one of the most common morbidities in very preterm infants. Rates 
of severe visual impairment or blindness increases with decreasing gestational age, 1–2% for at 
26–27 weeks, and 4–8% at 25 weeks or below (Marlow, et al., 2005; Vohr, et al., 2005). Myopia 
and hypermetropia occur in at least a quarter of children born before 28 weeks gestation 
(O’Connor, et al., 2002).  
Very low birth weight infants have central auditory processing difficulties, including difficulties 
involving auditory recognition and identifying simple speech sounds (Davis, et al., 2001).  
Hearing impairments have a negative impact on the acquisition of language skills and affects 
schooling.  
Studies have also found that infants born with very low birth weight have lower growth 
attainment in weight and length than their normal birth weight counterparts during infancy and 
early childhood (Kitchen, et al., 1992; Hack, et al., 1996). 
 
1.3.2.2 Resultant Mortality 
 
In spite of the advances in medical technology the mortality associated with prematurity remain 
significant, as high as 42% worldwide in 2005 (Beck, et al., 2010). An infectious etiology of 
premature labour seems to be of prime importance in the resultant mortality. A link between 
intrauterine/placental infection and inflammation and mortality has been established. An 
association between genital bacterial colonisation and premature delivery and mortality has been 
reported and placental inflammation has been found to be an independent risk factor for preterm 
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birth, low birth weight, stillbirth, and perinatal death (Osman, et al., 1995; Mwanyumba, et al., 
2003).  
An inflammatory response by the fetus has also been evidenced as part of the pathology leading 
to fetal death of infectious etiology. Moyo et al showed that 9% of stillbirths in their series but 
none of the live births, had evidence of vasculitis in the chorionic plate vasculitis of the chorionic 
plate, which verified an inflammatory response from the infant (OR: 14, 95% CI: 2.8-72) (Moyo, 
et al., 1996).  
 
1.3.2.3 Long Term Sequelae 
 
1.3.2.3.1   Chronic lung disease and Bronchopulmonary dysplasia 
 
The EPICure Study showed that the major cause of death for all infants less than 26 weeks was 
pulmonary insufficiency (Costeloe, et al., 2000). Bronchopulmonary dysplasia occurs in up to 
40% of very low birth weight babies and the rate rises below a birth weight of 1500g (Darlow, et 
al., 2003). Intrauterine inflammation (Speer, 2003) and antenatal exposure to proinflammatory 
cytokines with amniotic fluid concentrations of IL-8 >11.5 ng/ml (nanogram/millilitre) are risk 
factors for the development of bronchopulmonary dysplasia (Ghezzi, et al., 1998). The long term 
prognosis of these patients is chronic pulmonary dysfunction.  
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1.3.2.3.2   Neurological damage 
 
Intrauterine infection has been shown to lead to a fetal inflammatory response, which, in turn, 
results in adverse outcomes such as preterm labour and delivery, intraventricular haemorrhage, 
white matter damage, PVL and mainly CP (Dammann and Leviton, 2000). Mental retardations 
and sensory impairments can also present clinically in the early years.  
The prevalence of CP is 1.5 to 3 cases per 1000 live births and it is the most common cause of 
motor disability in childhood ((SCPE) Collaborative Group, 2000; Paneth, et al., 2006). The link 
between CP and perinatal complications was first proposed by William John Little in 1862. 
Increased risk for CP in intrapartum fever was first reported in 1955 by Eastman and DeLeon 
(Eastman and Deleon, 1955). A recent systematic review found that the proportion of CP 
associated with intrapartum hypoxia-ischemia is 14.5% (Graham, et al., 2008). Himmelman et al 
found perinatal hypoxic ischaemic encephalopathy in 71% of dyskinetic CP in children born at 
term (Himmelman, et al., 2005). In this group, multiple studies have shown clinical and 
histologic chorioamnionitis to be associated with increased risks of CP (Murphy, et al., 1995; 
Grether and Nelson, 1997; Alexander, et al., 1998; O’Shea, et al., 1998; Yoon, et al., 2000b; Wu 
and Colford, 2000) and white matter lesions to be associated with intrauterine inflammation and 
infection in preterm labour (Leviton, et al., 1999; Dammann, et al., 2002). Wu et al in their 
meta-analysis found that clinical chorioamnionitis is associated with an increased risk of both CP 
and white matter damage [RR 1.9 (95% CI:1.4-2.5) and 2.6 (95% CI: 1.7-3.9), respectively] (Wu 
and Colford, 2000).  
There is a strong association between prematurity and CP; the risk of CP is 70 times greater at 
delivery at less than 28 weeks of gestation compared with delivery at term. Half of all cases of 
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CP are seen in premature infants (McCormick, 1985). Premature infants mount an exaggerated 
fetal systemic inflammatory response and also have but a limited ability to buffer the effect of 
proinflammatory cytokines (Nelson, et al., 1998; Grether, et al., 1999; Dammann, et al., 2005). 
Studies have postulated that premature infants are unable to buffer the recruitment of peripheral 
leukocytes as their blood-brain barrier is immature. The presence of macrophages in sites of 
white matter injury indicated that activated leukocytes were involved in the neurological injury 
processes (Dammann, et al., 2001; Leviton, et al., 2005). Furthermore Lin et al found increased 
sensitivity to LPS in children with CP leading them to suggest that inflammation could have a 
programming effect resulting in the altered inflammatory responses in preterm children (Lin, et 
al., 2010). 
Multiple studies support a link between fetal inflammation and brain injury. Elevated 
concentrations of cytokines in fetal plasma (Yoon, et al., 1997a; Dammann and Leviton, 2000) 
and fetal vasculitis (Wharton, et al., 2004; Redline, 2005) are associated with intraventricular 
haemorrhage, white matter damage, and CP. Originally described by Virchow in 1867, PVL are 
cerebral lesions characterised by foci of necrosis in the white matter near the lateral ventricles. 
PVL is the most common form of brain injury in preterm infants (Inder, et al., 1999). Clinical 
(Leviton and Paneth, 1990; Verma, et al., 1997) and experimental evidence (Hagberg, et al., 
2002; Debillon, et al., 2003; Mallard, et al., 2003) indicates that intrauterine infection results in 
PVL and neuronal lesions. A meta-analysis examining the relationship between chorioamnionitis 
and PVL demonstrated that PVL was significantly associated with both clinical (RR, 3.0; 95% 
CI, 2.2–4.0) and histological chorioamnionitis (RR, 2.1; 95% CI, 1.5–2.9) (Wu and Colford, 
2000).  
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Inflammatory cytokines such as TNF-α induce fetal hypotension and brain ischemia, release 
tissue factor and platelet activating factor which leads to coagulation necrosis of white matter 
(Leviton, 1993; Kadhim, et al., 2003). TNF-α also has a direct cytotoxic effect on 
oligodendrocytes and myelin (Leviton, 1993). Deguchi et al has shown increased expression of 
TNF-α in the microglial cells in PVL lesions (Deguchi, et al., 1996). Elevated IL-6 levels are 
associated with an increased risk for PVL in infants born at less than 32 weeks gestation 
(Goepfert, et al., 2004). Recently experimental evidence points to TLRs as having a crucial role 
in white matter injury. Administration of bacterial LPS through the systemic activation of TLR-4 
has been shown to have toxic effects on the immature central nervous system (Mallard, et al., 
2003). A strong body of evidence implicates damage to immature oligodendrocytes as the 
pathology underlying PVL (Takashima, et al., 1995; Back, et al., 2001; Johnston, et al., 2001). 
 
1.3.2.3.3 Behavioural sequelae 
 
Prematurity leads to developmental and behavioural impairments which have long term effects 
and can persist into adulthood. Huddy et al found in their study that up to a third of 7-year-old 
children born at 32–35 weeks gestation had difficulties in motor, educational and behavioural 
skills (Huddy, et al., 2001).  Children born prematurely also exhibit high rates of executive 
dysfunction and global impairment in cognitive functions such as attention, visual processing 
and academic progress compared with their normal birth weight peers.  (Anderson, et al., 2004). 
The cognitive and educational problems associated with prematurity are hypothesised to be 
caused by brain injury. PVL, which is related to ischemia and results in focal or diffused lesions 
has been implicated in long term cognitive dysfunction (Volpe, 1998). Long-term follow-up 
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reveals that many of the above difficulties persist into adolescence and early adulthood, all of 
which have significant implications for educational services and costs. 
 
1.3.2.4 Fetal Inflammatory Response Syndrome 
 
The fetal inflammatory response syndrome (FIRS) is a condition characterised by systemic 
activation of the fetal innate immune system and was originally defined by an elevation of fetal 
plasma IL-6 concentration of >11pg/ml in fetuses with preterm labour and PROM (Gomez, et 
al., 1998b). The multisystemic organ involvement is evidenced by increased concentrations of 
fetal plasma matrix metalloproteinases (MMP-9) (Romero, et al., 1998). Prevalence of severe 
neonatal morbidity (defined as the presence of respiratory distress syndrome, suspected or 
proved neonatal sepsis, pneumonia, bronchopulmonary dysplasia. intraventricular haemorrhage, 
PVL, or necrotising enterocolitis) was higher in neonates with FIRS (Gomez, et al., 1998b). 
Funisitis and chorionic vasculitis are the histopathologic hallmarks of FIRS (Pacora, et al., 
2002a) and the endothelial activation associated with funisitis leads to organ damage and 
increased risk of sepsis (Yoon, et al., 2000a), bronchopulmonary dysplasia (Yoon, et al., 1999b) 
and CP (Yoon, et al., 2000b). 
Two thirds of fetuses with FIRS have neutrophilia and a higher median nucleated red blood cell 
(RBC) count (Gomez, et al., 1998a) and show evidence of monocyte and neutrophil activation 
with higher expressions of CD11c, CD13, CD15 and CD67 (Berry, et al., 1995).  
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Figure 1.6    Multiple fetal organs targeted during FIRS  
(from Romero, et al., (2006). Inflammation in preterm and term labour and delivery. Semin 
Fetal Neonatal Med. 11(5): 322)  
Fetal organs targeted during the fetal inflammatory response syndrome (FIRS) are the 
brain, haematopoietic system, adrenals, heart, lungs, kidneys and skin  
 
1.3.3 Molecular events in Spontaneous Preterm Labour 
 
The process of labour in preterm as well as in normal term gestation involves three 
physiologically interdependent processes: the initiation of rhythmic uterine contractions, 
remodelling of the cervical tissue to allow it to soften and stretch, and weakening and rupture of 
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the membranes. Microbial stimuli and stress related proteins act through TLRs and result in the 
release of cytokines and chemokines. These stimuli also activate the innate immune system 
within the pregnant uterus leading to release of MMPs, PGs and increase the collagenase activity 
resulting in rupture of the membranes (Romero, et al., 2007). Actions of the proinflammatory 
cytokines are key factors in the initiation of labour and they also act on the downstream PGs and 
tissue proteinases resulting in the recruitment of inflammatory neutrophils and macrophages 
(Patni, et al., 2007).  
 
1.3.3.1 Cervical Softening and Dilatation 
  
Liggins in the early 1980s described cervical ripening as an inflammatory process with an influx 
of leukocytes (Liggins, 1980). The proinflammatory cytokines; IL-8, IL-1ȕ, IL-6 and TNF-α 
increase at the onset of labour and act on downstream PGs to increase the production of tissue 
proteinases (Osman, et al., 2003). IL-1ȕ and TNF-α increase the production of MMP and 
cathepsins, and IL-1ȕ downregulates the expression of an endogenous inhibitor of MMP (Watari, 
et al., 1999). Cervical dilatation is also induced by cyclo-oxygenase (COX)-2 and PGE2 which is 
increased by IL-1ȕ and IL-1a.  PGE2 in turn increases the production of proteinases and the 
permeability of blood vessels for leukocyte recruitment, thus initiating and promoting labour 
(Kelly, 2002).  
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1.3.3.2 Onset of Myometrial Contractions 
 
The sequence of proinflammatory cytokine induced actions described above also occurs in the 
myometrium and facilitates onset of myometrial contractions. IL-1ȕ, TNF-α and IL-6 are mainly 
associated with labour (Young, et al., 2002; Osman, et al., 2003). IL-1ȕ and TNF-α increase the 
production of PGE2 and COX-2 by the myometrium (Pollard and Mitchell, 1996; Todd, et al., 
1996). PGE2 in turn increases the intracellular calcium concentrations in myometrial cells 
leading to increased contractility of the myometrial muscle cell and uterine contractions 
(Thornton, et al., 1992). IL-6 increases the expression of oxytocin receptors on myometrial cells 
and also increases its secretion by myometrial cells (Friebe-Hoffmann, et al., 2001; Rauk, et al., 
2001). Oxytocin has a similar action to PGE2 as outlined above and leads to uterine contractions. 
 
1.3.3.3 Rupture of membranes 
 
The molecular events leading to cervical dilatation also facilitate rupture of membranes. 
Increased production of proinflammatory cytokines from infiltrating leukocytes, decidual cells 
and amniochorionic cells lead to the increase in the production of PGs and MMP (Laham, et al., 
1999; Maymon, et al., 2000; Young, et al., 2002). There is also a significant upregulation of IL-
1ȕ and IL-6 seen in labour (Norman, et al., 2007). During labour at term the collagenase acts on 
the area of the fetal membranes overlying the cervix, altering its morphology and integrity and 
degrade the extracellular matrix resulting in rupture (Moore, et al., 2006). During preterm labour 
the degradation of the extracellular matrix is seen diffusely and is not isolated to the area of the 
fetal membranes overlying the cervix. The proinflammatory cytokines also promote interactions 
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between the fetal membranes and myometrium resulting in myometrial contractions (McLaren, 
et al., 1999; Osman, et al., 2006). 
 
1.3.4 Immunology of Spontaneous Preterm Labour 
 
Immunomodulations at the materno-fetal interface serve to protect fetal tissues and prevent 
rejection of the fetal allograft. Infections and other factors have been postulated to disrupt the 
delicate balance between pro and anti inflammatory modulations as discussed below, resulting in 
premature labour. There is strong evidence for the infectious aetiology and many studies have  
shown that bacteria can cross intact chorioamniotic membranes (Galask, et al., 1984; Romero, et 
al., 1987; Romero, et al., 1989b). 
 
1.3.4.1 Role of cellular mediators 
 
The innate immune system also recognises micro organisms through PRRs e.g. acute phase 
proteins and TLRs, which are crucial for the recognition of microorganisms. PRRs bind to 
patterns of molecular structures present on the surfaces of microorganisms. TLR-2 is involved in 
the response to products of gram-positive bacteria, mycoplasmas, and yeast and TLR-4 in the 
response to LPS (Akira, et al., 2001). To date eleven different TLRs have been recognised in 
humans and they are key upstream mediators of inflammation (Zhang, et al., 2004; Janeway, et 
al., 2005). Defective signalling through TLRs will impair defences against bacteria-induced 
preterm labour and there is experimental evidence that TLRs are crucial in the aetiology of 
preterm labour (Wang and Hirsch, 2003).  
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Studies have provided evidence for an association between raised markers of inflammation and 
subsequent preterm delivery. Raised levels of amniotic fluid MMP-8 (Yoon, et al., 2001) and 
angiogenin (Spong, et al., 1997) are some of the markers of inflammation implicated in the 
aetiology. Intravascular maternal inflammation in preterm labour of infectious aetiology leads to 
upregulation of maternal monocytic and granulocytic markers e.g. CD11b, CD15 and CD66 on 
granulocytes, and CD11b and CD15 on monocytes in preterm labour with intact membranes 
(Gervasi, et al., 2001). Similarly, PROM is associated with upregulation of CD11b, CD14, CD64 
and CD66b on granulocytes and CD11b on monocytes (Gervasi, et al., 2001). 
 
1.3.4.2 Role of cytokines 
 
Cytokines are small proteins in the extracellular environment that interact with specific receptors 
on target cells and facilitate communication between cell types (Peltier, 2003). Both pro as well 
as anti inflammatory cytokines play a central role in the aetiology of preterm parturition. 
Decidual cells produce the proinflammatory cytokines IL-1 and TNF-α in response to bacterial 
products such as LPS (Casey, et al., 1989; Romero, et al., 1989a). They increase in concentration 
and bioactivity in the amniotic fluid of women with preterm labour (Casey, et al., 1989; Romero, 
et al., 1989a). IL-1 is produced by activated monocytes and macrophages and stimulates 
myometrial contractions through the production of PGEβ and/or Fβα resulting in an increase in 
COX-2 synthesis and activity (Romero, et al., 1989c; Mitchell, et al., 1990).  
Other proinflammatory cytokines such as IL-6, IL-16, IL-18, colony stimulating factors, and 
chemokines such as IL-8 and monocyte chemotactic protein-1 are also implicated in the 
aetiology of preterm labour (Agrawal and Hirsch, 2011). Abrahams et al have shown that a 
INTRODUCTION 
 
72 
 
Gram-positive bacterial infection, through TLRs 1 and 2, promote trophoblast cell apoptosis 
(Abrahams, et al., 2008). Trophoblast cells secrete IL-6 and IL-8, which stimulate neutrophil and 
T cell chemotaxis and activation leading to apoptosis. The authors have postulated that may be 
one of the underlying mechanisms of preterm delivery. 
Anti-inflammatory cytokines contribute to the onset of preterm labour by their downregulation or 
cessation of activity. IL-10 is the key anti inflammatory cytokine for the maintenance of 
pregnancy, its downregulation is a central event prior to the onset of normal labour (Hanna, et 
al., 2000) and it is reduced in preterm labour (Blanco-Quiros, et al., 2000;  Hanna, et al., 2006). 
IL-10 inhibits the activation of T cells, monocytes and macrophages and has potent 
immunosuppressive activity by inhibiting both IL-12 and IFN-Ȗ synthesis thus maintaining the 
pregnancy (Moore, et al., 1993).  
 
1.3.5 Infections and Spontaneous Preterm Labour 
 
Microorganisms invade the uterine milieu through different routes such as retrograde from 
abdominal cavity and haematogeneously through placenta, but ascending infection through the 
vagina and cervix is the most common (Romero and Mazor, 1988). Ascending infection can 
reach the decidua and stimulate the production of proinflammatory cytokines and inflammatory 
cellular mediators. Transplacental infection and retrograde seeding through the fallopian tubes 
have been reported (Goldenberg, et al., 2000). Microorganisms cross the membranes into the 
amniotic cavity and they can also cause fetal infection resulting in a fetal inflammatory response 
syndrome (Gomez, et al., 1997a).  
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1.3.5.1 Infections and cytokines 
 
Studies have provided evidence suggesting that a chronic intra-amniotic inflammatory process is 
associated with spontaneous preterm labour and preterm delivery. The Preterm Prediction Study 
found that an elevation of cervicovaginal fluid IL-6 concentration above the 90th percentile was 
a risk factor for preterm delivery (Goepfert, et al., 2001).  
 
1.3.5.2 Infectious aetiology of Spontaneous Preterm Labour 
 
The relationship between genital tract infection and preterm delivery has been established on the 
basis of biochemical, microbiological and clinical evidence (Hay, et al., 1994; McGregor, et al., 
1994). It is the only pathological process for which a causal link with preterm birth has been 
established, especially in the preterm delivery at less than 30 weeks gestation (Gomez, et al., 
1997b).  
This evidence includes the following: (Romero, et al., 2007).  
(1) patients with preterm labour have been found to have higher levels of inflammatory cytokines 
and microbial colonisation than preterm patients not in labour and term patients in labour 
(Romero, et al., 1989b). 
(2) even subclinical intrauterine infections have been shown to be associated with preterm 
delivery (Gomez, et al., 1995). 
(3) intrauterine infection/inflammation in midtrimester has been shown to be a risk factor for 
subsequent preterm delivery (Gray, et al., 1992;  Wenstrom, et al., 1998; Yoon, et al., 2001). 
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(4) extrauterine maternal infections such as malaria, pyelonephritis, pneumonia and periodontal 
disease have been associated with premature parturition (Benedetti, et al., 1982; Fan, et al., 
1987; Xiong, et al., 2006). 
(5) animal studies have shown that intrauterine or systemic administration of microbes or 
microbial products to pregnant animals can result in preterm labour and delivery (Schlafer, et al., 
1994; Bennet, et al., 2000; Ilievski and Hirsch, 2010).  
Additionally women with PROM have a rate of positive amniotic fluid cultures of 32.4% 
(Goncalves, et al., 2002). This rate falls to 22% in women with preterm labour and intact 
membranes who deliver prematurely and is less than 1% in women not in labour at term 
(Goncalves, et al., 2002). Preterm labour with intact membranes is the final result of a 
multifactorial inflammatory pathway leading to initiation of parturition. Inflammatory processes 
triggered by infection along with a secondary component of protease activity leading to 
weakening of the membranes results in PPROM. Thus amniotic fluid cultures are higher in 
PPROM. A strong correlation between positive amniotic fluid cultures and histological 
chorioamnionitis has been shown (Romero, et al., 1992; Hillier, et al., 1993). The review by 
Romero et al found an association between preterm birth and the occurrence of acute 
chorioamnionitis (Romero, et al., 1993a). A positive correlation with the frequency of 
histological chorioamnionitis and lower gestational age at birth was also shown by Hillier et al 
(Hillier, et al., 1988).  
The most common micro organisms involved in intrauterine infections are Ureaplasma 
urealyticum, Fusobacterium species and Mycoplasma hominis (Goncalves, et al., 2002). Other 
microorganisms found in the amniotic cavity include Streptococcus agalactiae, Escherichia coli, 
Gardnerella vaginalis, Petostreptococcus species, Staphylococcus aureus, Streptococcus 
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viridans and Bacterioides spp. (Romero, et al., 1989b). Lactobacillus species, Enterococcus 
faecalis and Neisseria gonorrhea have been identified occasionally and Haemophilus influenzae, 
and Clostridium species are seen rarely (Hitti, et al., 1997; Alanen, 1998). Bacterial vaginosis 
during pregnancy is associated with a statistically significant increased risk for adverse outcomes 
(McGregor, 1994; Flynn, et al., 1999) as is genitourinary Chlamydia trachomatis infection 
(Andrews, et al., 2000) and Ureaplasma urealyticum (Abele-Horn, et al., 2000). Bacterial 
vaginosis is characterised by a change in the microbial ecosystem of the vagina and is a risk 
factor for spontaneous preterm delivery (Eschenbach, 1993; Gibbs, 1993; Hay, et al; 1994) and 
PROM (Gravett, et al., 1986; Lamont, 2003). 
Fetal infection takes place in approximately 10% of pregnancies with intra-amniotic infection, 
and is the most serious culmination of ascending infection. Although the fetus is capable of 
mounting an inflammatory response from the mid-trimester of pregnancy the mortality rate for 
congenital sepsis ranges from 25 to 90% (Gerdes, 1991; Thompson, et al., 1992). 
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1.4 MARKERS OF EXPOSURE TO INFECTION 
 
The cells of the immune system, including DCs, neutrophils and macrophages mediate and effect 
their immunological effects through cellular peptides and glycoprotein molecules. 
 
1.4.1 Cytokines and Chemokines 
 
Cytokines are soluble peptides or glycoproteins, which are produced by leukocytes, and whose 
primary function is intercellular communication. The primary role of cytokines is in cell-to-cell 
communications and they exert their effects by binding to specific receptors with high affinity. 
This receptor binding results in the expression of other cytokines and a network of activation is 
set into motion. Cytokines are categorised as: (1) interferons, (2) interleukins, (3) TNF and 
related molecules, (4) transforming growth factors, (5) haematopoietic growth factors, and (6) 
chemokines. Cytokines are also classified by their cellular origin into Th1 and Th2 cytokines. 
Th1 cytokines (i.e., IFN, IL-2, and TNF) mainly promote cell-mediated immunity for protection 
against intracellular bacteria and viruses and Th2 cytokines (i.e., IL-4, IL-6, IL-10, and IL-13) 
mainly promote humoral immunity for protection against extracellular pathogens (Gotsch, et al., 
2007). Cytokines can have proinflammatory (IFN-Ȗ, IL-1, IL-12, and TNF-α) as well as anti 
inflammatory (IL-4, IL-10, IL-11, IL-13) actions.  
Chemokines are substances that attract cells to migrate in a particular direction. DCs can recruit 
pathogen specific T cell subsets through their specific production of chemokines. DCs produce 
several chemokines specifically involved in DC maturation and migration to lymphnodes for T 
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cell stimulation (Sallusto, et al., 1999; Villadangos and Schnorrer, 2007). These include 
CCL17/TARC and CCR7.  CCR7 is key to DC migration to the lymphoid tissues.  
 
1.4.1.1   Interleukin-12 
 
IL-12 is a proinflammatory cytokine that induces the differentiation of Th1 cells and forms a link 
between innate and adaptive immunity (Kobayashi, et al., 1989; Hsieh, et al., 1993). IL-12 acts 
on pre-activated T cells and NK cells through IFN-Ȗ leading to their proliferation (Perussia, et 
al., 1992). It acts to enhance the generation of CTLs, augments the cytotoxic activity of CTLs 
and NK cells (Trinchieri, 1998) and induces T cells and NK cells to produce cytokines: GM-
CSF, TNF and IFN-Ȗ (Chan, et al., 1991; Kubin, et al., 1994). It acts on B cells and increases the 
activation and production of Th1-associated classes of Ig. DCs produce IL-12, independent of 
IFN-Ȗ and of signals from T cells, during interactions with T cells (Gazzinelli, et al., 1994; 
Macatonia, et al., 1995; Scharton-Kersten, et al., 1996). The above ability of IL-12 to promote an 
early nonspecific response via the innate system through NK activation and IFNȖ production and 
a late specific response adaptive immune reaction via Th1 differentiation allows it to link innate 
and adaptive immune mechanisms. 
It is a heterodimer and induces the production of mainly IFN-Ȗ. IL-12 is produced mainly from 
activated DCs and phagocytes (monocytes/macrophages and neutrophils). Production is triggered 
by activation through the Toll pathway as a response to pathogens; in response to signals from 
activated T cells and NK cells and also in response to inflammatory extracellular components.   
The production of IL-12 is regulated by positive and negative regulatory mechanisms. IFN-Ȗ, IL-
4 and IL-13 are potent stimulators of IL-1β production (D’Andrea, et al., 1995). Negative 
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regulation is mainly by the anti inflammatory cytokine IL-10 and acts by blocking transcription 
of both of its encoding genes (Aste-Amezaga, et al., 1998). IL-12 has been shown to increase not 
only in preterm labour and infections, but also in exposure of the fetoplacental unit to stressor 
stimuli such as in severe pre eclampsia (Dudley, et al., 1996). The ability of IL-12 to stimulate 
innate resistance as well as its action as a potent inducer of Th1 responses through its 
proinflammatory functions portrays IL-12 as a crucial link between the innate and adaptive arms 
of the immune system (Hsieh, et al., 1993; Manetti, et al., 1993). 
 
1.4.2 Costimulatory markers 
 
The term ‘‘costimulation’’ is used to describe the additional signals required to initiate T 
lymphocyte activation apart from an adhesion interaction (Schwartz, 1990). Activation of the 
Toll pathway induces upregulation of the surface costimulatory molecules which lead to 
induction of adaptive immune responses. The upregulated costimulatory molecules are presented 
by MHC class II proteins in DCs and initiation of the adaptive immune system takes place with 
activation of naïve CD4+T cells.  Mature DCs exhibit class I and class II MHC and costimulatory 
molecules such as CD40, CD80 and CD86 (Almeida, et al., 1999;  Almeida, et al., 2001). 
Immature DCs exhibit decreased expression of the costimulatory molecules (Banchereau, et al., 
2000). 
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1.4.2.1 CD40 
 
The CD40 molecule was first identified in human tonsil DC (Hart and McKenzie, 1988). It is a 
member of the TNF receptor family and its ligand CD40L is expressed on activated  
T lymphocytes (Fanslow, et al., 1994). CD40/CD40L is a major signalling pathway for DC 
maturation and enhanced stimulatory ability. DCs are activated by the ligation of CD40 by 
CD40L expressed on the surface of T lymphocytes (Schoenberger, et al., 1998). Ligation triggers 
production of high levels of IL-12 and activates DCs thus leading to T cell stimulation (Cella, et 
al., 1996). Ligation can also occur directly. The recognition of antigen loaded MHC class II 
molecules on the surface of DCs by the TCR on CD4+ T cells results in the upregulation of 
CD40L on the T cell surface and subsequent ligation to the DC CD40. This binding of 
CD40/CD40L upregulates costimulatory molecules and enables the DC to efficiently activate T 
lymphocytes (Ridge, et al., 1998).   
 
1.4.2.2 CD86 
 
CD86 is a member of the Ig superfamily. The costimulatory molecules CD80 and CD86 deliver 
signals which modulate DC function (Zheng, et al., 2004). The MHC-peptide complexes formed 
in the DC is transported to the cell surface in vesicles together with CD86. At the DC surface the 
complexes along with the CD86 molecule are deposited as stable clusters (Inaba, et al., 2000). 
They bind on to the CD28 molecules on T cells delivering a costimulatory signal without which 
antigen triggering of T lymphocytes could lead to anergy (Schwartz, 1990). CD86 molecules are 
not found on resting blood DC and are upregulated on DC activation (McLellan, et al., 1995) and 
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trigger a Th2 response preferentially. CD86 induction results in the subsequent secretion of IFN-
Ȗ (Logue and Sha, 2004).  
 
1.4.3 CD11b on neutrophils 
 
Neutrophils arrive at sites of inflammation before any other immunologically active cell and thus 
are key to the inflammatory process. Neutrophils are primed by proinflammatory cytokines and 
inflammatory mediators such as LPS (Hallett and Lloyds, 1995; Svanborg, et al., 1999). CD11b 
(Mac-1) is a ȕβ integrin; an adhesion glycoprotein involved in neutrophil adherence. It is a cell 
surface antigen, stored in intracellular granules and translocated to the neutrophil surface upon 
neutrophil activation and is expressed at a low level on the cell surface of nonactivated 
neutrophils (Weirich, et al., 1998). CD11b also activates other key adhesion and defence 
receptors (Springer, 1995; Plow and Zhang, 1997). CD11b adhesion results in attachment of the 
neutrophil to the endothelium, leading to transendothelial migration of the neutrophil to sites of 
inflammation/infection (Anderson, et al., 1984; Kishimoto, 1989; Jones, et al., 1990). Effective 
adhesion is complement receptor 3 (CR3/CD11b) dependent, upregulation of which is effected 
by the rapid degranulation of intracellular granules (Elghetany, 2002). The upregulation leads to 
phagocytosis and intracellular killing of opsonised infective agents (Lehrer, 2004). After 
neutrophil stimulation the number as well as the affinity of the CD11b receptors increases 
(Vedder and Harlan, 1988). Studies have shown that the average expression levels of CD11b on 
PB neutrophils can be over three and two-fold higher in bacterial infections compared with viral 
infections and controls (Nuutila, et al., 2006; Nuutila, et al., 2009). Thus, neutrophil surface 
density of the CD11b marker has been used to identify sepsis in term infants (Weirich, et al., 
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1998; Nupponen, et al., 2001; Cui, et al., 2003) and adults (Lin, et al., 1993; Kylanpaa-Back, et 
al., 2001). The overall reported incidence of neonatal sepsis is 1 to 10 per 1000 live births, the 
mortality rate is 4.2-26% and it is associated with 10% of cases of neonatal death (Stoll, et al., 
1998). But in infants with birth weight less than 1000g, the incidence is 16-21% and correlates 
inversely with birth weight (Stoll, et al., 2002b). Adib et al in their study to determine CD11b 
sensitivity and specificity for early detection of neonatal sepsis found that the sensitivity and 
specificity were 75% and 100% respectively. The positive and negative predictive values were 
100% and 86% respectively (Adib, et al., 2007). Thus measurement of neutrophil surface 
markers can be useful for diagnosis of neonatal sepsis in the early phases. FIRS is also associated 
with a higher expression of markers of monocyte and neutrophil activation (Berry, et al., 1995).  
Currently there is no reliable and accurate test to detect early onset of sepsis in the neonate. The 
clinical picture can be variable and contributes to the difficulty in early detection. Low serum 
levels of CRP do not exclude the possibility of onset of sepsis as de novo protein synthesis is 
necessary to elevate CRP levels (Benitz, et al., 1998; Ronnestad, et al., 1999). On the contrary, 
CD11b upregulation does not need de novo protein synthesis and occurs promptly with exposure 
to infectious stimuli (Calafat, et al., 1993). Additionally CD11b levels can be obtained with a 
very small volume of blood, 25 microlitre (µl), which makes it ideal for testing in premature 
infants. There are no associations between birth weight nor gestational age and the levels of 
CD11b thus increasing the accuracy of the test (Nupponen, et al., 2001). Increased usage in 
clinical setting is facilitated by the rapid availability of the results within 30-60 minutes after 
sampling, unlike cultures which usually take 3-5 days.  
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1.5 NEED FOR RELIABLE TEST TO IDENTIFY AT RISK NEONATES 
  
Microbial infections are responsible for more than 2 million annual deaths between the ages of 
1–6 months (Siegrist, 2007). Despite the development of advanced pharmacotherapeutics and 
life support treatment, infection in the neonate accounts for approximately 10% of cases of 
neonatal death (Stoll, et al., 1998). Pathologic examination has been the gold standard for the 
diagnosis of inflammation. However, chemotactic signals must be present for the white blood 
cells to migrate to the site of injury or infection.  
The innate immune system is activated within 12 hours of initial microbial exposure. Phagocytic 
cells such as neutrophils and macrophages and NK cells are activated. During this phase no 
symptomatology is present. This initiation of the inflammatory cascade results in the activation 
adaptive immune system with lymphocyte activation and antibody secretion, 12 hours to 5 days 
after exposure to microbial antigens (Abbas and Lichtman, 2003).  This results in 
microbiological evidence by culture which is seen as the ‘gold standard’ for diagnosis of sepsis. 
Thus there is a window of time in which infection/inflammation is present before 
histologic/microbiological evidence is observed and this results in false negative results.  
The following clinical criteria were used in the diagnosis of intra amniotic infection associated 
with microbial invasion of the amniotic cavity by Gibbs et al. Premature rupture of membranes, 
fever (~37.8 C), maternal tachycardia (pulse rate, >100/min), leukocytosis (~15,000 cells/rnm), 
fetal tachycardia (pulse rate, ~160/min), uterine tenderness, fetal distress and foul smelling 
amniotic fluid (Gibbs, et al., 1982).  Most cases of intra amniotic infections are subclinical in 
nature.  Romero et al found that clinical signs were present in only 12.5% of the patients with 
positive amniotic fluid cultures. (Romero, et al., 1989b). Additionally the majority of women 
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delivering before 30 weeks have clinically silent chorioamnionitis (Goldenberg, et al., 2000). 
Chorioamnionitis has been proven to be frequent, but only 2% of extremely preterm infants have 
positive blood cultures at birth (Stoll, et al., 2002a). Tests with such low sensitivity result in late 
diagnosis of neonates with infection and delay in instituting appropriate timely treatment which 
can result in fatalities. Treatment of asymptomatic women has been shown not to be of value. 
Guise et al has shown that routine screening and treatment of asymptomatic mothers for 
microbes associated with an increased frequency of preterm birth did not reduce adverse 
pregnancy outcome and preterm delivery (Guise, et al., 2001).  
To compound the above difficulties, current tests to detect neonatal infection are not accurate; 
reference ranges for neonatal neutrophil counts has been shown to have a sensitivity of only 77% 
and has a poor predictive value of the total cell count and differential (Manroe, et al., 1979). The 
frequently used CRP levels have a sensitivity and specificity of 80% and 92% respectively 
(Berger, et al., 1995). The gold standard for diagnosis of bacterial sepsis is blood cultures, but it 
has certain drawbacks in the neonate; false negatives are common in newborns, serial blood 
samples may be contraindicated especially in a preterm newborn and cultures may be negative as 
only very small quantities of blood can be used (Isaacman, et al., 1996).  
The early clinical signs of neonatal sepsis are variable and non specific and hence the diagnosis 
is difficult as routine laboratory markers, such as CRP is of limited value. Early diagnosis is 
imperative as prompt treatment with antibiotics improves outcomes. In early onset GBS the 
infection is acquired by the fetus in utero and hence neonatally symptoms of infection manifest 
within 3 days of birth and usually within the first 12 hours. Studies have shown with clarity that 
immediate introduction of antimicrobials is essential as most deaths associated with late-onset 
(occurring after 3 days of age) infections in low birth weight infants occur during the first few 
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days after sampling for blood culture (Stoll, et al., 2002b). On the contrary, indiscriminate use of 
antibiotics with no objective test to prove or disprove the presence of infection in the neonate is 
suboptimal. Screening for maternal infection has its down falls as exemplified by the maternal 
Group B streptococcus screening programmes in the UK and USA. Lin et al found 
approximately 10% of antenatally Group B Streptococcus negative women showed intrapartum 
carriage and missed antibiotic prophylaxis, whereas approximately 50% of antenatally Group B 
Streptococcus positive women were negative intrapartum and received intrapartum antibiotics 
(Lin, et al., 2011). A retrospective review by Puopolo et al found that the majority of cases of 
early onset Group B Steptococcal disease occurred in neonates whose mothers were screen 
negative (Puopolo, et al., 2005).  
Early detection of infection to facilitate start of antimicrobials is hampered by the lack of a 
reliable diagnostic test. Furthermore lack of a reliable diagnostic test makes the decision about 
antimicrobial therapy inaccurate (Krediet, et al., 1992; Benitz, et al., 1998; Ronnestad, et al., 
1999).  It is therefore accepted common practice that antimicrobial therapy is started on the basis 
of clinical signs. However, this indiscriminate use results in exposure of premature and low birth 
weight infants to side effects of the drugs and also results in multi drug resistant strains, 
increases risk of invasive fungal infections as well as increased hospital costs (Murray, 1994).  
Antibiotics have often been shown to be ineffective in treating preterm labour (Van Den Broek, 
et al., 2009). Additionally evidence has accumulated on the adverse fetal effects of antibiotics to 
treat preterm labour with or without rupture membranes (Shennan and Chandiramani, 2008). The 
ORACLE I randomised controlled trial found that co-amoxiclav usage in PPROM is associated 
with neonatal necrotising enterocolitis. (Kenyon, et al., 2001). Follow-up of participants in the 
found ORACLE trial an increased risk of CP at 7 years in the children of women with intact 
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membranes who received antibiotics for spontaneous preterm labour [odds ratio 1.93 (95% 
confidence interval 1.21 to 3.09) for erythromycin and 1.69 (1.07 to 2.67) for co-amoxiclav] 
(Kenyon, et al., 2008). Increased bacterial lysis effected by the antibiotic could amplify the 
inflammatory response mounted by the innate immune system, thereby increasing the fetal 
exposure to inflammatory mediators with subsequent multisystem organ damage (Holzheimer, 
2001). 
Furthermore very little is known about the response of CBDCs to maternal/intrauterine 
infections and the factors modulating the responses. Research investigating the fetal responses to 
infectious stimuli prior to birth as evidenced in the CB changes is essential to our understanding 
of the molecular basis of the clinical effects which in turn is essential for instigating efficient 
curative and preventative strategies. 
Thus, it is recognised that novel and reliable infection markers are needed to improve the prompt 
diagnosis of sepsis in premature infants. Tests based on immunological changes in response to 
infection have recently been proven to be advantageous over traditional tests. Premature infants 
are significantly more susceptible to infections. As discussed above the overall reported 
incidence of neonatal sepsis leading to neonatal death is 10% (Stoll, et al., 1998), but in infants 
with birth weight less than 1000g, the incidence is 16-21% and correlates inversely with birth 
weight (Stoll, et al., 2002b). Hence immunological tests have an advantage as they can 
discriminate between changes due to prematurity and infection and can identify the premature 
infant at risk. Testing with IL-8 levels was found to reduce unnecessary antibiotic therapy for 
newborn bacterial infants in a cost-effective manner by 73% (Franz, et al., 1999). Additionally 
no phenotypic changes consistent with inflammation have been detected in maternal immune 
cells during FIRS, while inflammatory changes have been detected consistently in fetal 
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granulocytes and monocytes (Kim, et al., 2009). Naccasha et al has shown that pregnant women 
with acute infection upregulate granulocytic and monocytic markers (Naccasha, et al., 2001). 
Thus FIRS does not seem to trigger a proinflammatory maternal immune response similar to the 
immune response triggered by a maternal infection. Hence analysis of CB would give an 
accurate depiction of the fetal immune status as opposed to analysing maternal blood.  
Cell surface markers, chemokines and cytokines and adhesion molecules have an advantage over 
traditional blood counts and cultures as their levels change early in the infective process, and 
thus they are promising diagnostic markers. Until recently their usefulness was limited to their 
assessment by ELISA performed in batches leading to delays in obtaining results. Advances in 
flow cytometric technology have resulted in quick and reliable detection of cell surface antigens 
on cells. Tests can be done on an ad-hoc basis and within a turnaround time of 4 hours, thus 
preventing compromise in the clinical care of the neonate (Ng and Lam, 2006). An additional 
major advantage is the requirement of only a minimal volume of blood sample (0.05ml of whole 
blood) enabling CB samples to be analysed, which provides information on the in utero infective 
status of the fetus and is the earliest test available other than analyses of cordocentesis samples. 
Thus developing future tests to analyse the cellular changes in CB in response to infection seem 
to be the logical solution to the above problems. 
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1.6 HYPOTHESIS AND AIMS 
 
Hypothesis:  
 
Fetal cord blood contains phenotypically and functionally distinct populations of dendritic cells, 
which mature with increasing gestational age and on exposure to intrauterine stressor stimuli. 
 
Specific aims: 
 
 To identify and characterise the phenotype and functions of the dendritic cell populations 
in cord blood. 
 To evaluate the measurement of neutrophil activation markers in conjunction with 
clinical parameters for the identification of cord bloods exposed to stressors and thus 
validate the clinical classification of cord bloods exposed to stressors.  
 To characterise the change in numbers of cord blood dendritic cell populations occurring 
with advancing gestational age and on exposure to intrauterine stressor stimuli.  
 To analyse the expressions of the costimulatory markers CD40 and CD86 and production 
of Interleukin-12 on cord blood dendritic cell populations occurring with advancing 
gestational age and on exposure to intrauterine stressor stimuli. 
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1.7    EXPANDED HYPOTHESIS 
 
 It was postulated that CB contained different populations of DC, the identification and 
phenotyping of which would serve to further our understanding of fetal immunology. 
The identification and phenotyping investigations were carried out on whole blood using 
monoclonal antibody labelling and multi colour flow cytometry. The functional studies 
included assessment of endocytic uptake of FITC labelled Dextran particles and 
assessment of lymphocytic stimulation by MLR.  The results are presented in chapter 3.  
   
 It was postulated that CBDC subpopulations changed with advancing age and exposure to 
stressors. Analysis was performed to assess the change in the expression of the 
maturation markers, CD45 and HLA-DR and the change in numbers of CBDC in the 
subpopulations with advancing age and exposure to intrauterine stressors. Analysis was 
done on whole blood using labelling with monoclonal antibodies and flow cytometry 
acquisition. The results are presented in chapter 5.    
 
 It was postulated that the CBDC subsets changed their regulation of the costimulatory 
markers, CD40 and CD86 with advancing age as well as on exposure to stressors. It was 
also postulated that the production of the intracellular cytokine, IL-12 changed with 
advancing age as well as exposure to stressors. Analyses of whole blood with monoclonal 
antibody labelling and flow cytometer acquisition were performed on all the CB samples. 
The results are presented in chapter 6. 
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
Materials are listed under the headings of Buffers and Media, Reagents, Cytokines, Plastics and 
Antibodies. Where materials have been prepared in the laboratory, details of protocol and 
individual constituents are described. 

	 


	

Complete medium used for dilution of blood consist of RPMI #1640 medium (Dutch 
Modification) (Sigma Chem Co, Poole, England) with added antibiotics (penicillin and 
streptomycin) (Sigma Aldrich Co, Poole, England) and L#glutamine (Sigma Aldrich Co, Poole, 
England). Antibiotics (0.25ml) and 0.25ml of L#glutamine were added to 23ml of the RPMI 
medium to make up a solution with 1001/ml penicillin, 1001/ml streptomycin and 20mM L#
glutamine.  
For cell culture: 10% w/v (10 ml) heat inactivated Fetal calf serum (FCS) (Tissue culture system, 
Berks, England) was added when the medium was used for cell culture. 
For FACS (Fluorescence Activated Cell Sorting) cell sorting: 5ml of 10% w/v FCS was added 
when the medium was used for cell sorting in FACS. 
 
	

A balanced salt solution used in cell culture,  it serves as an irrigating and diluting fluid while 
maintaining intra and extracellular osmotic balance of cells 
 
 and also  provides a 
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buffering system to maintain the medium within the physiological pH range (7.4#7.5) (Sigma 
Aldrich Co, Poole, England). 



 !
"#
Ficoll#Paque PLUS is a sterile density gradient centrifugation medium for separation of PBMCs 
(peripheral blood mononuclear cell) from peripheral whole blood (Pharmacia Biotech AB, 
Uppsala, Sweden). The density of Ficoll#paque solution is 1.076#1.078, it is stored at 4 0C and 
warmed to room temperature prior to use. 
 
$%%&
Cells prepared for flow cytometry were washed and re#suspended in FACS buffer. 
PBS containing  : 2% FCS  
                           : 0.02% Sodium Azide (NaN3) (BDH, Poole, England) 
                           : 1mM EDTA (Sigma Aldrich Co, Dorset, England) 
10ml FCS, 0.1gram (gm) NaN3 and 0.18gm EDTA were added to 500ml volume of PBS to make 
up the FACS buffer. 
 

	

PBS containing 5% FCS and 1mM EDTA.  

!
'
	
DCs were enriched from cord and peripheral whole blood over a 14.5% w/v metrizamide 
gradient (Sigma, Dorset, England). Metrizamide (7.25gm) is weighed out in a 50ml falcon tube 
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(Becton Dickinson, UK) and 40ml of HEPES#buffered RPMI#1640 at room temperature was 
added in 15ml stages, till all metrizamide is dissolved. Once dissolved, the volume was made up 
to 45ml with the RPMI medium at room temperature, divided into 2ml aliquots and stored at #20 
0C. FCS (5ml) was added to the above solution when used for culture and the suspension was 
filter sterilised with a 0.2 (micrometer) 1m filter (Nalgene, Rochester, NY, USA). 

!

!&
PBS containing 4% Bovine Serum Albumin (BSA) (Equitech Bio, USA) and 2mM EDTA was 
used as a buffer for heterogeneous cell suspensions during positive selection of human cells.  
For 50ml of MiniMACS buffer, 0.25gm BSA and 0.04gm of EDTA were added to PBS and the 
volume made up to 50ml.  The suspension was filter sterilised with a 0.21m Nalgene filter, 
stored at 20 C – 80 C, and reused after filtering for up to one month. 
 
"&	
Reagent A: Fixation medium (contains Formaldehyde 10%) 
Reagent B: Permeabilisation medium (contains Saponin) 
Leucoperm reagents were used for fixing cells in suspension with Reagent A and then 
permeabilising the cells with Reagent B during intracellular cytokine staining (Serotec, UK). 
This procedure gives antibodies access to intracellular structures leaving the morphological 
scatter characteristics of the cell surface intact.  
 
(!)*+,-	
!	



Tissue culture medium containing sodium salt buffers (Sigma Chem Co).  
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
Anti microbial supplements of Penicillin and Streptomycin (Sigma Aldrich Co) was used to 
ensure sterility in cell culture media. Sterile filtered and stored in aliquots at #200 C.  


&
&
BSA is also known as "Fraction V" and is a serum albumin protein used as a nutrient in cell 
culture (Equitech Bio). 


() .
 !
	
CaliBRITE beads simulate unstained cells and cells that have been labelled with fluorochrome 
conjugated antibodies and they are used to adjust the instrument settings before cell samples are 
run on the flow cytometer (BD Biosciences, Becton Dickinson, USA). 
 
. &
Ethylenediaminetetraacetic acid chelates metal ions to prevent clustering and was used as a 
component in FACS buffer and stored at room temperature (Sigma Aldrich Co). 
 

Fetal calf serum was used as a supplement for cell culture media as a source of nutrition. It 
blocks non specific binding during antibody labelling. Storage was done in aliquots at #800 C 
(Tissue culture system). 
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Fluorescein#isothiocyanato#dextran is the polysaccharide, dextran labelled with fluorescent dye 
and used to assay the endocytic activity of DC (Sigma, Poole, England). It was used in 
concentrations of 1mg/ml. 
 
$
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Flow#CountTM Fluorospheres are a suspension of fluorescent beads used to determine absolute 
counts on the flow cytometer (Beckman Coulter, USA). Each bead contains a dye which has a 
fluorescent emission range of 525nm to 700nm.  
 
"0

Essential amino acid used as a nutritional supplement in cell culture media (Sigma Aldrich Co). 
Storage was done in aliquots at #200 C. 
 
!

Monensin is a protein transport inhibitor used to enhance intracellular cytokine staining signals 
by blocking transport processes during cell activation leading to the accumulation of most 
cytokines at the Golgi Complex/Endoplasmic Reticulum (Sigma, MO, USA). The stock 
concentration of monensin has a concentration of 41.57Gg/5ml and is stored at 4° C. To 1ml of 
complete medium 7.51l of the above monensin stock solution is added. 100Gl of the above 
dilution is added to 900Gl of medium for a working concentration of 1 in 10 dilution of which 50 
Gl is added to each tube for intracellular cytokine staining.  
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OptiLyse C is an erythrolytic reagent used for lysing human RBCs following direct 
immunofluorescence staining of whole blood for flow cytometry (Immunotech, Marseille). 
 
	%	*2
Paraformaldehyde (1%) is afixative for surface immunophenotyping. Paraformaldehyde (1 gm) 
(BDH chemicals, Poole, England) was added to 100ml of PBS and heated at 700 C in a fume 
hood, till the solution was clear. A pH of 7.4 was achieved with 0.1M Sodium hydroxide 
(NaOH) or 0.1M Hydrogen chloride (HCL) as required. Storage was at 40 C in a foil wrapped 
bottle for no more than one month.  
 
	
&'
	
Sodium azide is a conservant for preservimg antibodies and prevents microbial contamination. It 
is added to an antibody preparation to a final concentration of 0.02% w/v (BDH). 

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
[H3]#Thymidine (concentration of 11g/ml) (specific activity 2 Ci/mmol, Amersham 
International, Buckinghamshire, UK) is a precursor of DNA and is incorporated into new DNA 
in proliferating cells. Metabolic incorporation of tritrated thymidine into cellular DNA is used to 
monitor rates of DNA synthesis and cell proliferation and used in MLR to assess stimulatory 
capacity of DC.  
 

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5% trichloroacetic acid was used in MLR (Fisons scientific equipment, Loughborough, UK). The 
mat filters were washed with 5% trichloroacetic acid to precipitate the cellular DNA prior to 
imaging.  
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%#
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PE conjugated Mouse Anti#Human IL#12 p70 heterodimer (BD Pharmingen, San Diego, USA) 
(Clone: C11.5, Isotype: Mouse IgG1).  
Biologically active IL#12 is secreted by activated B lymphocytes and macrophages as a 70 kD 
heterodimeric glycoprotein comprised of disulfide#bonded 35 kD (p35) and 40 kD (p40) 
subunits. It was used to assay intracellular DC levels of IL#12. Storage was done undiluted at 4° 
C and protected from prolonged exposure to light. 
 
	& '!

The following commercially available plastics were used during experiments: 
9

 !


04
 – Becton Dickinson, UK. 
& – 5 ml polystyrene round bottom test tubes # Becton Dickinson, UK. 

 – 100 x 16 mm conical based screw top tubes – Sterilin. 
 

 – 50 ml Falcon screw top tube # Becton Dickinson, UK. 
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 – Nalgene, 0.21m, 25 mm surfactant free, cellulose acetate membrane – (Cat no#
190#2520. Rochester, NY, USA). 
 87: – Canted neck tissue culture flasks # Becton Dickinson, UK. 
 :
  – Tissue culture plates with 60 wells for hanging drop cultures – Nunc, Life 
technologies, Scotland. 
!
 – for harvesting Thymidine pulsed cells # Skafron instruments, Suffolk, UK. 
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%#
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The antibody clones used, their fluorochrome conjugates, isotypes and suppliers for surface 
marker staining are listed in Table 2.I.  
The fluorochrome conjugates used were: FITC, PE (Phycoerythrin), PE#indotricarbocyanine 
(PE#Cy5), Allophycocyanin (APC) and phycoerythrin#cyanine5 conjugate (Cy#Chrome or PC5). 




















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BDCA2 AC 144 FITC Mouse IgG1 Miltenyi Biotec
CD11b ICRF44 (44) PE Mouse IgG1 Becton Dickinson 
CD11c KB90 FITC Mouse IgG1 Dako 
CD11c S#HCL PE Mouse IgG2b Becton Dickinson 
CD11c Bly6 Cychrome Mouse IgG1 Pharmingen 
CD123 7G3 PE Mouse IgG1 Becton Dickinson 
CD14 TUK4 Cy5 Mouse IgG1 Serotec 
CD14 RMO52 PC5 Mouse IgG2a Immunotech 
CD16 NKP15 FITC Mouse IgG1 Becton Dickinson 
CD16 3G8 Cychrome Mouse IgG1 Pharmingen 
CD16 3G8 PC5 Mouse IgG1 Immunotech 
CD19 SJ25#C1 Cy5 Mouse IgG1 Serotec 
CD19 J4.119 PC5 Mouse IgG1 Immunotech 
CD3 UCHT1 FITC Mouse IgG1 Pharmingen 
CD3 UCHT1 PE Mouse IgG1 Pharmingen 
CD3 UCHT1 Cychrome Mouse IgG1 Pharmingen 
CD3 UCHT1 PC5 Mouse IgG1 Immunotech 
CD3 SK7 APC Mouse IgG1 Pharmingen 
CD34 581 Cychrome Mouse IgG1 Pharmingen 
CD4 SK3 FITC Mouse IgG1 Becton Dickinson 
CD4 RPA#T4 PE Mouse IgG1 Becton Dickinson 
CD40 1590F FITC Mouse IgG1 Serotec 
CD45 2D1 FITC Mouse IgG1 Becton Dickinson 
CD45 H130 PE Mouse IgG1 Pharmingen 
CD45RA HI 100 FITC Mouse IgG1 Becton Dickinson 
CD45RO UCHL1 PE Mouse IgG2ak Pharmingen 
CD56 B159 Cychrome Mouse IgG1 Pharmingen 
CD56 N901 (NKH1) PC5 Mouse IgG1 Immunotech 
CD8 SK1 FITC Mouse IgG1 Becton Dickinson 
CD8 SK1 PE Mouse IgG1 Becton Dickinson 
CD8 HIT8A Cychrome Mouse IgG1 Pharmingen 
CD8 B9.11 PC5 Mouse IgG1 Immunotech 
CD8 SK1 APC Mouse IgG1 Becton Dickinson 
CD80 L307.4 FITC Mouse IgG1 Pharmingen 
CD83 HB15e FITC Mouse IgG1 Ancell 
CD86 1118F FITC Mouse IgG1 Serotec 
HLA#DR G46#6 APC Mouse IgG2a Pharmingen 
γ1 X40 FITC Mouse IgG1 Becton Dickinson 
γ1 X40 PE Mouse IgG1 Becton Dickinson 
γ1 MOPC#21 Cychrome Mouse IgG1 Pharmingen 
γ1 679.1Mc7 PC5 Mouse IgG1 Immunotech 
γ2a G155#178 PE Mouse IgG2a Pharmingen 
γ2a X39 Cychrome Mouse IgG2a Pharmingen 
γ2a U7.27 PC5 Mouse IgG2a Immunotech 
γ2a X39 APC Mouse IgG1 Becton Dickinson 
γ2b 27#35 PE Mouse IgG2b Pharmingen 
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CD (cluster of differentiation) antigens are used to designate the complex pattern of surface 
antigens found on immunologically active cells as they develop from precursor cells to 
functionally mature forms. The above antibodies bind to designated antigens facilitating 
identification of the antigen. 
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Ficoll#paque technique: A density#gradient centrifugation technique to separate lymphocytes 
from other cellular elements in the blood. 
PB was drawn into heparinised, green top vacuum tubes and diluted 1:2 with complete medium 
and layered over Ficoll#paque gradient in a 50ml Falcon tube. Five ml of Ficoll#paque/10ml of 
diluted blood was used. The above suspension was centrifuged for 30 minutes at 1700 rpm 
(650G) in a bench top centrifuge (Mistral 3000i). RBC and granulocytes pass through the Ficoll 
leaving the mononuclear cells as a band at the interface between the serum and the Ficoll (Figure 
2.1). RBC and polymorphs sediment at the bottom. PBMCs were removed from the interface 
with a pipette, washed three times with complete medium (1500 rpm for 5 minutes) and 
resuspended in 5ml of complete medium. Following the final wash the supernatant was discarded 
and the cell pellet was resuspended in 5ml of complete medium. The total number of 
mononuclear cells in suspension was calculated by Trypan blue viability count. 
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The PBMCs form a dark layer between the serum and the Ficoll layer facilitating 
harvesting of cells 
 
			 
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The PBMC cell suspension obtained by the above separation was made up to the required 
volume with complete medium (with added FCS) and added to T25 flasks (5ml in each flask) 
using sterile techniques. The flasks were left in the Carbon di oxide (CO2) incubator overnight 
with loosened caps. After 12 hours of incubation the base of the flasks were washed with 
complete medium and the cultured PBMCs were pipetted out. One aliquot of metrizamide each 
was poured into test tubes and 5 ml of cultured PBMC suspension was layered gently onto the 
metrizamide. The tubes were centrifuged for 10 minutes at 1700 rpm (650G) in a bench top 
centrifuge (Mistral 3000i). The DCs form a dark coloured layer at the interface between the 
culture medium and metrizamide and the lymphocytes sediment at the bottom of the tubes 
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(Figure 2.2). The DC layer was pipetted out, washed twice with complete medium and 
resuspended in 1 ml of complete medium. 
 
 
 
+		
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The DCs form the dark layer between the culture medium and the metrizamide thus 
providing an enriched layer for harvesting  
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Fetal venous CB and adult peripheral venous blood samples were obtained anti#coagulated in 
heparinised tubes. Both adult blood and CB samples were labelled in parallel to minimise inter 
experiment variations. Previous work had developed and validated a technique which permits the 
use of the small volume of whole blood available from preterm neonates (Mason, ., 2005). 
Analysis of whole blood eliminates the loss of cell populations associated with cell separation 
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procedures, and provides data which accurately reflect the 

 situation. Undiluted blood was 
used for staining of DC due to the inherent paucity of events.  
Whole blood (100l) was added to round bottomed tubes along with the appropriate volumes of 
flourochrome conjugated monoclonal antibodies as required (5#10Gl). The contents of the tubes 
were mixed gently and incubated in the dark at room temperature for 15 minutes. Red cells were 
lysed by adding 500l Optilyse C, and the cell suspension was incubated in the dark at room 
temperature for a further 20 minutes. Optilyse C (500Gl) was added to adult and term fetal CB, 
but 700Gl was added to preterm CB. The increased volumes were necessary as term CB RBCs 
are more resistant to lysis than adult RBCs, and preterm CB RBCs more resistant to lysis than 
term CB RBCs (Serrani, ., 1989; Bautista, ., 2003). 
Subsequent to the lysis, the tubes were topped up with FACS buffer solution and centrifuged at 
300g (1190 rpm) for 5 minutes. After centrifuging, the supernatant was poured off, the cells 
resuspended in FACS buffer, centrifuged for a further 5 minutes, drained and resuspended. 
Paraformaldehyde 1% was used to fix the cells, and 0.3ml was added to each tube. The tubes 
were covered with foil and stored in the refrigerator at 4 0C, until they were acquired on the flow 
cytometer. The tubes were covered in foil to slow down the photo#bleaching of the fluorophore 
colours or in other words to slow down the fading process of the fluorescent colours. 
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Antibody labelling for DC phenotyping and identification performed with parallel tubes of 
adult and fetal blood samples 
Dilutions  (see  !#	&  Determination of antibody dilutions)                                                 
HLA#DR =1:4 = 10l Ab to 30l medium and add 5l into each tube. 
Linear Cocktail (LIN#CK) = CD3 + CD14 + CD16 [1:25 DIL] + CD19 + CD34 + CD56 
[5l of each Ab or 30l of cocktail mixture into each tube] 
FITC = 10l into each tube. 
γ1 PC5 = 25l into each tube.    γ2a PC5 = 5l into each tube. 
All other Ab’s = 5l into each tube.  
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The paraformaldehyde fixed cell suspension was acquired in the flow cytometer (FACScalibur, 
Becton#Dickinson) using the four colour acquisition as given in the table above.  
Lineage cocktail conjugated with PC5 consisted of CD3 to label T cells, CD14 to label 
monocytes, CD19 to label B cells, CD16 to label granulocytes, CD56 to label NK cells and 
CD34 for the stem cells. Five Gl of each antibody was added to each tube. Isotype controls were 
used in parallel tubes to establish the limits of cell subset regions and CD8 labelled tubes with all 
the above fluorescent dyes were acquired in the respective channels for compensation. A single 
tube without any antibodies was also labelled to ensure changes seen were due to the phenotype 
and not due to any other intrinsic factor such as the low level of fluorescence inherent in all 
living cells known as autofluorescence. 
To assess whether the DC subpopulation of interest has a plasmacytoid or myeloid phenotype, 
blood was labelled with FITC conjugated CD45RA, BDCA2, CD33 and CD13 and acquired in 
FL#1 channel and PE conjugated CD123 was acquired in the FL#2 channel.  
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Labelling with antibodies for analyses of CD40 and CD86 markers. Antibody dilutions 
wereas described above                                                   
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The paraformaldehyde fixed cell suspension was acquired in the flow cytometer in the four 
colour channels as given in the table above.  
To free a fluorescence channel on the four colour flow cytometer in order to enable a detailed 
analysis of the CD11c# subset, the anti CD11c antibody was included in the lineage cocktail.   
Labelling was performed with CD40 and CD86 in parallel tubes. Isotype controls and the 
unlabelled tube were used as described above. 
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Labelling with antibodies for analyses of intracellular cytokine, IL#12. Antibody dilutions 
wereas described above                                                   
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Whole blood (50Gl) was added to round bottomed tubes, in two parallel sets of adult PB and fetal 
CB. RPMI medium (50Gl) was added to all tubes except the isotype and compensation labelling 
tubes to which 100Gl of the medium was added. 25Gl of the 1 in 10 dilution of monensin was 
added to alternating tubes, while the rest of the tubes, including the isotypes and compensation 
controls were incubated without monensin. All the tubes were incubated for 4 hours at 37 oC and 
5% CO2. After the 4 hour incubation period surface labelling was done by adding the required 
antibodies and labelling was done in two sets of parallel tubes as described above. After 
incubation with the antibodies for 15 minutes in the CO2 incubator, Optilyse C (5001l) was 
added to lyse the RBCs. The tubes were mixed with the vortex and incubated for 20 minutes in 
the dark. Subsequently they were washed with FACS buffer and 1001l of Leukoperm A was 
added to each tube to fix the cells. After 15 minutes incubation with Leukoperm A, the cells 
were washed again, resuspended and 1001l of Leukoperm B was added to each tube. Leukoperm 
B permeabilises the cell membrane, so as to allow the antibodies to penetrate and stain the 
intracellular cytokines. Along with Leukoperm B, 51l of IL#12 was added to the required tubes 
and incubated again for another 30 minutes. After centrifuging, the supernatant was poured off 
and the cells resuspended in FACS buffer, centrifuged for a further 5 minutes, drained and 
resuspended. Paraformaldehyde 1% was used to fix the cells, and 0.3ml was added to each tube. 
The tubes were covered with foil and stored in the refrigerator, until they were acquired on the 
flow cytometer in the four channels as described in the table above. 
Isotype controls and the unlabelled tube were used as described above.  
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Labelling with antibodies for analysis of the neutrophilic marker, CD11b and CD16. 
Antibody dilutions wereas described above                                                   

The paraformaldehyde fixed cell suspension was acquired in the flow cytometer in the four 
colour channels as given in the table above. Isotype controls and the unlabelled tube were used 
as described above. 
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The density gradient separated DCs from CB were used in functional assays. The functional 
capacity was assayed by labelling with FITC#dextran (see section 		for protocol) and also 
by culturing as stimulators in MLR after sorting on the flow cytometer (see section 			for 
protocol). 
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
The Becton#Dickinson FACSCalibur is a benchtop flow cytometer that can simultaneously 
analyse four fluorescent parameters using a dual argon and diode laser system (488nm argon 
laser and a 635nm diode laser). The detailed phenotypic properties of each cell can be 
established by using monoclonal antibodies to specific cell surface and intracellular antigens 
6%' 	7. The antibodies were conjugated to a fluorescent dye that emits light of a known 
wavelength when excited by laser energy. The four fluorochromes used were FITC, PE, Cy#
Chrome or PC5 and APC. The peak emission of FITC is approximately 515nm, it absorbs at 
488nm (argon laser) and is detected in the FL#1 channel. The peak emission of PE is 
approximately 580nm, it absorbs at 488nm (argon laser) and is detected in the FL#2 channel. 
PC5 is an energy transfer dye which consists of the indotricarbocyanine dye, Cy5 coupled to PE. 
Its peak emission is approximately 630nm, it absorbs at 488nm (argon laser) and is detected in 
the FL#3 channel. APC emits at about 680nm, and can be excited by either a dye laser (595#
605nm), or the Helium Neon laser at 633nm and is detected by the FL#4 channel. The emission 
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intensity detected in each channel is proportional to the amount of antibody labelling on that cell 
thus quantifying the levels of expression of the target antigen on that cell.  
 
 
 
 
+	!.-!#885#'#5!"#-!*(Rahman, M. (2006). An  
 
introduction to flow cytometry. Serotec Ltd. Oxford. UK.)  
The main components of the flow cytometer are shown: the laser system, the fluidics 
system and the filters with the detectors 
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The paraformaldehyde fixed cell suspension was acquired in the flow cytometer. The nozzle tip 
probe draws up the cell sample and the cells are passed singly through the path of the laser beam 
which takes measurements on cell size, granularity and complexity. This process is called 
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hydrodynamic focussing. For rare cell types, such as the DC a large number of events at a 
relatively low acquisition rate are used in order to improve accuracy. Prior to acquisition, the 
Flow CheckTM flourospheres were run through to ensure the laser was aligned and the fluidics 
system working correctly.  Data acquisition used the CellQuest software. 
 
		 '!'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
Prior to acquisition in the flow cytometer 201l of a prenumbered bead solution of a known 
concentration (Beckman Coulter flow countTM flourospheres) was added to each sample of cell 
suspension. Enumerating the bead events enabled accurate calculation of cell numbers in each 
cell subset, per 1l of blood.  

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
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The BD FACSCalibur cell sorting option allows identification and isolation of a population of 
interest. Initially a sort gate was created with plots drawn around the required regions. After the 
population of interest was gated, as the cells passes through the laser the cytometer electronics 
will establish if it is a cell of interest based on the sort gate characteristics. During acquisition 
once the cell is established as a target cell a unique catcher tube mechanism moves in and out of 
the sample core stream at a rate of roughly 300 times per second to capture target cells and direct 
them to a collection tube for further processing. The sort settings used in this study were low 
flow rate and 2000 events/sec. Exclusion mode was used as it yields high purity sample. After 
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the sorting, the collection tubes were centrifuged at 300g for 5 minutes to concentrate the cells 
and the cell pellet was resuspended in 0.5 ml of complete medium on ice.  
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In a four colour flow cytometer, the emission profiles of the different fluorochromes coincide 
and overlap. Thus measurements of the true fluorescence emitted by each fluorochrome can be 
inaccurate. Fluorescence compensation calculates how much interference a fluorochrome will 
have in a channel that was not assigned specifically to measure it. The interference is calculated 
in percentages and corrected. List mode data from all events were collected with online spectral 
compensation. Lymphocytes stained with CD8 antibody for each of the four fluorochromes 
(FITC, PE, PC5 and APC) were used as the spectral standards to compensate for each 
flourochrome and were included in all experiments and in all labelling protocols. Spectral 
compensation was achieved by data transfer off line and analysed using the Color Compensation 
Toolbox using the WinList flow cytometry analysis software (WinList Version 5.0, Verity, 
Topsham, ME).  
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Data from the flow cytometer was analysed using WinlistTM 5.0 software (Verity Software 
House, Topsham, ME, USA) and performed offline.  
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The viable cells are identified in the following regions: R2 region – Granulocytes; R3 
region – Monocytes; R4 region – Lymphocytes. Representative histogram of 40 
experiments shown 
 
Light that is scattered in the forward direction is collected by a lens known as the forward scatter 
channel (FSC) and consists of refracted laser light collected at low angles between 10 and 100. 
The intensity of the scattering denotes the particle’s size. Light that is scattered at a 90o angle to 
the excitation line is called side scatter is collected by a lens known as the side scatter channel 
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(SSC). Side scatter denotes the granular content and complexity within a particle. Both FSC and 
SSC are unique for every particle, and a combination of the two is used to differentiate different 
cell types e.g. lymphocytes have a low SSC (R4 region in Figure 2.4) and granulocytes have a 
high SSC (R2 region in Figure 2.4). These parameters are also used to distinguish between 
cellular debris and living cells as dead cells have lower FSC and higher SSC than living cells. 
 
 
 
 
+	( 
The two parameter histogram shows the DCs as the HLA#DR positive cell population in 
the right lower quadrant (R2, Region 2). Representative histogram of 40 experiments 
shown 
 
Initially the total viable cell region was delineated based on the FSC and SSC properties as 
described above. Identification of the DC region is done by drawing a region around the cell 
population positive for HLA#DR and negative/dim for LIN#CK and gated on the viable cell 
region (R2 in Figure 2.5). 
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DC subsets in adult blood were identified as CD11c+CD45+ (R3 region) and CD11c# 
CD45+ (R4 region). Representative histograms of 40 experiments shown 
 
Two populations of DCs can be seen in adult PB – the myeloid CD11c+CD45+ population (R3) 
and the plasmacytoid CD11c# CD45+ (R4) population. As discussed in chapter 1, pDCs in 
humans express the surface markers CD123, BDCA#2 and BDCA#4, but do not express high 
levels of CD11c, which distinguishes them from conventional (myeloid) dendritic cells. As our 
flow cytometer had only four channels it was not possible to identify the pDCs by positive 
selection using CD123. Presence of CD11c positively identified the cDCs and their absence was 
used to identify the pDCs, thus keeping the usage of channels to the minimum to allow further 
detailed analysis of the DC subsets. 
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The level of expression of a marker was determined by subtracting staining with an isotype#
matched control antibody from staining with the specific reagent (Winlist user guide, 2001). This 
was achieved using the super#enhanced Dmax normalized subtraction (SED) method of Winlist 
5.0. Also named as the KS statistic, it measures the maximum absolute difference or Dmax 
between two cumulative probability distributions. The data acquired by the flow cytometer is 
displayed in the form of a histogram. The frequency histogram is a graphical representation of 
the number of events occurring for each channel. The median values from both frequency 
histogram (test and control) distributions were linearised and the positive linearised median was 
divided by the control median. The intensity of the positive staining, termed the positive control 
intensity (PCI) ratio measures the ratio of linearised positive median to the linearised control 
median. Thus subtraction estimates the number of positive cells for the measured marker, in the 
test histogram.  
The Kolmogorov#Smirnov (K#S) algorithm is used to determine the confidence interval with 
which one can make the assertion that two flow cytometric univariate histograms are different. 
The significance of a SED result can be tested by calculating the critical D value (Dcrit) using the 
following equation: Dcrit = Dmax/√[(n1+n2)/(n1 x n2)] and validated using Kolmogov#Smirnov 
statistical tables. Dmax is the maximum value between the test and control samples after the two 
histograms have been converted into cumulative normalised histograms, n1 is the number of 
events in the test sample, and n2 is the number of events in the control sample. Only positive 
values which give a Dcrit with a  < 0.05 were accepted. Reversed histograms or  values >0.05 
were taken as having zero expression.  
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%'	3<#'-###8 -#8!%'
67  30
1.0727 0.200 
1.2238 0.100 
1.3581 0.050 
1.5174 0.020 
1.6276 0.010 
1.7317 0.005 
1.8585 0.002 
1.9526 0.001 

The table gives the p#values to calculate the critical Dmax (Dcrit) (Watson, 1992) 
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The percentage of DC expressing CD80 and CD86 was determined by subtracting staining with 
an isotype#matched control antibody from staining with the specific reagent. To free a 
fluorescence channel on the four colour flow cytometer in order to enable a detailed analysis of 
the CD11c# subset, the anti CD11c antibody was included in the lineage cocktail.  This removed 
the CD11c+ DCs from the DC gate staining, thus freeing up a channel. Freeing of one channel 
enabled the further delineation of CD11c# subsets with respect to their expression of CD40 and 
CD86 costimulatory markers (see section 		).  
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Neutrophils were identified on their light scattering properties and the positive expression of 
CD16 antigen gated on all the viable cells. The expression of CD11b on the CD16 positive 
neutrophils was calculated by subtracting the isotype histogram from the histogram delineating 
the CD11b expression. As CD16 is a PIG#A anchored glycoprotein any deficiency of cell surface 
proteins as seen in paroxysmal nocturnal hemoglobinuria could result in the absence of CD16. 
Of the 29 samples analysed in this study none were negative for CD16. 
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Histograms of FITC#dextran were plotted for all the DC subsets and the mean value was 
subtracted from the mean value of the negative control tubes. FITC#dextran uptake was 
measured at 40C and at 370C. The uptake at 40C was subtracted from that measured at 370C to 
obtain the net mean fluorescence intensity (MFI) which represented the active endocytosis. FITC 
Dextran shows an increase with uptake which is temperature dependant. Thus at 40 C binding 
takes place and uptake is mostly inhibited. With rising temperatures internalisation increases and 
is optimal at 370 C. Additionally, as more time elapses the amount of internalised particles 
increases and thus the MFI is higher at 30 minutes compared to 5 minutes. Thus we measured 
uptake at 4 and 370C and at 5 and 30 minutes time.  
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Labelling with antibodies (dilutions as before) for analysis of Dextran endocytosis 
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Adult and CB samples were labelled in parallel to minimise inter experiment variations. Whole 
blood (20ml) was Ficoll separated and the PBMCs resuspended with 1001l of complete medium 
in each tube. Half the tubes were incubated in a water bath at 37 0C and the other half at 4 0C on 
ice for 30 minutes to delineate the temperature dependant uptake. FITC#dextran solution (51l of 
a final concentration of 1mg/ml) was added at 5 and 30 minutes. A parallel set of tubes were 
labelled without FITC#dextran and used as controls. All the tubes were washed twice and 
resuspended with cold FACS buffer and kept on ice to halt the endocytosis process. All the other 
conjugated antibodies were added as above and the tubes were incubated in the dark on ice for 
15 minutes. The cell suspension was fixed with 3001l of 1% paraformaldehyde prior to 
acquisition on the flow cytometer. Isotype controls and the unlabelled tube were used as 
described above. 
 
		&	 #
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The stimulatory capacity of fetal DCs was assessed in an allogenic MLR using naïve T cells as 
responders. Heparinised tubes were used to collect the blood as the proliferative capacity of the 
lymphocytes is preserved in heparin (WeinbergA ;< 1998).  
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To obtain stimulator DCs, PBMCs in fetal venous CB were Ficoll separated and resuspended in 
5 ml of complete medium (see section 		 for protocol). The total number of PBMCs in 
suspension per ml was calculated by counting on the haemocytometer. The cell suspension was 
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diluted with 40 ml of complete medium and cultured overnight in T25 flasks. After the culture 
period, the low density cells (LDC) were separated out over a metrizamide gradient and 
resuspended in 1ml of complete medium (see section 			 for protocol). The total number of 
LDCs in suspension per ml was calculated by counting on the haemocytometer. One third of the 
cell suspension was removed to provide unlabelled DCs and serially diluted with complete 
medium to obtain four decreasing concentrations (3000 cells/101l, 1000 cells/101l, 300 
cells/101l and 100 cells/101l). The rest of the DC cell suspension was washed with MiniMacs 
buffer and labelled on ice to prevent DC activation.  
 
%'	3##!#'#'%''*###
% +	12 +1(2 ''
 HLA#DR LIN#CK All LDCs 
	   Fetal lymphocytes 
 CD8  Fetal lymphocytes 
&  CD8 Fetal lymphocytes 
 
Labelling with antibodies for identification of the DC populations. Antibody dilutions were
as described above                                                   
 
The cells were resuspended in 5001l of MiniMacs buffer. After labelling, a small volume (251l) 
was removed to plate as labelled DCs in wells of a Terasaki plate. The volume removed was 
added to 5001l of complete medium and serially diluted to obtain four decreasing concentrations 
(3000 cells/101l, 1000 cells/101l, 300 cells/101l and 100 cells/101l). The rest of the volume of 
labelled DC cell suspension was sorted for CBDCs through the flow cytometer. The sorted DCs 
were spun in cold centrifuge and resuspended in 5001l of complete medium and serially diluted 
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to obtain four decreasing concentrations (3000 cells/101l, 1000 cells/101l, 300 cells/101l and 
100 cells/101l). 

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Responder PBMCs were obtained from adult PB as described above. The total number of 
PBMCs in suspension per ml was calculated by counting on the haemocytometer. The cell 
suspension was serially diluted to obtain decreasing concentrations of 100,000, 50,000, 25,000 
and 12,500 PBMCs per 101l of cell suspension.  
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The responder cells were plated with the decreasing concentrations as above (101l aliquots in 
each well) of unlabelled DCs, labelled DCs and DCs sorted after labelling. Four Terasaki plates 
were plated; with concentrations of 100,000, 50,000, 25,000 and 12,500 PBMCs per 101l of cell 
suspension. Due to the small volumes involved additions to the plate were made using electronic 
dispensing pipette (Anachem) and drying out and pH changes were avoided. The plates were 
inverted over normotonic saline to form hanging droplet cultures. They were cultured for 4 days 
in a 37 0C humidifier incubator with 5% CO2, placed on a fenestrated stand without the lid to 
ensure adequate gas exchange.  



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After 4 days of culture, each well of the four Terasaki plates were pulsed with 1 1l of [H3]#
thymidine (concentration of 1 1g/ml) (specific activity 2 Ci/mmol, Amersham International, 
Buckinghamshire, UK) and incubated for two hours. During pulsing, care was taken not to 
disturb the cell pellet at the meniscus of the droplet and to keep the plates inverted. The plates 
were harvested onto mat filters using a vacuum pump and ensuring even suction across the 
harvesting head. The filters were washed with saline to clear the debris, with 5% trichloroacetic 
acid to precipitate the DNA and with methanol to dry the filter. Subsequently the filters were left 
to dry for two days and photoimaged on a benchtop liquid scintillation analyser for 4 hours 
(Packard, Berks, UK) and counted. 
 

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The above protocol shows the temporal sequence of PBMC separation, DC generation and  
coculture with responder cells and thymidine pulsing 






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The flow cytometer used had only four channels. In order to enable a detailed analysis of the CD 
11c# subset an extra channel was required. To free a fluorescence channel the CD11c+ subset was 
included within the cells stained by the lineage cocktail. To this purpose, cychrome conjugated 
CD11c was added to the lineage cocktail in the third channel which removed the CD11c+ DCs 
from the DC gate staining. Freeing of one channel enabled the further delineation of CD11c# 
subsets with respect to their expression of CD40 and CD86 costimulatory markers. Concurrent 
cell samples were stained with CD123 and CD45RA to ensure no loss of CD11c# DCs occurred 
due to the addition of CD11c to the lineage cocktail. 
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Antibody staining showing no loss of CD11c# DCs due to the addition of CD11c antibody 
to the lineage cocktail. Results from a single experiment 
 
Effective disappearance of the CD11c+ subset was confirmed by the above labelling. In Figure 
2.8A, the CD123low subset expresses CD11c (quadrant 6). This CD11c+ subset could be seen to 
disappear with the addition of CD11c to the cocktail (compare quadrant 5 in Figure 2.8B with 
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quadrant 5 in Figure 2.8C). This also demonstrates that there is no loss of the CD11c#/CD123+ 
subset with the addition of CD11c to the cocktail (compare quadrant 3 in Figure 2.8A with 
quadrant 3 in Figure 2.8C). 
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DC sorting and labelling experiment was conducted to check the integrity of flow cytometer 
sorting. Both adult and fetal samples were labelled and the protocol for DC sorting and labelling 
was followed as discussed above (see +	=).  
 

+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#-"#
Pre and post sorting two parameter histograms showing DC populations. Results from a 
single experiment 
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The purity of the sorted population after sorting was confirmed (compare region R2 in figure 
2.9A with region R2 in figure 2.9B). Effective disappearance of cell populations other than DCs 
was also confirmed. 
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DC sorting and labelling experiment was conducted to ascertain if subpopulations of DC, 
especially the novel fetal subpopulation of interest, which was identified on whole blood 
labelling (see !.*) could be identified without any loss after metrizamide labelling. 
Both adult and fetal samples were labelled and the protocol for DC sorting and labelling was 
followed as discussed above (see +	=).  
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Pre and post separation two parameter histograms after metrizamide separation showing 
DC populations in adult PB and fetal CB. Results from a single experiment 
 
No significant loss of DC populations was seen after metrizamide separation both in adult and 
fetal CB. 
 
 
MATERIALS AND METHODS 
 
132 
 
	 /.#'%'##'%''

A validated technique which permits usage of the small volumes of whole blood available from 
preterm neonates was used (Mason,  ;< 2005). All the experiments for DC phenotyping, 
costimulatory marker and intracellular cytokine analysis used whole blood. Analysis of whole 
blood precluded the usage of antibiotics in cell culture media which was important as this study 
assessed the effects of infections on DCs. Antibiotics in the media was used only in the 
functional studies which did not assess the effects of intrauterine infections. Additionally whole 
blood analysis eliminates any cell separation procedures with its potential loss of cell 
populations, and provides data which accurately reflect the 

state. 
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Optimal dilutions of each antibody used were determined based on the fluorescent intensity.  
Experiment was conducted to delineate staining of individual antibodies in the cocktail and 51l 
of each antibody was added. The results showed that CD16 stained very brightly while CD19, 
CD34 and CD56 hardly stained. CD14 and CD3 flourescence was optimal for detection. A repeat 
experiment was performed with serial dilutions of CD16, double dilutions of CD19, CD34 and 
CD56. The optimal concentrations arrived at were as follows and were used in all the 
experiments:  
HLA#DR =1:4 = 10l Ab to 30l medium and add 5l into each tube. 
Linear Cocktail (LIN#CK) = CD3 + CD14 + CD16 [1:25 DIL] + CD19 + CD34 + CD56 
[5l of each Ab or 30l of cocktail mixture into each tube] 
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FITC = 10l into each tube. 
γ1 PC5 = 25l into each tube.    γ2a PC5 = 5l into each tube. 
All other Ab’s = 5l into each tube.  
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Ethical approval for the study was obtained from the Harrow Research Ethics Committee (ethics 
number#3244). 

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Samples were obtained from CB of fetuses delivered at Northwick Park Hospital NHS Trust, UK 
and from personnel working in the above Trust who volunteered. Informed consent was obtained 
from all mothers who donated the CB towards this study and also from all adult volunteers who 
donated PB. Adult PB were taken from both male and female donors and were not gender 
compatible with the fetal sample. The researchers did not find any evidence to date of gender 
related differences in CBDC. 
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All the blood samples taken were antibody labelled within 1#2 hours of delivery of the fetus, to 
eliminate changes in immunological activity occurring with time. To eliminate systematic 
variations over time we have analysed each fetal sample with an adult sample with the labelling 
done contemporaneously. All the labelling and analyses were done by the MD candidate. 
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Umbilical CB was obtained by venupuncture of the placental vein near the insertion of the 
umbilical cord into the placental base. Between 5 and 10 ml of CB was drawn into heparinised 
tubes immediately following the delivery of the baby.  
A total number of 43 CB samples (26 preterm and 17 term) were analysed for the identification 
of CBDC subsets. Their expression of CD45 and HLA#DR was analysed in 40 CB samples (26 
preterm and 14 term). Blood from the umbilical cord of 25 preterm neonates (less than 37 
completed weeks of gestation) and 12 term neonates (more than 37 completed weeks of 
gestation) was analysed for their CBDC change in numbers with age and exposure to stressors.  
Neutrophilic activation markers were analysed in a subsection of the above 37 samples (term#18; 
preterm#11). To obtain more detailed information on the functional aspects of the DC subsets, a 
subset of the preterm and term CB collected were analysed for costimulatory markers (CB from 
14 preterm and 7 term neonates) and IL#12 production (CB from 8 preterm and 10 term 
neonates). CB samples from complicated and uncomplicated pregnancies as well as vaginal and 
caesarean births were analysed to incorporate all the parameters which influence changes 

.  
As infections and its sequelae are retrospective diagnoses when the CB for analysis is taken (at 
the time of birth), we have used various factors to differentiate those neonates considered to have 
been ‘stressed’ or exposed to intrauterine infectious/stressor stimuli and those neonates who were 
‘non#stressed’. The following criteria were employed to classify the neonates into the two groups 
of stressed or non#stressed. The first criteria used to classify babies as stressed were clinical signs 
and symptoms of infection with or without support by laboratory tests. Neonates with prolonged, 
complicated labours or other clinical findings indicating a higher infection risk, intrauterine 
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growth restriction and non#reassuring patterns on the fetal heart rate monitor indicating fetal 
hypoxia or acidosis which required urgent delivery were also classified as stressed. Other 
obstetric complications such as severe pre eclampsia requiring delivery were also classified as 
stressed. Preterm neonates delivered for maternal indications or acute events not affecting the 
fetus such as APH and vaginal deliveries with no signs of infection were classified in the non 
stressed group. Term neonates with an uncomplicated intrapartum period and a normal antenatal 
period were classified in the non#stressed group. Equal numbers of babies in the stressed and non 
stressed groups had antenatal steroids (two doses for prematurity). No fetuses were exposed to 
long term steroid or anti inflammatory therapy for maternal indications. (See !.* & for 
validation of the classification).  

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Forty three samples of adult blood for analysis were obtained after informed consent from non#
pregnant healthy volunteers between the age groups of 22 to 56 years, by venupuncture of the 
ante#cubital vein.  







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Gestation Delivery 
Gr
ou
p 
Gestation Delivery 
Gr
ou
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21/40 
Twin2, IU infection, PROM, 
twin1 Intra uterine death 
S 38+/40 Twin1, Elective LSCS NS 
27/40 
Preterm labour, Vaginal 
Delivery 
S 38+/4 Twin2, Elective LSCS NS 
29+6/40 
Emergency LSCS, fulminating 
PET 
S 39/40, Elective LSCS, Breech NS 
32/40 LSCS, maternal indication NS 39/40 
Spontaneous vaginal 
delivery 
NS 
30+2/40 Emergency LSCS, APH NS 39/40 
Elective LSCS, previous 
LSCS 
NS 
32/40 LSCS, maternal indication NS 39+/40 
Elective LSCS, previous 
LSCS 
NS 
33/40 Severe maternal PET S 40/40 
Elective LSCS, previous 
LSCS 
NS 
34/40 
Twin1,Elective LSCS, severe 
IUGR 
S 40/40 Emergency LSCS NS 
34/40 
Twin2,Elective LSCS, severe 
IUGR 
S 40/40 
Emergency LSCS, 
Elective in labour 
NS 
34+4/40 
twin1, Elective LSCS, severe 
IUGR 
S 40/40 
Emergency LSCS,  
Elective in labour 
NS 
34+4/40 
twin2, Elective LSCS, severe 
IUGR 
S 40/40 
Emergency LSCS,  
Elective in labour 
NS 
35/40 
Elective LSCS, fulminating 
maternal PET 
S 40/40 Twin1, Elective LSCS NS 
35/40 
Vaginal Delivery, IOL, maternal 
PET 
S 40/40 
Ventouse, failure to 
progress 
S 
35+1/40 Emergency LSCS, APH NS 40/40 
Ventouse, failure to 
progress 
S 
35+1/40 
Twin1, Spontaneous labour, 
Vaginal delivery # infection 
S 40/40 
Ventouse, failure to 
progress 
S 
35+1/40 
Twin2, Spontaneous labour, 
Vaginal delivery # infection 
S 40/40 
Ventouse, failure to 
progress 
S 
36/40 Spontaneous Vaginal Delivery NS 40/40 
Emergency LSCS, 
failure to progress 
S 
36/40 
Spontaneous Vaginal Delivery, 
infection clinically 
S    
36/40 
Twin1,LSCS, inf 
malpresentation, GDM 
S    
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36/40 
Twin2,LSCS, inf 
malpresentation, GDM 
S    
36/40 
twin1, Emergency LSCS, in 
labour, booked elective 
NS    
36/40 
twin2, Emergency LSCS, in 
labour, booked elective 
NS    
36+/40 
Emergency LSCS, in labour, 
booked elective  
NS    
36+1/40 
Spontaneous labour, Vaginal 
delivery 
NS    
36+3/40 
Twin1, Emergency LSCS, 
PROM 
S    
36+3/40 
Twin2, Emergency LSCS, 
PROM 
S    
%%8#D 
S Exposed to stressors 
NS Not exposed to stressors 
IU infection Intra uterine infection 
PROM Premature rupture of membranes 
PET Pre eclamptic Toxaemia 
IUGR Intra uterine growth restriction 
GDM Gestational Diabetes mellitus 
APH Antepartum haemorrhage 
IOL Induction of labour 
LSCS Lower Segment Cesarean section 
Clinical parameters and the gestational age of the CB samples are given above 
 
	( !''"
Statistical analysis was performed using the SigmaStat 3.0 software programme (SPSS Inc. 
Chicago). Pooled data were expressed as mean values +/# standard deviation. The number and 
proportions of the different cellular groups were compared between fetus and adult and also 
between preterm and term births. One Way Analysis of Variance (ANOVA) was used to 
compare multiple groups in all the analyses and corrections for multiple comparisons were 
included if appropriate. Where data were non parametric pair#wise comparisons were made using 
the Mann#Whitney Rank Sum Test.  A  value of <0X05 was considered significant. 
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Significant exposure of the unborn fetus to infection is clinically and microbiologically poorly 
defined and difficult to identify. DCs as potent APCs are at the forefront of immunological 
responses in the defence against infections and their responses to infection occur rapidly. It was 
postulated that identifying DC subsets in CB and their phenotypic changes in response to an 
infectious stimuli could further the understanding of the fetal response to infectious and stressor 
stimuli.  
The identification and phenotyping investigations were carried out on whole blood using 
monoclonal antibody labelling and multi colour flow cytometry. The functional studies included 
assessment of endocytic uptake of FITC labelled Dextran particles and assessment of 
lymphocytic stimulation by MLR.      
CB contained distinct populations of DCs, and this study has successfully identified both the 
plasmacytoid (HLA,DR
+
CD11c
,
) and myeloid (HLA,DR
+
CD11c
+
) DC populations in CB as 
seen in adult PB. In addition to the above two populations, this study has also identified an 
immature putative DC subset with a HLA,DR
+
CD11c
,
CD45
intermediate(inm)
 phenotype in CB and 
present only as a trace population in adult PB. This population was positive for HLA,DR, 
expressed a lower level of CD45 compared with the plasmacytoid and myeloid CBDCs, and did 
not express CD123, BDCA2 or CD45RA showing it to be phenotypically distinct from the 
plasmacytoid DC subset. These putative DCs were also negative for the myeloid lineage markers 
of CD33 and CD13. The above three CBDC populations were identified consistently in all the 
CB samples analysed for the purposes of this study (=43). 
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The functional studies revealed that all three subsets exhibited the canonical feature of DCs 
which was macropinocytosis and was measured by endocytic uptake of Dextran particles. 
Gradient separated unlabelled CBDCs exhibited lymphocytic stimulatory capacity, but this 
stimulatory function diminished with antibody labelling and cell sorting in the flow cytometer.  
Taken together, these data indicate that CB contains the known plasmacytoid (HLA,DR
+
CD11c
,
) 
and myeloid (HLA,DR
+
CD11c
+
) DC populations as seen in adult PB. In addition to the above 
two populations this study has identified a hitherto unreported putative subset of CBDC with an 
immature phenotype, exhibiting endocytic activity and phenotypically distinct from 
plasmacytoid DCs. 
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In adults two distinct pathways of DC development have been identified historically, as myeloid 
(CD11c
+
/CD123
,
/CD45
hi
) and plasmacytoid (CD11c
,
/CD123
+
/CD45
hi
) (Robinson, ., 1999).  
The Myeloid/plasmacytoid nomenclature has been shed in the light of recent new data on DC 
ontogeny and the two major subsets of DC have been named as conventional/myeloid (cDC) and 
the plasmacytoid/lymphoid (pDC) (Shortman and Liu, 2002; Randolph, ., 2005; Shortman 
and Naik, 2007; Wu and Liu, 2007; Hochrein and O’Keeffe, 2008).
The fetal and neonatal immune systems are functionally and phenotypically different from that 
of the adult. Little is known about the development or activation of the immune system during 
the development of the human fetus and the role of APCs in the maturation of fetal immunity 
(Hayward, 1981). The few studies conducted on human fetal tissue show that 
monocytes/macrophages are the first cells to appear in the fetal circulation
 
(Linch, 1982) 
and T cells are detected in the fetal lamina propria from as early as 12 weeks gestation (Spencer, 
1986). Both plasmacytoid (HLA,DR
+
CD11c
,
) and myeloid (HLA,DR
+
CD11c
+
) DCs have 
been identified in CB. CBDCs have been identified by the presence of the cell surface marker 
HLA,DR, and lack of the CD3, CD14, CD16, CD19, CD34, and CD56 markers. This population 
represents only about 0.3% of CB mononuclear cells (Sorg,  ., 1999). The majority of 
CBDCs show a plasmacytoid phenotype resulting in an inverted CD11c
+
/CD11c
,
 ratio with 
predominant CD11c
,
 DCs, when compared with adult peripheral blood DCs; in adults CD11c
+
 
DCs dominate with a predominant myeloid phenotype (Borras,  ., 2001; Drohan,  ., 
2004). CBDCs are immature compared with adult DCs; showing high levels of CD34, low CD4, 
low CD83, and lower levels of HLA,DR, CD40 and CD86 (Holloway, ., 2000). They have a 
RESULTS I 
 
143 
 
reduced ability to attain a fully mature adult phenotype and to activate CD4
+
 T cells to produce 
IFN,α (Langrish, ., 2002).  
Preterm birth is the major cause of perinatal mortality and morbidity in the developed world 
(Magowan, ., 1998; Wood, ., 2000). Approximately 65% of babies born between 22 and 
26 weeks gestation will die before discharge from hospital and in the survivors at 30 months of 
age, half will have some form of disability and in half of these that disability will be severe 
(Wood, ., 2000). The aetiology of preterm birth is multifactorial, but there is overwhelming 
evidence that infection is responsible in up to 40% of cases, particularly in very early preterm 
birth (Seo, ., 1992; Lettieri, ., 1993). In the amniotic fluid of babies born preterm due to 
infection, there is a significantly increased concentration of proinflammatory cytokines and these 
babies are more likely to suffer long term lung and brain tissue damage leading to 
bronchopulmonary dysplasia, PVL and CP (Yoon, ., 1996; Romero,  ., 1997; Yoon, 
., 1997b; Yoon, ., 2000b).  
The aim of this study was to elucidate the different DC subsets present in CB and adult PB, in 
terms of their phenotypic and functional characteristics. The present study characterised the 
different CBDC subsets as well as analysed the differences seen with the adult DC subsets.  This 
is important in understanding the function of the immune system as a whole as each subset seems 
to have a different role in the activation of the immune system (Thomas and Lipsky, 1994; Reid, 
2000). Understanding the differential role of the DC subsets in the fetal circulation would 
serve to illuminate the immunological basis of the neonatal response to infection.  
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Blood from the umbilical cord of 26 preterm babies and 17 term babies was analysed for 
identification of the DC subsets. Blood from the umbilical cord of 25 preterm babies and 12 term 
babies was analysed for numbers of the DC subsets. CB samples from complicated and 
uncomplicated pregnancies as well as vaginal and caesarean deliveries were analysed to 
incorporate all the parameters which influence changes 	 
	
. Forty three samples of adult 
peripheral venous blood from healthy non,pregnant volunteers were obtained for analysis. 


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

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As discussed above the validated technique which permits usage of the small volumes of whole 
blood available from preterm neonates was used (Mason, 2005). Analysis of whole blood 
eliminates any cell separation procedures with its potential loss of cell populations, and provides 
data which accurately reflect the 	 
	
 state. All the CB samples were analysed within 1,2 
hours after delivery to obtain information as close to the 	
	
 state as possible and adult PB 
DCs were labelled and analysed contemporaneously as controls. 
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The two major subsets of DCs namely; CD11c
+
CD45
hi
 (myeloid) and CD11c
,
CD45
hi 
(plasmacytoid) were identified in both CB and adult PB. 
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DCs were identified by expression of HLA,DR and LIN,CK. The viable cell region (R1) 
was identified on the SSC and FSC histogram (Figure 3.1A). The DC region (R2) was 
positive for HLA,DR and negative/dim for LIN,CK and gated on the viable cell region, R1 
(Figure 3.1B).The DC subsets were delineated by their expression of CD45 and CD11c 
(Figure 3.1C and 3.1D). Representative histograms from 43 experiments shown 
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Initially the total viable cell region was delineated based on the FSC and SSC properties. DCs 
were identified as HLA,DR
+
 and LIN,CK
neg
 (Almeida, ., 1999) (Figure 3.1A). The lineage 
cocktail consisted of antibodies to markers of other leukocyte populations; namely CD3 (T cells), 
CD14 (monocytes), CD34 (stem cells), CD16 (granulocytes), CD19 (B cells) and CD56 (NK 
cells). DCs in both CB and adult PB were defined as a population positive for HLA,DR and 
negative/dim for LIN,CK (i.e. expressing little or no CD3, CD14, CD34, CD16, CD19 and 
CD56) (Figure 3.1B). DC subsets were further delineated based on their expression of CD11c 
and CD45 (Figure 3.1C and 3.1D).  
As seen above the two major subsets of DC, namely CD11c
+
 (myeloid) and CD11c
, 
(plasmacytoid) DCs were present in adult (Region (R3) and Region (R4) respectively in Figure 
3.1C) as well as in CB (Region (R3) and Region (R4) respectively in Figure 3.1D). Both subsets 
expressed high levels of CD45. Both the myeloid and the plasmacytoid DC populations were 
identified consistently in all the CB (=43) and adult PB samples (=43). Region 5 in Figure 
3.1D represented a CD45 intermediate subset of DC in the CB samples which is delineated and 
discussed further below. 
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The two parameter histograms above delineates the myeloid and plasmacytoid DC subsets 
in adult PB (R3: CD11c
+
CD45
hi
, R4: CD11c
,
CD45
hi
) (Figure 3.2C) and their position on 
the HLA,DR
+
/Lineage cocktail
neg
 gating (Figure 3.2B) and the gating on total viable cells 
(Figure 3.2A). Representative histograms shown from 43 experiments shown  
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The adult myeloid and plasmacytoid DC populations can be identified as discrete cell 
populations in the HLA,DR/LIN,CK plot and within the region of total viable cells. This 
establishes that DC populations identified on the CD11c/CD45 phenotype can be traced back as 
discrete cell populations.  
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The two parameter histograms above delineates the myeloid and plasmacytoid DC subsets 
in CB (R3: CD11c
+
CD45
hi
, R4: CD11c
,
CD45
hi
) (Figure 3.3C) and their position on the 
HLA,DR
+
/Lineage cocktail
neg
 gating (Figure 3.3B) and the gating on total viable cells 
(Figure 3.3A). Representative histograms shown from 43 experiments shown  
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The fetal myeloid and plasmacytoid DC populations can be identified as discrete cell populations 
in the HLA,DR/LIN,CK plot and within the region of total viable cells. This establishes that 
CBDC populations identified on the CD11c/CD45 phenotype can be traced back as discrete cell 
populations. The CBDC populations lie in the same area of the total viable cell histogram as the 
adult PB DCs (compare Figure 3.3A with Figure 3.2A).  

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The absolute numbers of DC per Gl of blood are given below (see !."$+ 0 for further 
elucidation). 
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 %&(=25)

%'(=37)
CD11c
+
CD45
hi
 DC 20.88+/,12.22 24.92+/,31.34 
CD11c
,
CD45
hi
 18.56+/,14.26 37.43+/,50.13 
 
                               Mean values and the numbers analysed in each subset are given 
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A third population of DC was identified in CB. These DCs did not express CD11c and 
expressed intermediate levels of CD45 (Regions (R5) in Figure 3.1D and in Figure 3.4). 
Representative histograms from 43 experiments shown 
 
In addition to the myeloid DCs (CD11c
+
CD45
hi
) Region R3 in Figure 3.4 and the plasmacytoid 
DCs (CD11c
,
CD45
hi
) Region R4 in Figure 3.4, CB contained a third population of putative DCs 
comprising of HLA,DR
+
/lin
,
 cells which had a CD11c
,
CD45
inm
 phenotype (Regions R5 in 
Figure 3.1D and 3.4). In Figure 3.4, the region marked R5 was this subset which appeared almost 
absent in the adult sample (compare with Figure 3.1C). This subset was developmentally 
immature as seen by the lower intensity of expression of CD45 (CD45
inm
 subset). On comparison 
between term and preterm CB, this subset was seen to be more predominant in the preterm fetus 
(compare Regions R5 in Figure 3.1D and in Figure 3.4). This CB population was identified 
consistently in all the CB samples (=43). 
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The histograms in Figure 3.3 delineates the CD11c
,
CD45
inm
 CBDC subset (Region R5 in Figure 
3.3C) and its position on the HLA,DR
+
/LIN,CK
neg
 gating (Figure 3.3B) and the gating on total 
viable cells (Figure 3.3A). Thus this CBDC population can be identified as a discrete cell 
population in the HLA,DR/LIN,CK plot and within the region of total viable cells. It lies in the 
same area of the total viable cell histogram as the adult PB DCs (compare Figure 3.3A with 
Figure 3.2A).  

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The absolute numbers of DC per Gl of blood are given below (see !."$+ 0 for further 
elucidation). 
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 %&(=25)

%'(=37)
CD11c
+
CD45
inm
 DC 0.64+/,1.02 25.22+/,42.26 
 
                               Mean values and the numbers analysed in each subset are given 
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The CD11c
+
CD45
hi 
and the CD11c
,
CD45
hi
 DC subsets in CB and adult PB, and additionally the 
CD11c
,
CD45
inm
 DC subset in CB were analysed for their phenotypic characters. 
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To explore the potential relationship between CD11c
,
 DC populations expressing high or 
intermediate levels of CD45, expression of CD123, BDCA2 and CD45RA, markers 
characteristic of the plasmacytoid DC, was examined.  The shaded histograms represent the 
proportion that was positive, i.e. the DCs exhibiting the marker. The CBDC subsets of 
CD11c
+
CD45
hi
 and CD11c
,
CD45
hi
 were analysed for their expression of the plasmacytoid 
phenotypic markers: CD123, CD45RA and BDCA2. Both the subsets exhibited differential 
levels of these markers. 
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Representative histograms of three experiments are shown above. The PCI ratio for CD123 
in the CD11c
+
CD45
hi
 subset was low/negative (average PCI ratio of 15.43) and the PCI 
ratio for CD123 in the CD11c
,
CD45
hi
 subset was high/positive at (average PCI ratio of 
131.30). The PCI ratios for CD45RA in the CD11c
+
CD45
hi
 and the CD11c
,
CD45
hi
 subset 
were low/negative (average PCI ratios of 1.82 and 2.08 respectively). The PCI ratio for 
BDCA2 in the CD11c
+
CD45
hi
 subset was low/negative (average PCI ratio of 1.23) and the 
PCI ratio for BDCA2 in the CD11c
,
CD45
hi
 subset was high/positive (average PCI ratio of 
24.30) 
 
The CD11c
+
 subset was negative for and the CD11c
,
 subset was positive for the expression of 
CD123 and BDCA2. Both the subsets were negative for the expression of CD45RA. 


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To explore the potential lineage of the DC subsets, the expression of the myeloid markers CD33 
and CD13 was examined. The shaded histograms represent the proportion that was positive, i.e. 
the DCs exhibiting the marker. 
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Representative histograms of three experiments are shown above. The PCI ratios for CD33 
in the CD11c
+
CD45
hi
 and the CD11c
,
CD45
hi
 subset were low/negative at 3.00 and 7.27 
respectively 
 
The CD11c
+
 subset and the CD11c
,
 subset were negative for the expression of CD33 and CD13.  
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Adult DC subsets were analysed for their expression of the plasmacytoid phenotypic markers: 
CD123, CD45RA and BDCA2.  
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Representative histograms of three experiments are shown above. The PCI ratio for CD123 
in the CD11c
+
 subset was low/negative (average PCI ratio of 27.77) and the PCI ratio for 
CD123 in the CD11c
,
 subset was high/positive (average PCI ratio of 169.11). The PCI 
ratios for CD45RA in the CD11c
+
 subset and the CD11c
,
 subset were negative (average 
PCI ratio of 1.82 and 2.60 respectively).  The PCI ratio for BDCA2 in the CD11c
+
 subset 
was low/negative (average PCI ratio of  1.40) and the PCI ratio for BDCA2 in the CD11c
,
 
subset was high/positive (average PCI ratio of 49.50) 
 
The CD11c
+
 subset was negative for and the CD11c
,
 subset was positive for the expression of 
CD123 and BDCA2 markers. The CD11c
+
 and the CD11c
,
 subsets were negative for the 
expression of CD45RA.  
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To explore the potential lineage of the DC subsets, the expression of the myeloid markers CD33 
and CD13 was examined. The shaded histograms represent the proportion that was positive, i.e. 
the DCs exhibiting the marker. 
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Representative histograms of three experiments are shown above. The PCI ratios for CD33 
in the CD11c
+
 and the CD11c
,
 subset were low/negative at 3.03 and 1.73 respectively. The 
PCI ratios for CD13 in the CD11c
+
 and the CD11c
,
 subset were high/positive at 29.66 and 
13.93 respectively 
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The CD11c
+
 and the CD11c
,
 subsets were negative for the expression of CD33 and positive for 
the expression of CD13. 
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The CD11c
,
CD45
inm
 putative CBDC population was analysed for the expression of plasmacytoid 
and myeloid lineage markers. All comparisons were made with the known myeloid and 
plasmacytoid CBDC subsets and within the same individual sample. 
 
		 !
1
0
)
$%"3'##4$+'')"+,+'# $&"')"!(#
 
To explore the potential relationship between CD11c
,
 DC populations expressing high or 
intermediate levels of CD45, expression of CD123, BDCA2 and CD45RA, markers 
characteristic of the plasmacytoid DC, was examined.   
The shaded histograms in Figure 3.9 represent the proportion of DCs in the subpopulation that 
was positive, i.e. the DCs exhibiting the marker. The CD11c
,
CD45
inm
 putative CBDCs were 
negative for BDCA2, CD45RA and CD123
 
(Figure 3.9). Taken together these data suggested 
that the CD11c
,
CD45
inm
 population represented a distinct subset, rather than the classical 
plasmacytoid DC expressing reduced levels of CD45.  
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Representative histograms of three experiments are shown above. The subset of CD11c
,
CD45
inm 
putative
 
CBDC was negative for CD123 (average PCI ratio of 2.12), negative for 
CD45RA (average PCI ratio of 1.29) and negative for BDCA2 (average PCI ratio of 3.79)  
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To explore the potential lineage of this putative DC subset, the expression of the myeloid 
markers CD33 and CD13 was examined.  
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Representative histograms of three experiments are shown above. The CD11c
,
CD45
inm 
putative DC subset was negative for CD33 (PCI ratio of 2.49) and negative for CD13 (PCI 
ratio of 2.67) 
 
The shaded histograms in Figure 3.10 represent the proportion of DCs in the subpopulation that 
was positive, i.e. the DCs exhibiting the marker. The CD11c
,
CD45
inm
 putative CBDCs were 
negative for CD33 and CD13 (Figure 3.10). Taken together these data suggest that the CD11c
,
CD45
inm
 population represents a distinct subset, rather than the myeloid subset of CBDCs 
expressing reduced levels of CD45. 
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The endocytic activity of CB and adult PB DC subsets was assessed by measuring the 
temperature dependent uptake of FITC labelled Dextran.  
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The endocytic activity of the CD11c
+
CD45
hi 
and the CD11c
,
CD45
hi
 DC populations in CB and 
adult PB was assessed by measuring the temperature dependent uptake of FITC labelled Dextran 
(Figure 3.11A and Figure 3.11B). Both these subsets exhibited endocytosis which exponentially 
increased at 30 minute. The endocytosis exhibited by the CBDC subsets was comparable to the 
adult PB DC activity. However the net MFI exhibited by the CD11c
,
 DC populations (adult PB 
DC mean:5.91+/,0.63, =4; CBDC mean:9.24+/,15.69, =3) both in adult PB and in CB appear 
to be less than the endocytic activity exhibited by the CD11c
+ 
DC populations (adult PB DC 
mean:15.52+/,10.12, =4; CBDC mean:34.69+/,45.29, =3) (see section 			). 
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Net MFI at 5 minute and 30 minute are shown. Data is shown from four adult samples and 
three CB samples from term fetuses. Both subsets exhibited antigen uptake mainly at 30 
minute with the CD11c
+ 
DC subset (Figure 3.11A) exhibiting higher MFI than the CD11c
,
 
DC subset (Figure 3.11B). CBDCs show similar values of MFI compared to adult PB DCs 
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Ficoll separated CBDCs were incubated with and without FITC,Dextran at 37
0
 and 4
0 
over 
the course of 30 minute to assay endocytic capacity. The uptake of FITC,Dextran was 
determined at 5 and 30 minute time intervals and the net MFI at each time point was 
calculated by substracting the net MFI at 4
0
 from the net MFI at 37
0
. The subtraction was 
performed to correct for passive absorption and temperature independent uptake. Data is 
displayed from three CBDC samples from term neonates 
 
The cells in the CD11c
,
CD45
inm
 subset exhibited the characteristic activity of the APC by 
endocytosing Dextran with the level of activity increasing at higher temperatures (mean: 
15.78+/,18.05, =3) (Figure 3.12).
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The antigen uptake capacity of the novel CD11c
,
CD45
inm
 subset was analysed by comparison to 
the endocytic capacity of the other known CD11c
+
 and CD11c
,
 DC subsets.  Net uptake at 30 
minutes was compared. In adult samples the CD11c
+
 DCs showed increased levels of activity 
(mean:15.52+/,10.12, =4) when compared to the CD11c
,
 DC subset (mean:5.91+/,0.63, =4) 
(p=0.007). The CB samples showed no such difference (CD11c
+
 CBDCs; mean:34.69+/,45.29, 
=3; CD11c
,
 CBDC subset; mean:9.24+/,15.69, =3) (p=0.410). The CD11c
,
45
inm
 putative DCs 
(mean:15.78+/,18.05, =3) exhibited activity comparable with the known endocytically active 
subset of adult CD11c
+
 DCs. That is both groups were not significantly different (p=0.982) 
(Figure 3.13). 
 

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Net MFI at 30 minute is shown for all the DC subsets as the activity was negligible at 5 
minute. Mean values with standard errors shown 
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MLR is a lymphocyte proliferation assay which tests the ability of DCs to activate lymphocytes 
to undergo a clonal proliferation. Lymphocytes proliferate in response to antigenic peptides in 
association with class II MHC molecules on DCs. Lymphocytes were cocultured with DCs and 
pulsed with H
3
,thymidine which is a radioactive nucleoside and a precursor of thymine found in 
DNA. Lymphocytes activated by DCs proliferate and replicate their chromosomal DNA, thus 
incorporating H
3
,thymidine into the new strands. Using a scintillation beta,counter the extent of 
cell proliferation was measured as counts per minute (cpm) and is proportional to the number of 
proliferating cells, which in turn is a function of the number of lymphocytes that were stimulated 
to enter the proliferative response. 
DCs were obtained using two methods: 
;'(*+"'$"+"## '-PBMCs in fetal venous CB were Ficoll separated (see 
!."$+'!#  for protocol). The cell suspension was cultured overnight and the 
LDCs were separated out over a metrizamide gradient (see !."$+ '!#  for 
protocol) and cultured with responder PBMCs. 
; &#: !(#)+ '#+ '- LDCs in suspension was serially diluted and labelled with 
monoclonal antibodies: HLA,DR and antibodies in the lineage cocktail (!."$+"2& 
<). The rest of the DC cell suspension was sorted for fetal DCs through the flow 
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cytometer. Terasaki plates were plated with the unlabelled DCs, labelled DCs and sorted 
DCs. Detailed protocol for DC sorting is given in !."$+'!#and*%+6 
The antibody labelled DC plate functioned as a control to check the effects of antibody 
labelling on the stimulatory capacity of the DCs. 
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
DCs were cultured in four decreasing concentrations (3000 cells/10Gl, 1000 cells/10Gl, 300 
cells/10Gl and 100 cells/10Gl). Four concentrations of PBMCs per 10Gl of cell suspension were 
used; 100,000, 50,000, 25,000 and 12,500.  
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The multigraph details the stimulatory capacity of CBDCs related to the number of 
responder cells. Representative data from 2 experiments shown 
 
CBDCs showed stimulatory capacity with unlabelled DCs inducing the highest level of 
proliferation and the highest level of stimulation was seen with 100,000 responders (Figure 
3.14). As seen from the graphs above the stimulatory capacity is diminished with antibody 
labelling and sorting of the DCs through the flow cytometer. 
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The stimulatory capacity of unlabelled adult DCs and CDBCs were compared.  CBDCs showed 
similar levels of stimulation when compared with adult PB DCs.  

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The sample labelled fetus 2 showed a similar profile to stimulation by adult PB DCs in the 
coculture with higher numbers of responder cells. Data shown from two CB samples 


Unlabelled DCs were used for coculture as antibody labelling and sorting of DCs were found to 
decrease their stimulatory capacity. Fetal DCs showed stimulatory capacity comparable to adult 
DCs. 





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This study has confirmed that comparable DC subsets can be identified in CB similar to adult 
PB. DC subsets in umbilical CB were analysed for their phenotype and functional 
characterisations. CB contained distinct populations of DCs, and we have identified the myeloid 
(CD11c
+
CD45
hi
) and the plasmacytoid (CD11c
,
CD45
hi
) DC subsets in fetal CB and in adult PB. 
In addition to the above two populations this study has identified an immature putative DC 
subset with a CD11c
,
CD45
inm
 phenotype in CB and seen only as a trace population in adult PB.  
The tested method of monoclonal antibody labelling and multi colour flow cytometry was used 
to establish the fact that the phenotype of the CB subsets concurred with the conventional DC 
phenotype. To date studies in the fetus have been limited by the lack of availability of tissues 
with samples from the intrauterine period very difficult to access. CB samples have been 
traditionally used as tissue samples obtained immediately after delivery are deemed to reflect the 
intrauterine/fetal milieu. This usage has been limited by the small volumes usually available as 
well as techniques of analyses leading to modifications in the cellular properties. To overcome 
these issues analyses was performed on whole blood in order to reflect the 	
	
environment 
as closely as possible as lack of a centrifugation step minimised 	
	 induced changes of the 
surface phenotype. Studies using cell separation techniques have the attendant risk of loss of cell 
populations which can be avoided by analysing whole blood. Whole blood analysis has also 
enabled investigation of blood samples from very preterm neonates where the volume of blood 
available is usually minimal. This method has been shown to be reliable and reproducible with 
consistency throughout our study. 
The myeloid and plasmacytoid CB subsets were identified as HLA,DR positive and negative for 
antibodies in the lineage cocktail and similar to the DC subsets in adult PB.  Human DCs are 
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identified phenotypically based on their surface expression of HLA,DR and lack of expression of 
lineage associated markers (CD3, CD14, CD16, CD19, CD34 and CD56) (Knight, 1984; Reid, 
1997; Banchereau, ., 2000). The term ‘lineage’ includes all cells that express markers for 
lymphocytes, granulocytes, monocytes, NK cells and stem cells. In practice DCs do not appear 
as truly lineage negative as they show some labelling above background levels due to low levels 
expression of CD34 on both subsets and of CD14 on the CD11c
+
  DC subset. Nevertheless, this 
minor degree of labelling did not prevent discrimination between the DCs and other lineage 
positive cells. Additional to the myeloid and plasmacytoid DC populations in CB, we have 
identified a third population of DCs consistently in all the CB samples. The cells in the novel CB 
subset of interest stained positive for HLA,DR and was negative for lineage associated markers 
and were readily identified as a discrete population of cells in the lower right quadrant of the 
lineage cocktail versus HLA,DR histogram.  
All the major studies of fetal/CBDCs concur that fetal DCs are immature in their function and 
phenotype. Hence we analysed the expression of CD45 on our CBDCs. CD45 is a leukocyte 
specific protein tyrosine phosphatase present on the surface of all nucleated, haematopoietic 
cells. It is a regulator of TLR,mediated cytokine secretion in DCs and directs the outcome of the 
adaptive immune response (Cross, ., 2008). CD45 has been shown to increase in intensity as 
maturation takes place, thus these putative DCs appear to be immature compared to the myeloid 
and plasmacytoid CBDC subsets (Borowitz, ., 1993; Jennings and Foon, 1997). The CD11c
,
CD45
inm
 putative DC subset exhibited lower levels of CD45 (enumerated further in !."$+0) 
and has thus been classified as CD45 intermediate (inm). The CD11c
,
CD45
inm
 putative DC 
subset was present only as a trace population in the adult. 
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Analysis was also performed for expression of plasmacytoid and myeloid lineage markers. The 
two main populations in CBDC and adult PB, the CD11c
+
CD45
hi
 myeloid and CD11c
,
CD45
hi 
plasmacytoid DC subsets were analysed for the plasmacytoid markers of CD123, CD45RA and 
BDCA,2. pDCs in blood and bone marrow are CD11c
–
, CD123
high
, CD4
+
, Lin
–
, CD45RA
+
, 
CD304 (BDCA,4/Neuropilin,1)
+
, CD141 (BDCA,3)
low
, CD1c (BDCA,1)
–
, CD14
–
 and CD2
–
. 
They express neither myeloid lineage markers (CD13, CD33) nor Fc receptors (CD32, CD64, 
FcRI). Human CD45RA is a transmembrane tyrosine phosphate and is expressed on all cells of 
haematopoietic origin, except erythrocytes. CD45RA is expressed on approximately 75% of 
CD8 lymphocytes and 50% of CD4 lymphocytes, all B cells and NK Cells, as well as on pDCs. 
BDCA,2 is a novel type II C,type lectin, expressed on pDCs in blood, lymphoid and non,
lymphoid tissue. In blood, BDCA,2 is expressed on CD11c
, 
CD123
bright
 pDCs but not detectable 
on a third blood DC population, which is CD1c
+
CD11c
bright 
CD123
dim
, or on any other cells in 
blood. Both the CBDC and adult PB DC subsets showed similar expressions of the plasmacytoid 
markers. The CD11c
+
 myeloid subset was negative for and the CD11c
,
 plasmacytoid subset was 
positive for the expression of CD123 and BDCA2. Both the subsets were negative for the 
expression of CD45RA.  
The CD11c
,
CD45
inm
 novel CB subset was negative for the expression of the surface markers 
CD123, CD45RA and BDCA2, indicating that it is not plasmacytoid in origin (Dzionek, ., 
2000; Liu, et al., 2001; Comeau, ., 2002). In literature to date, previous reports of increased 
CD11c
,
 DC in CB have not distinguished pDCs from the distinct CD45
inm
 population described 
here. 
The two main populations in CBDC and adult PB, the CD11c
+
CD45
hi
 myeloid and CD11c
,
CD45
hi 
plasmacytoid DC subsets were analysed for the myeloid lineage markers of CD33 and 
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CD13. CD33 is a transmembrane receptor; a 67 kDa glycoprotein expressed on cells of myeloid 
lineage, usually considered myeloid,specific and represents an important marker of myeloid cell 
differentiation. It is expressed on myeloid progenitors, monocytes, granulocytes, pDCs and mast 
cells and is absent on normal platelets, lymphocytes, erythrocytes and haematopoietic stem cells. 
CD13 is a 150,170 kD type II transmembrane glycoprotein expressed on the majority of 
peripheral blood monocytes, granulocytes, myeloid progenitors, endothelial cells, epithelial cells 
and subsets of granular lymphoid cells. It is not expressed on B cells, T cells, platelets or 
erythrocytes. In the fetus both the CD11c
+
 myeloid and the CD11c
,
 plasmacytoid subset were 
negative for the expression of CD33 and CD13. In the adult PB both subsets were negative for 
the expression of CD33 and positive for the expression of CD13.  
Analysis of the novel CD11c
,
CD45
inm
 subset found their expression to be similar to the other 
CBDC subsets with the DCs negative for the myeloid lineage markers of CD33 and CD13. 
The cardinal feature of the DC as an APC is antigen presentation, and endocytosis of antigen is 
integral to the two main pathways of MHC I and MHC II as well as the mechanism of cross 
presentation. Both the adult and fetal CD11c
+ 
DC subsets exhibited endocytotic activity as was 
expected of myeloid DCs. The CD11c
, 
plasmacytoid
 
DC subset in adult and CB exhibited 
endocytic activity, but the capacity was less on comparison with the myeloid DC subset. 
The CD11c
,
CD45
inm
 putative DC subset was analysed for their capacity to endocytose FITC 
labelled dextran particles. In concurrence with the functioning of a conventional DC, cells in this 
subset showed endocytic capacity.  The level of endocytosis exhibited by the novel subset was 
similar to that of the adult CD11c
+
 DC subset. This finding is in line with the established 
observations of an immature phenotype of CBDCs, but with ability as potent stimulators of 
allogenic CB T cells (Pacora, .,2002b).  
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Analysis of the capacity of the CBDC to stimulate lymphocyte proliferation was assessed in a 
MLR. CBDCs were analysed in three conditions; as unlabelled DCs, DCs labelled with 
monoclonal antibodies and DCs sorted by the flow cytometer after labelling. The CBDCs 
stimulated lymphocytic proliferation and comparison with adult PB DCs showed similar levels 
of proliferation. Unlabelled DCs induced the highest levels of proliferations, with labelled DCs 
showing reduced levels and sorted DCs exhibiting the lowest level of proliferation.  
These results indicated that labelling and manipulation of DCs decreased their lymphocytic 
stimulatory capacity. This is probable as labelling with HLA,DR antibody blocks the HLA,DR 
receptors and this decreases the receptor sites available for lymphocyte activation. This could 
also be the case for other receptor sites used in lymphocyte activation. Additionally further cell 
handling and washing with chemicals as occurs during cell sorting could affect the DC’s ability 
to activate lymphocytes. The results could also be affected by the degree of maturity of the 
CBDCs. Many DC functions such as antigen uptake and lymphocyte activation are regulated 
during DC maturation. As the maturation stage of DC may vary from sample to sample, 
especially in a rapidly changing milieu such as the fetal immune system, this could affect the 
functioning of the DC. To minimise the above, all the CB samples used in the functional studies 
were acquired from full term neonates with no other pathology.  
Further functional analysis of the CD11c
,
CD45
inm
 CBDC subset would have been pertinent to 
firmly establish the identity of these cells as DCs. Lymphocytic proliferation assays on a DC 
subset necessitate labelling and sorting of the DCs. For the reasons explained above the 
lymphocytic capacity diminishes and is almost negative with antibody labelling and sorting. 
Thus the stimulatory capacity of CBDCs as a whole could be assessed as unlabelled DCs were 
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used, but the stimulatory capacity of the individual CBDC subsets could not be assessed as 
labelling was required to separate the subsets.  
Taken together these data indicate that CB contained discrete subsets of DCs which were 
comparable to adult CB subsets and can be identified in whole blood. The myeloid and 
plasmacytoid DC subsets exhibited similar phenotypic and functional characteristics in adult PB 
and fetal CB. Additionally the third population of CD11c
,
CD45
inm
 CBDCs exhibited phenotypic 
and functional characteristics identifying it as a population of putative DCs in CB. As this 
population was present mainly in the fetus, these putative DCs appear to be immunologically 
active in the fetus as opposed to the adult. This also raises the question of the role of this 
immature cell population in the stimulation and organisation of the fetal immune system. As DCs 
have been found to be central in orchestrating the immune response, and the subset described 
above is seen in the fetal circulation, these putative DCs could play an important role in the early 
development of the fetal immune system especially the establishment of the adaptive arm. It is 
possible that these immature putative DCs are evolving into a mature form as the immune system 
of the fetus ages with increasing gestational age. This could mean that these cells are central to 
the fetal defence against infection and the evolving change from immature to mature is necessary 
to mask fetal antigens in the initial temporal sequence of gestation. Fetal immune system has a 
general haemopoietic immaturity which inhibits immune responses and maintains a tolerogenic 
environment essential for the survival of the fetus with its ‘foreign’ antigens within a potential 
hostile maternal environment. The CD11c
,
CD45
inm
 immature DC population could facilitate 
mechanisms through which tolerogenic signals are promoted and presented to the maternal 
immune surveillance. Further evaluation of this subset and their response to increasing 
gestational age and exposure to antigenic stimuli 	 
	
 could contribute far towards our 
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understanding of the fetal immune system and its development from an immature innate form to 
a mature adaptive form. 
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The classification of CB samples into those exposed and not exposed to stressor stimuli was 
based on clinical criteria. The response of the CBDC subsets to stressor stimuli was studied 
based on that classification (see  !" # and $). It would add to the validity of the 
classification if in the same samples, indicators of infection were positive using another cellular 
marker other than the DC profiling. Downregulation of neutrophilic activation antigens have 
been used as markers of infections with high sensitivity and specificity (Cui, ., 2003; Huang, 
., 2009). Hence the neutrophilic activation markers; CD11b and CD16 were analysed in CB. 
Labelling of whole blood with monoclonal antibodies and flow cytometry analyses was used to 
identify the neutrophils and analyse their expression of CD11b and CD16 surface markers. 
Analysis was performed on 29 of the 37 CB samples classified into stressed and non stressed and 
used for the DC studies.  
Correlation analyses of the change in numbers of CD11b and CD16 with the change in numbers 
of CD11c
.
CD45
inm
 CBDCs in the same samples was performed to assess the validity of the 
clinical classification. The preterm stressed samples showed a statistically significant negative 
correlation; with the CD11b and CD16 numbers decreasing with increasing CD11c
.
CD45
inm
 
numbers on exposure to stressors ( values 0.0218 and 0.0262 respectively). The preterm non 
stressed samples showed no such correlation.  
For the purposes of our study, analyses of the neutrophilic markers and their significant 
correlation with the CBDC numbers on exposure to stressors, validates our clinical classification 
of CBs into stressed and non stressed. 
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Polymorphonuclear neutrophils constitute the majority of blood leukocytes, 95% of circulating 
granulocytes and have a characteristic multilobed nucleus containing azurophilic and secondary 
cytoplasmic granules used in phagocytosis (Malech and Gallin, 1987). This first line of defence 
depends on the two mechanisms of toxic oxygen metabolites produced by the NADPH oxidase 
system and the release of proteolytic enzyme granules (Henson and Johnston, 1987). Resting 
neutrophils are activated by chemotactic stimuli resulting in margination, diapedesis and 
congregation at sites of injury/infection where they show adherence to matrix components such 
as fibronectin and laminin (Yamashiro,  ., 2001). The chemotactic factors include; C5a 
released on complement activation, products of platelets, bacteria and other leucocytes (Colotta, 
., 1992). Cytokines, mainly IL.8 also known as the neutrophil activating factor as well as IL.
1, TNF.α and IL.6;  lead to activation of neutrophil β2 integrins (Weissman,  ., 1980). 
Neutrophils respond to and are modulated by different bacterial antigens through TLRs which 
stimulate neutrophils to recruit immune cells to the sites of infection (Hayashi,  ., 2003). 
Bacterial DNA induces neutrophil activation evidenced by L.selectin shedding, CD11b 
upregulation and IL.8 secretion (Trevani, ., 2003). 
The innate neonatal immune system is functionally immature and the leukocytes of stressed 
newborn infants are deficient in their bactericidal activity and this intrinsic immaturity 
contributes to the neonatal increased susceptibility to infections (Hill, 1987; Levy, ., 1999). 
Neutrophil function and phagocytosis are well established to be deficient in the neonate, 
especially chemotaxis (Falconer,  ., 1995). Neonates express less CD11b/CD18 on their 
neutrophils which contributes to their deficient diapedesis, bactericidal activity and chemotaxis 
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(Sacchi,  ., 1982; Reddy,  ., 1998). In particular, the immune function of the preterm 
infant is functionally immature compared to the term fetus (Abughali,  ., 1994; Kotiranta.
ainamo, ., 1999). This is seen in the decreased amount of total cell content of CD11b/CD18 
in preterm infants compared to term infants (McEvoy,  ., 1996). Preterm infants exhibit a 
lower neutrophilic cell mass and a decreased capacity to increase progenitor proliferation 
resulting in the premature neonates’ response to infection with neutropenia (Carr, 2000). Preterm 
neutrophils also exhibit a diminished upregulation of CD11b expression after stimulation which 
reflects in the functional defects and the increased susceptibility to infections (Smith,  ., 
1991; Kaufman, ., 1999). 
Binding of immunoglobulin to cell surface receptors improves clearing of bacteria by 
neutrophils. These surface antigens play a key role in the recruitment and endothelial 
transmigration of neutrophils into tissues and their upregulation indicate neutrophil activation 
(Simms and D’Amico, 1995). Important cell surface receptors responsible for binding 
immunoglobulin include CD11b and FC g.receptor III (CD16). CD11b is a β2 integrin which are 
type 1 transmembrane glycoproteins mediating intercellular and cell.substrate interactions and 
expressed mainly on granulocytes as well as on monocytes and NK cells (Smyth, ., 1993). It 
is part of the CD11b/CD18 heterodimer (Mac.1), also known as the C3 complement receptor 
(Petty and Todd, 1996). Integrins are heterodimeric cell surface receptors that are composed of 
noncovalently associated α and β subunits (Hynes, 1987). The leukocyte integrins CD11a,b,c,d 
are associated with CD18 β2 chains and promote neutrophil attachment to the endothelium with 
subsequent transmigration (Bevilacqua, 1993). Neutrophil degranulation is channelled through 
CD11b/CD18 (Arnaout, 1990). The functional importance of the subset of integrins, 
CD11b/CD18 (Mac.1) is emphasised by the recurrent bacterial infections and impaired wound 
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healing seen in patients with Mac.1 deficiency (Crowley, ., 1980). The expression of Mac.1 
is upregulated by infectious stimuli, and chemoattractants mobilise the Mac.1 from the 
intracellular granules to the cell surface (Corbi, ., 1988). As the molecule serving as an iC3b.
receptor, the CD11b/CD18 integrin is responsible for recognising microbial pathogens opsonised 
with iC3b (Wright,  ., 1983). PB polymorphonuclear cells activated with activating agents 
such as zymosan activated plasma show a marked increase in the expression of the CD11b/CD18 
integrins (Klut, ., 1997). Hence monitoring of the CD11b levels also indicate the functional 
state and priming of the neutrophil (Wittman, ., 2004). CD11b is stored in the secondary and 
tertiary intracellular granules and the cell surface expression changes within minutes of 
activation by soluble stimuli (Wright and Meyer, 1986) enabling levels of CD11b expression to 
be used as a diagnostic marker for early onset neonatal sepsis (Weirich, ., 1998; Nupponen, 
., 2001).  
The CD16 is a neutrophilic surface antigen (the Fc gammareceptor III) which induces 
phagocytosis of bacteria and binds to the Fc region of immunoglobulin G. It is expressed largely 
on neutrophils and hence used as a surface marker for their identification and activation status. It 
is a heavily glycosylated protein of 50–70 kd that is linked to the plasma membrane of the 
neutrophil. (Huizinga, ., 1990; De Haas M, ., 1995). Preformed intracellular stores of 
CD16 are mobilised to the cell surface to balance the rates of shedding and thus maintain surface 
membrane levels (Middelhoven, ., 1999; Moldovan, ., 1999; Middelhoven, ., 2001). 
For a holistic view of the neutrophilic interactions leading to immune activation, we have 
analysed the changes in CD11b and CD16 expression with advancing age. CD11b has been 
shown to be downregulated in prolonged complicated labour (Banasik, ., 2000) and hence 
the effect of labour on the expression of these markers was also analysed.  
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Neutrophil activation results in physical changes of the cell characterised by the rounding and 
condensation of the characteristic multi.lobed nucleus, decrease in granularity and cell 
shrinkage. These physical changes were assessed by analysing the size and granularity of the 
cells in accordance with their light scatter properties. 
The research focuses on analysing the expression of CD11b and CD16 on CB neutrophils and 
their change when exposed to infectious/stressor stimuli. Analysis of the response to stressors of 
another cellular marker other than the DC would serve to validate the clinical classification of 
exposure to stressors. 
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Umbilical CB was obtained and collected as described previously. Umbilical CB from 18 
preterm babies and 11 term babies were analysed. Of the 18 preterm CB samples, 9 were 
exposed and 9 were not exposed to stressors. All the 11 term samples were not exposed to 
stressors. 
Adult blood obtained from 18 healthy non.pregnant volunteers was analysed. All the blood 
samples taken have been analysed within 1.2 hours of delivery of the fetus, to eliminate changes 
in immunological activity occurring with time.  
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Whole blood was labelled with monoclonal antibodies to CD11b and CD16 and analysed using 
the flow cytometer (See  !%0" /*.%%%	for a detailed description). 
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Region R1 shows the viable cell gate in Figure 4.1A. The histogram in Figure 4.1B shows 
the neutrophils identified as Region R2, on their basis of granularity (SSC) and expression 
of CD16 and gated on the viable cell region. Representative histograms from 29 
experiments shown 
Neutrophils were identified based on their light scattering properties as discussed above in 
Figure 4.1. The mean SSC positively identified the cells based on their granularity.  
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The subtraction histogram for the expression of the CD11b surface marker on neutrophils 
is shown above. The shaded region in Figure 4.2A represents the subtracted histogram of 
the isotype control from the histogram of the number of neutrophils positively expressing 
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the CD11b surface marker. Single parameter histogram of the isotype staining of CD11b is 
shown in Figure 4.2B. Representative histograms of CB neutrophils from 29 experiments 
shown 
 
Isotype controls were used to delineate the negative expression of the marker to be identified 
(CD11b). To measure the expression of the marker on the required cell population, the isotype 
control (negative) histogram is subtracted from the histogram expressing the marker (test) 
histogram (Figure 4.2A). Subtraction estimates the number of positive cells for the measured 
marker, in the test histogram. The frequency histogram is a graphical representation of the 
number of events occurring for each channel. The median values from both frequency histogram 
(test and control) distributions were linearised and the positive linearised median was divided by 
the control median. The intensity of the positive staining, termed the PCI ratio measures the ratio 
of linearised positive median to the linearised control median. Thus subtraction estimates the 
number of positive cells for the measured marker, in the test histogram (see  !%0" /*.
%%&%% for a detailed explanation).  
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The above single parameter histogram shows the expression of the CD16 surface marker 
on neutrophils gated on the total viable cells. The region marked R2 outlines the cells 
positively expressing CD16. Representative histogram of CB sample from 29 experiments 
shown 

Neutrophils identified on their light scattering properties and the positive expression of CD16 
antigen as discussed above are gated on all the viable cells (Figure 4.3). The region R2 measures 
the number of cells positively expressing CD16. 
 
 
 


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As infections and its sequelae are retrospective diagnoses at the time of birth when the CB for 
analysis is taken, various factors were used to classify the neonates into the two groups of 
infected/stressed or non infected/non stressed. The following criteria were employed to 
differentiate those neonates considered to have been ‘stressed’ or exposed to intrauterine 
infectious/stressor stimuli and those neonates who were ‘non.stressed’. Essentially the first 
criteria used to classify neonates as ‘stressed’ were clinical signs and symptoms of infection 
without or without confirmation by laboratory tests. Neonates with PROM, albeit with a full 
course of antibiotics, were considered in the group labelled as ‘stressed’. Neonates with an 
abnormal or suboptimal antenatal and intrapartum period or with any positive lab tests for 
infection necessitating neonatal or maternal antibiotic treatment were classified in the stressed 
group. In order to broaden our understanding of the immunogenic stimuli and its response in the 
fetal microenvironment, we have also analysed various pathological factors which could result in 
stress to the fetus, in addition to the known factor of infection. Thus neonates with prolonged 
complicated labours or other clinical findings indicating a higher infection risk and intrauterine 
growth restriction with compromised pattern on fetal monitoring necessitating urgent delivery 
were also classified as infected/stressed. Other obstetric complications such as severe pre 
eclampsia necessitating delivery were also classified in the stressed group. Preterm neonates 
delivered for maternal indications or acute events not affecting the fetus such as APH and 
vaginal deliveries with no signs of infection were classified in the non stressed group. Neonates 
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with an uncomplicated intrapartum period and a normal antenatal period were classified in the 
non stressed group.   
Detailed table of patient demographics and CB classification is given in  !%06) %8

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It was felt that validation of this clinical classification was needed and assessment of the 
response to stressors in the same group of CBs using another cellular marker would serve to 
validate the classification. Neutrophilic activation markers have been used as markers of 
infection and there is ample evidence in the literature of their change with neonatal exposure to 
infection (Carr and Davies, 1990; Weirich, ., 1998; Nupponen, ., 2001). Hence we have 
analysed the expression of CD11b and CD16 on CB neutrophils and their change on exposure to 
infectious/stressor stimuli. Neutrophils from adult PB samples were labelled and analysed 
concurrently to act as controls. 
Of the 43 CB samples used in this body of work, 37 were classified into stressed and non 
stressed groups and changes on CBDC populations on exposure to stressors were analysed (See 
 !"#and$). The CD11b and CD16 neutrophilic activation markers were assessed in 29 of 
the 37 CB samples which were classified into stressed and non stressed.  
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The above multigraph with correlation point plots show the change in absolute numbers of 
CD11b and CD16 together with the change in numbers of the CD11c
.
CD45
inm
 CBDC 
population on exposure to stressors. Pearson Product Moment Correlation was used as the 
data passed the test of normality 
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Correlation coefficient .  .0.7430 .0.7278 0.6163 0.6306 
 value  0.0218 0.0262 0.1037 0.0937 
 
Correlation coefficients of the change in absolute numbers of CD11b and CD16 with the 
change in numbers of DC in the CD11c
.
CD45
inm
 CB population are shown above 
 
Of the three identified CBDC populations, the CD11c
.
CD45
inm
 CBDC population was found to 
be the most responsive to stressor stimuli (see  ! $). Thus the numbers of this CBDC 
population was used to analyse the correlation with numbers of CD11b and CD16 on exposure to 
stressors. Comparison was made within the preterm samples (stressed and non stressed). The 
term stressed and non stressed samples could not be compared as term stressed samples were not 
available for the current study.  
Figures 4.4A and 4.4B show that in the preterm stressed CBs the numbers of CD11b and CD16 
showed a significant correlation with DC numbers. The numbers of both neutrophilic activation 
markers decreased on exposure to infection and correlated with the increase in DC numbers on 
exposure to stressors (see  !# for the change in DC numbers). The preterm non stressed 
samples showed no such correlation (Figures 4.4C and 4.4D).  
It can be seen that the neutrophilic markers indicate exposure to stressor stimuli in the same 
subset of CB samples classified as stressed and analysed for DC phenotypic and functional 
changes.  Hence the justifiable conclusion can be drawn that the additional parallel changes seen 
on another cellular marker validates the clinical classification of CB samples into those exposed 
and not exposed to stressors. 
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Alterations in the neutrophilic activation markers were assessed with age and on exposure to 
stressors.  
 
		& ) !/*."*3 6-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2 
 
6) 	%*..2 /.6) : )"+/2  
!/2/.*3"-) 
 .;<=
 *>*3
"-) "?@6"*)4 .4-6 !" A*"//:  /*
Adult 3149.94+/.1423.97 99.24+/.0.98 58.88+/.44.82 18 
Term fetus 6012.82+/.1737.17 98.17+/.2.67 56.31+/.41.45 11 
Preterm fetus 2301.83+/.1700.92 95.93+/.5.68 26.48+/.34.24 18 
 
Absolute numbers of neutrophils positive for CD11b expression, percentage positive and 
PCI ratios are given above 
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Multigraph with dot plots and  values delineating the expression of CD11b in adult, term 
and preterm fetuses. Absolute numbers of CD11b positive neutrophils (Figure 4.5A), 
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percentage positive (Figure 4.5B) and PCI ratios (Figure 4.5C) are given. Both stressed and 
non stressed samples were included in the fetal samples 
Figure 4.5 exhibit that the preterm samples significantly expressed the lowest levels of CD11b in 
all three parameters of absolute numbers, percentage positive and PCI ratios. The expression 
increases with advancing age. The absolute numbers were highest in term samples and decreases 
again significantly in the adult (Figure 4.5A and Table 4.2). 
The percentage of positive cells and the PCI ratios were highest in adult samples. Although 
adults showed the highest expression in the above two parameters the increase from term 
samples to adult samples was not statistically significant (Figures 4.5B, 4.5C and Table 4.2). 
 

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As discussed above a subset (.29) of the 37 stressed/non stressed samples used for DC analyses 
was used to analyse the changes in CD11b expression on exposure to stressors (term non 
stressed: 	11; preterm non stressed: 	9; preterm stressed: 	9). All the term samples used were 
non stressed.  
6) 	&*..2 /.6) : )"+/"! ""*!" 
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-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"-) "?@6"*)4 .4-6 !" A*"//:  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Term non stressed 6012.82+/.1737.17 98.17+/.2.67 56.31+/.41.45 11 
Preterm non stressed 2428.78+/.2132.78 93.32+/.7.13 37.04+/.46.4 9 
Preterm stressed 2174.89+/.1250.16 98.53+/.1.59 15.92+/.9.35 9 
 
Absolute numbers of neutrophils positive for CD11b expression, percentage positive and 
PCI ratios are given above 
RESULTS II 
 
198 
 
Absolute numbers
No of CD11b positive
neutrophils per l of blood
0
20
00
40
00
60
00
80
00
10
00
0

	

	
	
Term
Non stressed
Preterm
Non stressed
Preterm
stressed
A

 
% Positive
% of neutrophils positive for CD11b
0 50 10
0
15
0
Term
Non stressed
Preterm
Non stressed
Preterm
stressed
B



PCI Ratio
PCI Ratio of CD11b positive neutrophils
0 50 10
0
15
0
Term
Non stressed
Preterm
Non stressed
Preterm
stressed
C



Expression of CD11b on CB neutrophils on exposure to stressors
 

/24! 	$.2 /.6 7! ""/*.+/"! ""*!" 
Multigraph with column bars and  values showing CD11b expression on preterm stressed, 
preterm non stressed and term non stressed CB 

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The absolute numbers and PCI ratios showed similar results with the preterm stressed samples 
having the lowest expression of CD11b (Figures 4.6A, 4.6C and Table 4.3). The values did not 
reach statistical significance on comparison with the preterm non stressed samples, and this 
could be an effect of the very small numbers of samples. 
There was an age related increase with the term samples expressing more CD11b than the 
preterm non stressed samples in absolute numbers and PCI ratios.  
The percentages of positive cells for CD11b were highest in the preterm stressed samples, this 
could be a result of a change in another cell population and not thought to be significant (Figure 
4.6B and Table 4.3). 

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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"-) "?@6"*)4 .4-6 !" A*3:/6)  ))"
/*Adult 3322.39+/.1238.2 66.93+/.10.68 18 
Term fetus 6138.55+/.1863.5 57.33+/.12.53 11 
Preterm fetus 2367.89+/.1709.9 32.24+/.19.52 18 
 
Absolute numbers of neutrophils positive for CD16 expression and percentage positive 
neutrophils of total number of viable cells are given above 
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Multigraph with column bars and  values delineating CD16 expression in adult, term and 
preterm fetuses. Absolute numbers of CD16 positive neutrophils (Figure 4.7A) and 
percentage positive in total number of viable cells (Figure 4.7B) are given. Both stressed 
and non stressed samples were included in the fetal samples 

The change in absolute numbers of neutrophils expressing CD16 was analysed with advancing 
age. Additionally the percentage of CD16 positive neutrophils in total number of viable cells 
have been assessed as fetal CB was found to have increased number of viable cells when 
compared to adult PB (see  !#0" /*.#	%	). The total number of viable cells in the CB 
was significantly increased when compared to the adult. There was also a significant increase 
with advancing gestational age with term samples having more number of viable cells than 
preterm samples (fetus: mean.7630.89+/.3960.52, n.37 [preterm: mean. 6530.32+/.3786.48,  
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n.25; term: mean.9923.75+/.3400.81, n.12]; adult: mean.4409.36+/.1960.57, n.25) (see  !
#0/24! #B).  
The absolute numbers showed a significant upregulation from preterm to term (Table 4.4). The 
numbers decreased significantly in the adult compared to term samples (Figure 4.7A).  
The preterm samples showed the least percentage and represented only 32% of the total viable 
cell number compared to term CB which represented 57% of the total viable cells (Figure 4.7B). 
Adult samples showed the highest percentage representation of 67% which could be due to the 
decreased total number of viable cells in the adult. 

		&	 ) !/*."*3 $-!9 !*. 7*"4! *"! ""*!"

As discussed above a subset (.29) of the 37 stressed/non stressed samples used for DC analyses 
was used to analyse the changes in CD16 expression on exposure to stressors (term non stressed: 
	11; preterm non stressed: 	9; preterm stressed: 	9). All the term samples used were non 
stressed.  
 
6) 	#*..2 /.$) : )"+/"! ""*!" 
!/2/.*3"-) 
 .;<=
 *>*3
"-) "?@6"*)4 .4-6 !" A*3:/6)  ))"
/*Term non stressed 6138.55+/.1863.5 57.33+/.12.53 11 
Preterm non stressed 2520.78+/.2125.49 37.38+/.24.84 9 
Preterm stressed 2215+/.1281.68 27.67+/.13.12 9 
 
Absolute numbers of CD16 positive neutrophils and percentage positive neutrophils of 
total number of viable cells are given above 
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Multigraph with column bars and  values showing CD16 expression on preterm stressed, 
preterm non stressed and term non stressed CB samples 
 
The preterm stressed samples showed the lowest expression of CD16 in absolute numbers when 
compared with that of term but the results did not achieve statistical significance when 
comparing stressed vs non stressed. There was also an age related increase with the term samples 
expressing more CD16 than the preterm non stressed samples in absolute numbers (Figure 4.8A 
and Table 4.5).  
The percentages showed the preterm stressed samples to be the lowest proportion at 27.67% 
compared with that of term, but did not achieve statistical significance on comparison with the 
preterm non stressed samples (Figure 4.8B and Table 4.5).   
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As infection and stress are high turnover states and result in neutrophil activation, which is 
reflected in the decrease in size and granularity of neutrophils, we have analysed the size and 
granularity by flow cytometry. FSC assessed the size of the neutrophil and SSC assessed the 
granularity. Geometric means of the single parameter histograms of the above were analysed for 
the changes in size and granularity. 
 
			 ) !/*."/.. 4!*/)/"/C 

6) 	$*.) !/*."/.. 4!*/)/"/C  
.2 +/2 
6"*)4 .4-6 !"
?- .;<=
@
*>*3
"-) "?@
Adult 57.54+/.7.5 18 
Term 61.68+/.10.57 11 
Preterm 60.61+/.11.82 18 
7*"4! *"! ""*!"
6"*)4 .4-6 !"
?- .;<=
@
*>*3
"-) "?@
Term non stressed 61.68+/.10.57 11 
Preterm non stressed 63.19+/.10.66 9 
Preterm stressed 57.39+/.13.12 9 
 
         Neutrophilic size at different age groups and with stressors are given above 
 
There was no significant difference in the size of the neutrophils with advancing age on 
comparison between the three groups of preterm, term and adult ( 0.516).  
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There was also no significant difference in the size of the neutrophils with exposure to stressors 
on comparison between the three groups of preterm stressed, preterm non stressed and term non 
stressed CB samples ( 0.551).  
 
			% ) !/*."/.. 4!*/)/2!.4)!/,

6) 	B*.) !/*."/.. 4!*/)/2!.4)!/, 
.2 +/2 
6"*)4 .4-6 !"
?- .;<=
@
*>*3
"-) "?@
Adult 156.79+/.42.56 18 
Term 163.26+/.44.84 11 
Preterm 138.5+/.39.5 18 
7*"4! *"! ""*!"
6"*)4 .4-6 !"
?- .;<=
@
*>*3
"-) "?@
Term non stressed 163.26+/.44.84 11 
Preterm non stressed 151.3+/.28.15 9 
Preterm stressed 122.51+/.47.44 9 

Neutrophilic granularities at different age groups and with stressors are given above 
 
There was no significant difference in neutrophilic granularity with advancing age on 
comparison between the three groups of preterm, term and adult ( 0.251). 
There was also no significant difference in the neutrophilic granularity with exposure to stressors 
on comparison between the three groups of preterm stressed, preterm non stressed and term non 
stressed CB samples ( 0.112). 




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There is evidence in the literature to support the hypothesis that labour itself could activate 
neutrophils (Weinschenk, 
 1998; Gronlund, ., 1999). Hence the change in expressions 
of both CD11b and CD16 were analysed and compared between CB of neonates who underwent 
labour with those who were delivered prior to the start of labour.  
 
6) 	8*.6.5$) !/*."+/)6*4! 

-) "
6"*)4 .4-6 !"?- .;<=
@ *>*3
"-) "?@6 7! ""/*. $ 7! ""/*.
Labourers 3762.53+/.2469.38 3841.37+/.2465.98 19 
Non labourers 3608.6+/.2655.6 3716+/.2827.3 10 

Absolute numbers of neutrophils expressing CD11b and CD16 in labourers and non 
labourers are given above 
 
There was no change in CD11b expression ( 0.878) and CD16 expression ( 0.902) with the 
difference in labour.  



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This study confirms a statistically significant negative correlation between the neutrophilic 
activation markers numbers and CD11c
.
CD45
inm
 DC numbers in the same CB samples classified 
as stressed and used for the DC studies. Evidence in literature supports a downregulation of the 
neutrophilic activation markers; CD11b and CD16 in infectious states. There was a decrease of 
the neutrophilic activation markers; CD11b and CD16 in the same CB samples that exhibited the 
rise in CBDC numbers and these findings confirm the exposure to infectious/stressor stimuli in 
these CB samples and validate the above clinical classification.  
Analysis was done on whole blood without cell separation in order to mimic the  
environment as closely as possible. Studies using cell separation techniques have the attendant 
risk of loss of cell populations which has been avoided by analysing whole blood. Centrifugation 
on density gradients have been shown to upregulate surface antigens, especially CD16, CD45 
and the CD18 integrins (Kuijpers,  ., 1991). Flow cytometric techniques have been used 
throughout to measure the phenotypic expressions. Unlike the use of morphological criteria to 
identify cells, the use of monoclonal antibodies enables the accurate and objective analysis and 
eliminates observer variation. Heparinised tubes were used for blood collection as EDTA has 
been shown to activate CD11b expression (Repo, ., 1995). All the blood samples have been 
analysed within two hours of collection and at stable room temperature as studies have shown 
that CD11b is spontaneously upregulated after two hours in room temperature (Weirich, ., 
1998). It is submitted that the results of the investigations using these methods reflect the 
state, without any modulations. 
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Our analysis did not show a statistically significant change in the expression of CD11b on 
neutrophils when fetuses had been exposed to intrauterine stress or infections. This could be due 
to the small numbers of samples in the study. Previous studies show decreased bactericidal and 
phagocytic activity of stressed new born infants (Wright,  ., 1975; Cui,  ., 2003). The 
functional deficiency of the neonatal immune system, in particular the activation of the 
neutrophils, is reflected in the decreased upregulation of the CD11b integrin and is proven by the 
immune response of neutropenia to sepsis seen in the neonate as opposed to the neutrophilia 
mounted by the more mature adult immune system (Carr, 2000). Evidence in literature points to 
a modulation of neutrophilic surface receptors expression across the continuum of sepsis, and 
enhanced or decreased expression is dependant on the stage of the disease. In the early stages of 
sepsis, studies have identified an upregulation of CD11b indicating an active immune system 
(Weirich,  ., 1998; Nupponen,  ., 2001). In profound sepsis especially with the added 
conundrum of an immature immune system with prematurity, a significant downregulation has 
been identified (Wright, ., 1975; Cui, ., 2003; Huang, ., 2009). 
Analysis of the CD16 marker paralleled the CD11b analysis. Studies have shown that in patients 
with severe bacterial infections CD16 is partially lost from the surface (Wagner, ., 2003). 
Carr and Davies showed that stress (respiratory distress syndrome or sepsis) in extremely 
premature babies was associated with a reduction of neutrophilic CD16 surface expression that 
persisted over at least the first 3 weeks of post.natal life (Carr and Davies, 1990). This finding 
correlates with the shedding of the antigen from the neutrophil surface on neutrophil activation 
due to an immunogenic stimulus.  
To further understand the mechanics of the fetal immune system we have analysed the 
differences in the neutrophilic expression of CD11b and CD16 seen with advancing age. The 
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analysis of CD11b expression on term and preterm neutrophils revealed an upregulation in the 
term CB. The numbers of CD11b positive neutrophils decrease in the adult but the percentage of 
positive cells and their PCI ratio is higher when compared to preterm CB. This again indicates 
the comparative greater functional maturity of the adult neutrophils. Thus the alterations of 
neutrophilic CD11b with age indicated the functional immaturity and decreased priming of the 
fetal neutrophils compared to the adult blood. It also indicated an ongoing process of maturation 
along with fetal development and increasing gestation, as the term neutrophils express more 
CD11b than the preterm blood.  
Analysis of CD16 expression with age was similar and revealed an upregulation in term CB 
compared to preterm CB. This finding is in line with the reasons expanded on above and 
indicates that premature neutrophils are functionally immature and mature with increasing 
gestation. Henneke and Berner in their study showed that CD16 expression can be significantly 
lower in polymorphonuclear cells from very premature neonates as compared with term 
neonates, and the expression rises towards adult levels over the first post.natal weeks (Henneke 
and Berner, 2006). 
Previous studies have shown the mode of delivery and length of labour to affect neutrophil 
activation (Weinschenk, 
 1998; Gronlund, ., 1999; Banasik, ., 2000). In our study 
there were no significant differences seen with the mode of delivery in the expression of CD11b 
and CD16 in any of our group of neonates, but this could be due to the small numbers of 
samples.  
As infectious states result in a high neutrophil turnover and increased apoptosis we have 
analysed the neutrophilic size and granularity according to their light scatter properties. The 
enzymes in the intracellular neutrophilic granules play the central role in phagocytosis and 
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degranulation indicates an activated functional neutrophil (Stephen, ., 1999). Also apoptotic 
cells have reduced forward scatter properties due to their loss of water and they become less 
granular resulting in reduced side scatter (Gorman, ., 1997). There is a 10.100 fold increase 
in neutrophilic turnover during acute infections (McAfee and Thakur, 1976) and ageing 
neutrophils develop morphological features typical of apoptosis (Whyte, ., 1993). Hence we 
investigated the SSC and FSC properties of the adult and CB neutrophils. In our study there were 
no significant differences with age or exposure to stressors, but again this could be due to the 
small numbers of samples. 
The phenotypic and functional immaturity of the fetal and neonatal immune system has been 
evidenced in numerous studies and contributes to the higher incidence of infections seen in 
neonates compared to adults. Preterm neonates of 28 to 34 weeks gestational age exhibit 
decreased polymorphonuclear opsonic capacity, phagocytosis and respiratory burst compared 
with term neonates and adults, and this may be worse in very premature neonates (Drossou, 
., 1997; Bialek and Bartmann, 1998; Kallman, ., 1998; Henneke and Berner, 2006). It has 
been shown that the regulation of phenotypical parameters such as the adhesion molecules, 
CD11b and L.selectin indicates upregulation of the functional status or increasing maturity on 
activation by infectious or immunogenic stimuli. Thus analysing the changes of CD11b 
expression would serve to identify the group of babies exposed to infectious stimuli, prior to the 
onset of clinical infection. Cui   showed that the detection of CD11b (</= 600 MFI) for 
suspected sepsis showed a sensitivity of 86.3%, a specificity of 100%, a positive predictive value 
of 100%, and a negative predictive value of 68.2%. The positive rate of CD11b detection was 
86.3%, which was higher than the blood culture test (< 0.05) (Cui, ., 2003). 
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There was a statistically significant negative correlation between the neutrophilic activation 
markers numbers and CD11c
.
CD45
inm
 DC numbers in the same CB samples classified as 
stressed and used for the DC studies, indicating a real pathology in the chosen samples. Thus for 
the purposes of this study, the significant correlation between the changes in neutrophilic 
markers and CBDC numbers in the CB samples classified as stressed validates the clinical 
classification and adds credence to the CBDC studies discussed in the later chapters.  
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The myeloid and plasmacytoid subpopulations of DCs in adult PB and CB and the additional 
CD11c

CD45
inm
 CBDC subpopulation were identified and their phenotypic and functional 
characteristics established previously. The aim of this study was to assess the changes on the 
CBDC subpopulations with advancing age and exposure to stressors. Analysis was performed to 
assess the change in the expression of the maturation markers, CD45 and HLADR and the 
change in numbers.  
All analysis was performed using labelling with monoclonal antibodies and flow cytometry 
acquisition. 
Analysis of the expression of maturation markers showed the myeloid and plasmacytoid CBDC 
and adult PB DC populations to express similar amounts of CD45 and HLADR. The CD11c

CD45
inm
 DCs were immature compared with the myeloid and plasmacytoid subset, expressing 
significantly lower levels of CD45 and HLADR. There was no significant change in the 
expression of CD45 and HLADR with age and on exposure to stressors in the fetal CBDCs and 
adult PB DCs. 
Analysis of the numbers showed that the myeloid CD11c
+
CD45
hi
 DC subset predominated in 
adult PB when compared to CBDC. There was no significant change seen in the CD11c

CD45
hi 
plasmacytoid DC subset between adult and CBDC. The myeloid and plasmacytoid CBDC 
subsets did not change with increasing gestation from preterm to term. The novel CD11c

CD45
inm
 putative CBDC subset decreased significantly with increasing gestational age as they 
were less prominent in the term fetus compared to the preterm fetus and almost absent in the 
adult. This subset represented 31.33% of the total number of DC in the preterm CB, but 
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represented 21.26% of the total number of DC in the term CB samples and only 1.54% of the 
total number of DC in adult PB.  
Taken together, these data indicated that the myeloid and plasmacytoid CBDC populations were 
comparable in maturity to the adult PB DC subsets. They showed no significant difference in 
numbers between adult and fetus and no change in numbers with advancing gestational age. Both 
the subsets increased in numbers on exposure to stressor stimuli. The novel CD11c

CD45
inm
 
CBDCs were immature expressing lower levels of CD45 and HLADR and their numbers 
decreased with increasing gestational age. They also significantly increased in numbers on 
exposure to stressor stimuli. Thus, of the three subsets of CBDCs, the novel CD11c

CD45
inm
 
CBDC subset seemed to be the most kinetic, changing with advancing gestation as well as 
exposure to stressor stimuli.  
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CBDCs have been identified by the presence of the cell surface marker HLADR and lack of the 
CD3, CD14, CD16, CD19, CD34, and CD56 markers, as has been followed in the identification 
of adult DCs. This population was a minority and represents only about 0.3% of CB 
mononuclear cells (Sorg, ., 1999). The composition and maturity of CBDC subpopulations 
vary when compared to the adult DC populations. The majority of CBDCs show a plasmacytoid 
phenotype resulting in an inverted CD11c
+
/CD11c

 ratio with predominant CD11c

 DCs, when 
compared with adult PB DCs; in adults CD11c
+
 DCs dominate with a predominant myeloid 
phenotype (Borras,  ., 2001; Drohan,  ., 2004). CBDCs are immature when compared 
with adult DCs; showing high levels of CD34, low CD4, low CD83, and lower levels of HLA
DR, CD40 and CD86 (Holloway, ., 2000). A lower functional capacity has been attributed to 
CBDCs when compared to adult DCs. They have a reduced ability to attain a fully mature adult 
phenotype and to activate CD4
+
 T cells to produce IFNα (Langrish, ., 2002).  
This study investigated the above background literature of differing composition and maturity of 
CBDC subsets when compared to adults. The aim of this study was to identify and further 
analyse the changes occurring on CBDC subsets with increasing gestational age and on exposure 
to stressors. As discussed previously three subsets of CBDCs were identified and of those the 
CD11c

CD45
inm
 subset was of interest as to date it had not been identified in CB.  The immature 
CD11c

 CBDC subsets described in the literature has been identified as either CD123
+ 
(plasmacytoid) or CD123
dim
, but this putative subset was negative for the expression of CD123. 
Thus it was of interest to investigate the evolution of this novel subset and the change in numbers 
and in maturation markers occurring with age and on exposure to stressors.  
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It was hypothesised that CBDC populations change with increasing gestational age, during the 
intrauterine period and into the neonatal period. It was also hypothesised that exposure to 
‘stressors’ such as intrauterine infection and immunogenic stimuli can accelerate and modify 
these changes. If proven, these changes which occur due to infectious/immunogenic stimuli may 
serve to identify immature infants exposed to infections 	
The ability of DCs to alter their 
phenotype and function in response to microbial exposure suggests that changes in CBDC 
populations may be useful markers of exposure to intrauterine infection or stress and hence the 
risk of adverse neonatal sequelae (Huang, ., 2001). Also understanding the composition and 
change in CBDC populations would further our understanding of the genesis and organisation of 
the immune system.  
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Blood from the umbilical cord of 25 preterm babies and 12 term babies was analysed for 
numbers of the DC subsets and their change with age and exposure to stressors. Blood from the 
umbilical cord of 26 preterm babies and 14 term babies was analysed for expression of CD45 
and HLADR. Adult peripheral venous blood for analysis was obtained from 32 healthy non
pregnant volunteers. Changes in numbers of the fetal CBDC subsets on exposure to stressor 
stimuli were evaluated. All the term fetuses evaluated (12) were not exposed to stressor stimuli 
 	
, while of the preterm fetuses, 17 were exposed to stressor stimuli and 8 were not 
exposed to stressor stimuli. Detailed discussion about the criteria for classification and validation 
by neutrophilic activation markers is given in  !"#$%.  
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS III 
 
217 
 
	% 



	% &!$#''()*)+%	 *,-)* *, ,./"!)!./ "()*

In the preceding chapter, the CBDC subsets were identified based on their expression of HLA
DR and Lineage cocktail and further identification of subsets were done based on their 
expression of CD45 and CD11c. The levels of expression of the CD45 and HLADR markers 
was analysed on the CBDC subsets as differential expression by these subsets were noted on the 
histograms. It was felt that analyses of the levels of expression of CD45 and HLADR will give 
information on the comparative maturation states of the CBDC subsets. The usually studied DC 
markers of maturation will be analysed in the next chapter. 

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Expression of CD45 and HLADR was assessed by comparison of the geometric x mean of the 
positive histograms (40).  
 
 3/#	 " )*#&!$#''()*)+%	 *,-)*01#/)(, *,!/ '0 21")(,
'.3'#"' 

# *45-
 )6)+
' 0!/#'78%	 -
1#/)(,'.3'#"  
Adult 2409.06+/1641.63 640.83+/459.81 32 
Fetus 1904.64+/1474.94 781.11+/626.08 40 
values adult vs fetus 0.231 0.360  
/ '0 21")(,'.3'#"  
Adult 2295.06+/1588.19 612.18+/496.94 32 
Fetus 2037.95+/1502.52 736.72+/722.78 40 
values adult vs fetus 0.603 0.449  
          
         Expressions of CD45 and HLADR by CBDCs in the various age groups  
 
The myeloid and the plasmacytoid DC subsets in adult and CB expressed similar amounts of 
CD45 and HLADR.  
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The two parameter histogram above delineate the three CBDC subsets (R3: 
CD11c
+
CD45
hi
, R4: CD11c

CD45
hi
, R5: CD11c

CD45
inm
) (Figure 5.1A) and the backgated 
single parameter histogram show the expressions of CD45 (Figure 5.1B) and HLADR 
(Figure 5.1C). Representative histograms shown from 40 experiments 
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The back gated histograms gave a clear visual impression of lower level of expression of these 
maturation markers on the CD11c

CD45
inm 
subset. Comparison of intensity values were made to 
investigate the above observation further. 
Comparison of DC subsets
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Bar graphs of CD45 and HLADR levels on the three CBDC subsets are shown. 
Expression was assessed by comparison of the geometric x mean of the positive histograms 
(40). Mean values with standard error shown (CD11c

CD45
inm
: CD45 <0.001; HLA
DR<0.001; myeloid vs plasmacytoid: CD45  0.602; HLADR  0.512) 
 
The results show that CD11c

CD45
inm
 DCs expressed significantly lesser amounts of both CD45 
and HLADR when compared with the myeloid and plasmacytoid DC populations (CD45: mean 
497.34+/460.53, <0.001; HLADR: mean318.95+/274.52, <0.001). Both the myeloid and 
plasmacytoid subsets expressed higher amounts and were similar (CD45:  0.602; HLADR: 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0.512). Taken together the data expressed in Figures 5.1 and 5.2 suggest that the CD11c

CD45
inm
 
DCs were immature compared to the myeloid and plasmacytoid CBDC populations. 
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The changes seen in numbers of cells were analysed in the CBDC subsets and also on adult PB 
DCs for comparison.  
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Two parameter histograms shown of the adult PB (Figure 5.3A) and CBDC subsets (Figure 
5.3B) based on their expression of CD45 and CD11c phenotypic markers. Representative 
histograms shown from 43 experiments 

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Figure 5.3 showed an apparent decrease in the myeloid subset in the term fetus when compared 
to adult PB. This was analysed further. Both absolute numbers as well as the percentage of total 
viable cells and of the total number of DCs that the subset represented were compared. 
Comparison was made between adult, term and preterm samples to assess the change with 
advancing age. 
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Adult 20.88+/12.22 0.58+/0.52 52.88+/17.94 25 
Term fetus 17.83+/8.99 0.24+/0.30 32.97+/8.04 12 
Preterm fetus 28.32+/37.41 0.61+/0.91 29.44+/14.34 25 
Fetus (term & 
preterm) 
24.92+/31.34 0C48+/0C78 31.20+/12.62 37 
 
The difference in numbers of CD11c
+
CD45
hi 
DCs with age is shown in absolute numbers, 
percentage of total viable cells and percentage of total DCs 
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Multigraph with point plots and  values showing the difference in the numbers of myeloid 
DCs as absolute numbers, percentage of total viable cells and percentage of total DCs  
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The absolute numbers of CD11c
+
CD45
hi
 DC did not show a significant difference between adult, 
preterm and term CB (Figure 5.4A).  
The percentage of CD11c
+
CD45
hi
 DC in the total viable cells showed a significant difference 
between adult and preterm and between adult and term.  Percentage was highest in preterm CB 
(Figure 5.4B).  
The percentage of CD11c
+
CD45
hi
 DC in the total number of DC showed a significant difference 
between adult and preterm and between adult and term.  Percentage was highest in the adult and 
this subset formed 52.88% of the total adult DCs (Figure 5.4C).  
Comparison was made between adult and fetal samples to assess the change with age. The 
absolute numbers showed no significant difference ( 0.532). On comparison as proportion of 
the total number of viable cells ( 0.001) and as proportion of the total number of DCs (<0.001) 
the myeloid DCs showed predominance in adult blood when compared to CB.  
This data indicates that although the differences in absolute numbers of cells did not reach 
statistical significance, the myeloid population is the predominant DC population in the adult 
when compared to the fetus. 
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Adult 18.56+/14.26 0.59+/0.58 45.58+/18.38 25 
Term fetus 25+/16.69 0.33+/0.44 45.77+/13.22 12 
Preterm fetus 43.4+/59.4 1.17+/1.84 39.23+/16.82 25 
Fetus (term & 
preterm) 
37.43+/50.13 0.9+/1.57 40.74+/15.86 37 
 
The difference in numbers of CD11c

CD45
hi 
DC subset with age is shown in absolute 
numbers, percentage of total viable cells and percentage of total DCs 
 
There was no significant change seen in the CD11c

CD45
hi 
DC subset with respect to increasing 
age and gestational age. There were no significant differences between adult, term and preterm 
samples as well as between adult and fetus in the above parameters. 
P values between term and preterm for change with increasing gestation (absolute numbers:  
0.147; % of viable cells:  0.188; % of total DCs:  0.246).  
P values between adult and fetus for change with age (absolute numbers:  0.053; % of viable 
cells:  0.491; % of total DCs:  0.344).  
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Adult 0.64+/1.02 0.01+/0.02 1.54+/2.26 25 
Term fetus 10.25+/5.96 0.13+/0.11 21.26+/14.71 12 
Preterm fetus 40.56+/53.58 0.59+/0.77 31.33+/19.72 25 
Fetus (term & preterm) 25.22+/42.26 0.44+/0.67 28.06+/18.66 37 
 
The difference in numbers of CD11c

CD45
inm 
DC subset with age is shown in absolute 
numbers, percentage of total viable cells and percentage of total DCs (values: Absolute 
numbers: adult vs term <0.001, adult vs preterm  <0.001, term vs preterm – 0.039; % of 
total viable cells: adult vs term  <0.001, adult vs preterm  <0.001, term vs preterm – 
0.026; % of total DC – adult vs term  <0.001, adult vs preterm  <0.001, term vs preterm – 
0.035) 
 
The two parameter histograms in Figure 5.5 below showed the CD11c

CD45
inm
 CBDC subset to 
change with advancing gestational age. The subset appeared more prominent in the preterm fetus 
and less so in the term fetus. This change in numbers seemed to be evolving into the neonatal 
period as the histogram of the adult DCs revealed the subset to be almost absent. 
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In Figure 5.5, this subset (R3) was more pronounced in the preterm fetus and becomes less 
pronounced as gestation increases (compare subset in R3 in Figure 5.5A with subset in R3 
in Figure 5.5B). Additionally the subset was absent in the adult (compare R3 in Figure 
5.5A with R3 in Figure 5.5C). Representative histograms shown of 43 experiments 
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Multigraph with point plots and  values showing the difference in the numbers of CD11c

CD45
inm 
DC subset as absolute numbers, percentage of total viable cells and percentage of 
total DCs  
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To further ascertain the changes seen in the two parameter histograms, comparison of the 
absolute numbers of the CD11c

CD45
inm 
subset per Fl of blood between the preterm, term CB 
and adult PB was performed (Figure 5.6A). To rule out the possibility that the increase in 
numbers observed in both preterm and term CBs was a simple reflection of the increased 
cellularity of fetal samples, the CD11c

CD45
inm
numbers was examined as a proportion of total 
viable cells and as a proportion of total number of DCs (Figure 5.6B and Figure 5.6C).  
Comparison of absolute numbers and percentage of viable cells showed a statistically significant 
decrease with advancing gestational age on comparison between preterm and term samples.  The 
decrease continued after birth as adult blood showed a statistically significant decrease when 
compared with both preterm as well as term CB. (Figures 5.6A and 5.6B).  
There was a significant decrease in the proportions of total DC with gestational age on 
comparison between preterm and term samples. The proportions showed a significant increase in 
the preterm as well as the term CB samples, compared with adult PB (Figure 5.6C). This subset 
represented 31.33% of the total number of DC in the preterm CB, but represented 21.26% of the 
total number of DC in the term CB samples and only 1.54% of the total number of DC in adult 
PB (Table 5.4).  
Taken together these results highlighted in Figure 5.6 indicate that there is a real decrease in the 
numbers of the CD11c

CD45
inm
population with increasing age. The numbers in the fetus 
decreases towards term and the changes continue into the neonatal and adult period as reflected 
by their almost absence in the adult. 
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To assess the validity of the changes in the different CBDC subsets in relation to global changes 
in cell numbers with age, changes in the total numbers of viable cells and total number of DCs 
were analysed between the adult PB and CB samples. 
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The above point plots with values show the difference in the total number of viable cells 
and in the total number of DCs in adult PB and CB samples  
 

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Adult 4409.36+/1960.57 40.12+/20.25 25 
Term fetus 9923.75+/3400.81 53.08+/24.11 12 
Preterm fetus 6530.32+/3786.48 112.28+/134.73 25 
Fetus (term & preterm) 7630C89+/3960.52 93.08+/114.32 37 
 
The total numbers of viable cells and the total numbers of DCs in the various age groups 
are shown above 
 
Fetal CB was found to have significantly increased cellularity when compared to adult PB. 
Within the gestational period the cellularity significantly increased with term samples having 
more number of viable cells than preterm samples (Figure 5.7A).  
The total number of DCs was statistically increased in the preterm compared to the adult. But 
there was no significant difference between adult and term samples as well as between term and 
preterm samples (Figure 5.7B).  
Taken together with the data discussed above, this finding showed that the significant increase in 
the DC numbers in the preterm is probably a reflection of the increased CD11c

CD45
inm
 subset, 
as the myeloid and plasmacytoid subsets showed no significant change. The increase in 
cellularity in the fetus was not a reflection of a change in DC populations, but a probable change 
in numbers of other cellular groups which was not investigated further in our study. 
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Comparison of the percentages and numbers were made to further understand the composition of 
CBDCs and adult PB DCs. 
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In adults the predominant DC population is myeloid followed by plasmacytoid. Conversely 
the plasmacytoid DC population predominated in both preterm and term CB. The CD11c

CD45
inm
 population formed a larger percentage in the preterm compared to the term fetus 
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Adult 
52.88+/17.94 
(52.88%) 
45.58+/18.38 
(45.58%) 
1.54+/2.26 
(1.54%) 25 
Term fetus 
32.97+/8.04 
(32.97%) 
45.77+/13.22 
(45.77%) 
21.26+/14.71 
(21.26%) 12 
Preterm fetus 
29.44+/14.34 
(29.44%) 
39.23+/16.82 
(39.23%) 
31.33+/19.72 
(31.33%) 25 
Fetus (term & preterm) 
31.20+/12.62 
(31.20%) 
40.74+/15.86 
(40.74%) 
28.06+/18.66 
(28.06%) 37 
 
The percentage of the CBDC subsets in the total number of DCs for the various age groups 
are given above 
 
As is shown by Figure 5.8 above, the plasmacytoid subset forms similar percentages and 
predominates in the fetal blood. The myeloid subset forms similar proportion in CB, but 
predominates in the adult. The CD11c

CD45
inm
 population decreases with increasing age and is 
seen most predominantly in the preterm fetus and almost absent in the adult. 
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The ratio of CD11c
+
 to CD11c

 numbers was analysed as literature to date supports a reversal of 
ratio in fetal circulation with predominance of CD11c

 numbers. 
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The above point plot with  values shows the difference in the CD11c
+
/CD11c
 
ratio 
between preterm (25), term (12) and adult blood (25) 
 
The ratio of CD11c
+
/CD11c

 was increased significantly in adults compared to the fetus (fetus: 
ratio0C90; adult ratio1C63, <0C020), and appeared to be due to the increased numbers of 
CD11c
+
 DCs in comparison to the CD11c

 DCs. Thus the ratio in adults is positive as the 
CD11c
+
 DCs predominate. The ratio is less than one in all the CBDC samples as the CD11c

 DC 
subset predominates (preterm ratio  0.96; term ratio  0.78). 
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As the various CBDC populations were found to vary in their expressions of the above markers, 
their potential alteration with advancing gestational age was analysed.  
The myeloid and plasmacytoid subset showed no alterations in CD45 and HLADR with 
increasing age and advancing gestational age. The CD11c

CD45
inm
 CBDC populationshowed no 
significant change in CD45 and HLADR with advancing gestational age.  
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Adult 2409.06+/1641.63 2295.06+/1588.19 NA 32 
Term fetus 1937.01+/1543.79 2184.71+/1630.72 552.85+/617.71 14 
Preterm fetus 1884.25+/1459.49 1945.54+/1440.22 462.39+/335.66 26 
Fetus (term & 
preterm) 
1904.64+/1474.94 2037.95+/1502.52 497.30+/460.50 40 
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Adult 640.82+/459.81 612.18+/496.94 NA 32 
Term fetus 645.62+/413.64 616.68+/422.76 285.87+/270.29 14 
Preterm fetus 866.42+/723.48 812.3+/859.45 339.78+/280.20 26 
Fetus (term & 
preterm) 
781.11+/626.08 736.72+/722.78 318.90+/274.50 40 
 
The absolute numbers of CD45 and HLADR expression by CBDCs in the various age 
groups are given above 
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CD45 expression on CD11c +CD45hi DCs
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HLADR expression on CD11cCD45inm DCs
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Multigraph of point plots with  values showing CD45 and HLADR expression on DC 
subsets in CB and adult PB  
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It was postulated that increasing gestational age as well as fetal/intrauterine stressors could lead 
to identifiable changes in CBDC subsets. To distinguish between the effects of exposure to 
stressors and of increasing gestational age all the preterm CB samples (25) were analysed in 
two groups; samples from fetuses with (17) and without (8) stressor stimuli. All the term CB 
analysed did not have any exposure to stressor stimuli (12).  
To rule out the possibility that the increase in CBDC numbers was a simple reflection of the 
increased cellularity of fetal samples, we also examined the CBDC numbers as a proportion of 
total number of viable cells and of total number of DCs.  
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Term non stressed 17.83+/8.99 0.24+/0.30 34.5+/10.08 12 
Preterm non stressed 8.88+/5.72 0.13+/0.06 30.63+/16.31 8 
Preterm stressed 37.47+/42.5 0.84+/1.03 37.24+/12.17 17 
 
The change in myeloid CBDC subset with stressors is given in absolute numbers, 
percentage of viable cells and percentage of total number of DCs 
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The above multigraph with column bars and  values shows the difference in numbers of 
myeloid subset. Figure 5.11A shows the absolute numbers of DCs per Fl of blood and 
Figures 5.11B and 5.11C show the proportion of total viable cells and of total DCs 
respectively 
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On comparison of absolute numbers the two groups that significantly differed were the preterm 
stressed vs preterm non stressed and the term vs preterm non stressed (Figure 5.11A).  
The numbers as a proportion of total viable cells showed an increase in the preterm stressed 
samples (Figure 5.11B), while the proportions of total number of DCs were not significantly 
different (Figure 5.11C).  
This data evidences that exposure to stressor stimuli increases the numbers of the CD11c
+
CD45
hi 
DCs as the preterm stressed CB showed a significant increase compared to the preterm non 
stressed CB.  
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Term non stressed 25+/16.69 0.33+/0.44 43.25+/10.15 12 
Preterm non stressed 12.13+/5.96 0.25+/0.23 43.24+/22.43 8 
Preterm stressed 58.12+/67.51 1.61+/2.10 24.99+/6.39 17 
 
The change in plasmacytoid CBDC subset with stressors is given in absolute numbers, 
percentage of viable cells and percentage of total number of DCs 
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The above multigraph with column bars and values shows the difference in numbers of 
plasmacytoid subset. Figure 5.12A shows the absolute numbers of DCs per Fl of blood and 
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Figures 5.12B and 5.12C show the proportion of total viable cells and of total DCs 
respectively 
The changes in the plasmacytoid CBDC population paralleled the changes in the myeloid CBDC 
population. On comparison of absolute numbers the two groups that significantly differed were 
the preterm stressed vs preterm non stressed and the term vs preterm non stressed (Figure 
5.12A).  
The numbers as a proportion of total viable cells showed an increase in the preterm stressed 
samples (Figure 5.12B), while the proportions of total number of DCs were not significant 
(Figure 5.12C).  
This data evidences that exposure to stressor stimuli increases the numbers of the CD11c

CD45
hi 
DC subset as the preterm stressed CB showed a significant increase compared to the preterm non 
stressed CB.  
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Term non stressed 10.25+/5.96 0.13+/0.11 22.25+/15.25 12 
Preterm non stressed 7.88+/6.15 0.11+/0.06 26.13+/14.05 8 
Preterm stressed 43.94+/57.33 0.81+/0.85 37.77+/26.84 17 
 
The change in CD11c

CD45
inm
 CBDC subset with stressors is given in absolute numbers, 
percentage of viable cells and percentage of total number of DCs 
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The above multigraph with column bars and values shows the difference in numbers of 
CD11c

CD45
inm 
DCs. Figure 5.13A shows the absolute numbers of DCs per Fl of blood 
and Figures 5.13B and 5.13C show the proportion of total viable cells and of total DCs 
respectively 
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Differences with adult PB CD11c

CD45
inm
 DCs could not be ascertained due to the significant 
lack of the CD11c

CD45
inm
 subset in the adult.  
On analyses of absolute numbers, preterm stressed CB showed a statistically significant increase 
in absolute numbers when compared with preterm non stressed CB (Figure 5.13A).  
The CD11c

CD45
inm
subset as a percentage of the total number of viable cells was significantly 
increased in preterm stressed CB when compared with the preterm non stressed CB (Figure 
5.13B). Analysis of the subset as a percentage of the total number of DCs showed no significant 
change in preterm stressed CB (Figure 5.13C). 
Taken together the data above indicate that exposure to stressors increased the numbers of 
CD11c

CD45
inm
 CBDCs significantly.  
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To assess the validity of the changes in the different CBDC subsets in relation to global changes 
in cell numbers, the change in the total numbers of viable cells and total DCs were analysed 
between the three groups of term non stressed, preterm non stressed and preterm stressed. 
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The above multigraph with column bars and  values shows the difference in the total 
number of viable cells and the total number of DCs per Fl of blood  
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Term non stressed 9923.75+/3400.81 53.08+/24.10 12 
Preterm non stressed 6991.63+/3539.15 28.88+/9.08 8 
Preterm stressed 6313.24+/3983.68 139.53+/154.41 17 
 
The total numbers of viable cells and the total numbers of DCs in the various age groups 
are shown above 
 
On comparison of the total number of viable cells there was no significant effect of exposure to 
stressors. The effect of advancing gestational age was seen with the term CB showing more 
cellularity (Figure 5.14A).  
On comparison of the total number of DCs, the two groups that significantly differed were the 
preterm stressed vs preterm non stressed and the term vs preterm non stressed (Figure 5.14B). 
Thus exposure to stressor stimuli was shown to increase the total DC numbers. 
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As the various CBDC populations were found to vary in their expressions of the above 
maturation markers, their potential alteration on exposure to stressors was analysed.  
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The expressions of CD45 and HLADR by the CBDC subsets in the various age groups 
are given above
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In summary from the data shown above, the myeloid, plasmacytoid and the CD11c

CD45
inm
 
CBDC subsets did not show any alterations in their expression of CD45 and HLADR on 
exposure to stressors.   
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This study analysed the changes that occurred in the umbilical CBDC subsets with increasing 
gestational age and exposure to stressor stimuli. The CD11c

CD45
inm
 subset decreased 
significantly with increasing gestational age and was seen only as a trace population in the adult. 
The myeloid and plasmacytoid CBDC subsets showed no change with increasing gestational age. 
All three CBDC subsets increased in numbers on exposure to stressor stimuli. The myeloid and 
plasmacytoid subsets expressed similar amounts of CD45 and HLADR when compared with the 
adult PB DCs, while the CD11c

CD45
inm
 subset expressed lower levels indicating an immature 
phenotype. These changes may be a reflection of the maturation and activation of the immune 
system with increasing gestational age or with intrauterine stressor stimuli.
Analysis was performed on whole blood in order to reflect the 
environment as closely as 
possible with its attendant advantages and with the appropriate controls as discussed previously.  
CD45 (PTPRC, leukocyte common antigen, B220, T200) is a signalling molecule expressed on 
all nucleated haematopoietic cells and is therefore widely used as a panleukocyte maturation 
marker molecule. It has a central role in antigen stimulation of T lymphocytes and is a marker of 
functional maturation (Trowbridge and Thomas, 1994). CD45 mutations result in severe 
combined immunodeficiency phenotype, systemic lupus erythematosus, and many other diseases 
(Cale, ., 1997; Kung,  ., 2000; Tchilian, ., 2001). Cross  have shown that CD45, 
though not required for the development of DCs, does influence DC maturation induced by TLR 
agonists and that CD45null DCs had a reduced ability to activate NK and Th1 cells to produce 
IFNγ indicating functional immaturity (Cross, ., 2008). CD45 has been shown to increase in 
intensity as maturation takes place, thus the CD11c

CD45
inm
 CBDCs appear to be immature 
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compared to the myeloid and plasmacytoid CBDC subsets (Borowitz, ., 1993; Jennings and 
Foon, 1997). 
There were no differences in the expression of the markers of maturity i.e. CD45 and HLADR 
on myeloid and plasmacytoid CBDC subsets when compared with adult PB DCs. As the CD11c

CD45
inm
 subset expressed both CD45 and HLADR at a lower intermediate level, they appear to 
be a group of immature DCs undergoing change. By its very definition HLA is necessary for the 
main DC function of antigen presentation and reduced expression of which could readily result 
in functional immaturity. Unfortunately adult PB did not have enough numbers of cells within 
the novel subset to compare the expression of the maturation markers. The conclusion could be 
drawn that as the myeloid and plasmacytoid CBDC subsets have the same level of maturity as 
adult PB DCs, the immature CD11c

CD45
inm
 subset must be a major contributing factor to the 
immature functioning of fetal DCs. The probable key role played by this subset in the fetal 
immune system was in line with the finding that this subset formed a large percentage in the 
fetus and was almost absent in the adult. The study did not identify any significant change in the 
expression of these maturation markers with age or with exposure to stressors. The lack of a 
significant change in these markers could be a real effect or a reflection of the inadequate power 
of the study and analyses of a larger number of samples could be more sensitive in elucidating 
these changes.  
In order to investigate the changes in the CBDC subsets occurring in parallel with the 
development of the fetal immune system, we have analysed the changes in numbers occurring 
with increasing gestational age. Analyses of the myeloid and plasmacytoid CBDC subsets 
showed no change with increasing gestational age. Drohan   found that adult blood had a 
significantly higher proportion of myeloid DC than did CB (Drohan,  ., 2004) which was 
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confirmed in this study. As had been observed in other studies there was a reversal of ratio in the 
fetus with the plasmacytoid subset predominating. In adults the predominant DC population is 
CD11c
+
 myeloid (52.88%) followed by the CD11c

 plasmacytoid (45.58%). Conversely the 
CD11c

 DC population predominated in the fetus (40.74%).  
We have studied the numbers and percentages of the CD11c

CD45
inm
 DC subset in preterm and 
term CB and also adult PB. In line with the observation of an evolving, maturing DC subset, we 
have found this subgroup predominantly in preterm CB when compared with term CB. 
Comparison of this subset in the CB with adult PB revealed an almost absence of these DCs in 
adult blood. This subset represented 21.26% of the total DC population in the term CB, but 
formed 31.33% of the total DC population in the preterm CB, and only 1.54% in adult blood. It 
could be argued that the decreasing number of cells indicates the population to be evolving into a 
more mature phenotype.  
This study also analysed the change in numbers of the CBDC subsets on exposure to stressor 
stimuli. The myeloid and plasmacytoid subsets showed a significant increase in numbers on 
exposure to stressors. A significant increase in numbers of the novel CD11c

CD45
inm
 DC subset 
in response to stressor stimuli was also identified.  This DC subset increased in absolute numbers 
as well as percentage of total viable cells in the preterm stressed CB, when compared with the 
preterm non stressed. Thus this subset appears to respond to stressor stimuli with an increase in 
numbers.   
CB was more cellular as the total number of viable cells was significantly more than seen in the 
adult and there was a significant increase in the viable cells in the term CB as opposed to preterm 
CB. Whether this indicates preparation for parturition and delivery with an increase in leukocytes 
in anticipation of infectious stimuli is a question which cannot currently be answered. There was 
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no significant change in the total number of DCs with increasing gestational age and on 
comparison between fetal and adult samples, but exposure to stressors increased the numbers. 
This increase in numbers on exposure to stressors could be due to the identified increase of the 
CBDC subsets by peripheral recruitment in response to infection and again this hypothesis needs 
to be elucidated further. 
The neonatal immune system can be deficient in its efficacy and is also functionally different 
from the adult system (Hunt, ., 1994). The innate neonatal immune system is functionally
 
and phenotypically immature (Levy,  ., 1999; Sorg,  ., 1999). CBDCs tend to express 
lower levels of the γchain IL2 receptor (CD132) and of the CD86 costimulatory molecule, 
supporting a higher degree of immaturity as compared to adult DCs (Crespo, ., 2004). As a 
result of the immaturity, it would appear that development and maturity of the fetal immune 
system involves specific cell populations being upregulated and exhibiting a more mature 
phenotype. This idea is supported by our findings of decreasing percentages of the CD11c

CD45
inm
 subset with advancing gestational age. Additionally exposure to stressor stimuli 
increased the numbers of all three CBDC subsets.  This increased response of CBDC subsets to 
stressor stimuli mean that fetal DCs are immunologically active, changing with the rapidly 
changing fetal environment which needs to adapt swiftly from immunotolerance to response 
against infections. Thus the positive response on exposure to stressors seen in these subsets 
confers a central role for these DCs in the response to stressor stimuli and fetal defences against 
infections.  
The above observations from this study raise the question whether the level of maturity and 
numbers of the immature CD11c

CD45
inm 
DC subset could be used to indicate the 
immunocompetence of and exposure to infectious stimuli of immature, preterm infants. The 
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responsiveness of this DC subset to stressor stimuli and the additional decrease in numbers with 
a maturing immune system would suggest that this subset is most active immunologically and 
investigating this subset would  be indicative of an  	
 exposure to infectious/stressor 
stimuli. This in turn would contribute towards a more accurate diagnosis and management with 
improved prognosis for the premature neonate.  
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The three DC subsets in CB of myeloid, plasmacytoid and the novel CD11c

CD45
inm
 subset were 
analysed for potential proinflammatory changes on exposure to stressor stimuli. This involved 
analyses of the costimulatory markers, CD40 and CD86 expression and the production of the 
intracellular cytokine, IL12 with advancing age as well as exposure to stressors.  
Analyses of whole blood with monoclonal antibody labelling and flow cytometer acquisition 
were performed on all the CB samples. 
 As advancing gestational age itself alters the CBDC subsets, analysis of their change in 
expressions of CD40 and CD86 and IL12 production with age was performed. The myeloid DC 
subset increased, and the plasmacytoid subset decreased expression of CD40 with advancing age 
to adult. Both the above subsets showed no change in the expression of CD86.  Only the CD11c

CD45
inm
 showed a change with advancing gestational age from preterm to term by increasing in 
numbers and upregulating CD40 and CD86 expression. The myeloid and the plasmacytoid 
population increased IL12 production with increasing age, while the CD11c

CD45
inm
 CBDC 
population showed no change in IL12 production with advancing gestational age.  
Changes of the CBDC subsets in response to exposure to stressors were identified. The numbers 
of CD11c

CD45
inm
 DCs expressing CD40 and CD86 increased significantly on exposure to 
stressors. Conversely the myeloid and the plasmacytoid CBDC subsets showed no upregulation 
of CD40 and CD86 on exposure to stressors. The numbers of CBDC in the CD11c

CD45
inm
 
CBDC population producing IL12 increased significantly on exposure to stressors independent 
of gestation. The myeloid DC subsets decreased while the plasmacytoid DC subset increased the 
numbers of IL12 producing DCs on exposure to stressors.  
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Thus the CD11c

CD45
inm
 DCs exhibited immunogenic capacity both by their upregulation of the 
costimulatory markers and their production of IL12 on exposure to stressors. These changes in 
the CD11c

CD45
inm 
CBDC subset in response to stressors and the changes in numbers with 
increasing gestational age confirmed the postulation that increasing gestational age as well as 
exposure to stressors induced proinflammatory and maturation changes in this subset. 
Significantly only the CD11c

CD45
inm 
DC subset showed a costimulatory response to the stressor 
stimuli suggesting that this evolving DC subset in the fetus could be key to the antigen presenting 
capacity of the fetal immune system.  
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A Th2 bias or immunoprotective function is the hallmark of the fetal immune system and is 
essential for masking the fetal antigens from the maternal immune system, thus ensuring a 
successful pregnancy. This fetal innate immune system response may result in deficient 
immunocompetence against infections and underlie the neonatal susceptibility to infections. The 
relative inefficiency of CBDCs in the activation of T cells has been shown to be linked to their 
low cell surface expression of MHC and cell adhesion molecules (Petty and Hunt, 1998). Fetal 
biology changes with the onset of maternal/intrauterine infection, with a rise in IL8 
concentration in CB (Dembinski, ., 2002). Infection is a major cause of neonatal morbidity 
and the immunodeficiency of the fetal immune system seems to play a major part in these 
adverse outcomes.  
The ability of DC to alter their phenotype and function in response to microbial exposure 
suggests that changes of CBDC populations will be useful markers of intrauterine infection or 
stress and neonatal sequelae (Huang, ., 2001). Thus we have compared the DC phenotype of 
CB from neonates who have undergone intrauterine stress or exposure to infections 	
with 
the DC phenotype of CB from neonates with a normal antenatal and intrapartum period. The 
previously described changes on the CBDC subsets with increasing gestational age raised the 
question whether an antigen stimulus could result in a consistently identifiable phenotypic 
change.  
The expression of the costimulatory markers, CD40 and CD86 have been analysed on the DCs, 
in conjunction with the changes induced by an infectious or immunogenic stimulus. Products of 
infection and inflammation such as LPS induce DC maturation, release chemokines and 
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cytokines and exhibit costimulatory molecules on their surface such as CD40 and CD86. The 
upregulated costimulatory molecules are presented by MHC class II proteins in DCs and 
initiation of the adaptive immune system takes place with activation of naïve CD4
+
T cells.  
Mature DCs exhibit class I and class II MHC and costimulatory molecules such as CD40, CD80 
and CD86 (Almeida,  ., 1999;  Almeida,  ., 2001). Immature DCs exhibit decreased 
expression of the costimulatory molecules (Banchereau,  ., 2000).  
IL12 is a proinflammatory cytokine that induces the differentiation of Th1 cells and forms a link 
between innate and adaptive immunity (Kobayashi,  ., 1989; Hsieh,  ., 1993). IL12 is 
produced mainly from activated DCs and phagocytes (monocytes/macrophages and neutrophils). 
IL12 has been shown to increase not only in preterm labour and infections, but also on exposure 
of the fetoplacental unit to stressor stimuli such as in severe preeclampsia (Dudley, ., 1996).
Our overall aim was to test the hypothesis thatchanges inCBDC populations are consistently 
identifiable and can be used as biomarkers of intrauterine infection or exposure to stressor 
stimuli. The research focuses on analysing the phenotypic changes of the costimulatory markers 
CD40 and CD86 on CBDC subsets and the production of IL12 by CBDCs, to identify that group 
of neonates who were potentially exposed to intrauterine stressor and may provide an indicator of 
the risk of developing short and long term infectious sequelae. 
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Blood from the umbilical cord of 14 preterm neonates and 7 term neonates were analysed for 
costimulatory markers. Blood from the umbilical cord of 8 preterm neonates and 10 term 
neonates were analysed for production of IL12. Adult blood for analysis was obtained from 14 
nonpregnant healthy volunteers between the age groups of 22 to 56 years.  
Clinical criteria were employed to differentiate those neonates considered to have been ‘stressed’ 
and those neonates who were ‘nonstressed’ (Detailed discussion about the criteria for 
classification and validation by neutrophilic activation markers is given in  !"#$%&).  
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Isotype controls were used to delineate the negative expression of the markers to be 
identified (Figure 6.1B). The costimulatory marker expression was determined by 
subtracting staining with an isotype matched control antibody from staining with the 
marker (Figure 6.1A).Representative histograms shown from 21 experiments 
 
The amount of costimulatory marker expression was analysed using the subtraction method as 
described above in Figure 6.1 (see 4 !"#$%6($4#)'0 for a detailed explanation).  
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As evidence in literature points to a reduced immunocompetence in the fetus, the expression of 
costimulatory markers on fetal CBDCs was analysed prior to assessing whether upregulation 
takes place with advancing age and on exposure to stressors. 
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Myeloid subset 5.44+/5.38 12.20+/8.28 0.002 21 
Plasmacytoid subset 13.24+/10.92 6.30+/5.01 0.003 21 
CD11c

CD45
inm
 
subset 
4.90+/4.51 6.19+/4.21 0.197 21 
 @"'()#)?$  
Myeloid subset 32.83+/20.99 79.52+/21.82 <0.001 21 
Plasmacytoid subset 62.30+/22.39 32.61+/20.37 <0.001 21 
CD11c

CD45
inm
 
subset 
52.68+/23.10 67.15+/18.81 0.032 21 
 %!#)'  
Myeloid subset 4.04+/2.02 6.68+/5.19 0.048 21 
Plasmacytoid subset 10.57+/9.36 2.49+/1.37 <0.001 21 
CD11c

CD45
inm
 
subset 
3.01+/3.22 2.90+/2.54 0.481 21 
 
Absolute numbers of DCs expressing CD40 and CD86, percentage of positive DCs and 
their PCI ratios are shown.  values shown are for comparisons between expressions of 
CD40 and CD86 by each subset 
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The above multigraph with column and error bars shows the comparison of expressions of 
the CD40 and CD86 on the various CBDC populations  
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Costimulatory marker expression was analysed by comparison of the absolute numbers and the 
percentage of DCs expressing the marker (Figures 6.2A, 6.2B, 6.2D and 6.2E). As these values 
could be misleading if significant numbers of DCs expressed the marker but with low intensity, 
the PCI ratio was also compared (Figures 6.2C and 6.2F).  
Comparison of CD40 expression between subsets showed it to be highest on the plasmacytoid 
subset on analysis of absolute numbers, percentage positive and PCI ratio. The CD86 expression 
was highest on the myeloid subset on analysis of absolute numbers, percentage positive and PCI 
ratio ( values on Figure 6.2). 
Analysis of the markers on each subset revealed that all the CBDC subsets expressed CD40 and 
CD86 but the levels varied. The CD11c

CD45
inm
 subset expressed equal amounts of CD40 and 
CD86 on at least more than 50% of the DCs in this subset. The myeloid DC subset expressed 
significantly more CD86 than CD40 and this finding was reversed in the plasmacytoid subset 
(Table 6.1). 
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
The major DC subsets were analysed for the expression of the CD40 and CD86 costimulatory 
markers in adult PB and additionally, the CD11c

CD45
inm
 subset in CB.  Differences in the 
expression of the CD40 and CD86 markers between adult and CD11c

CD45
inm
 CBDCs could not 
be ascertained as the number of DCs in the adult exhibiting the CD11c

CD45
inm 
phenotype was 
found to be negligible, ie: 0.64 DCs per Cl of blood. 
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Multigraph with point plots and  values shown. Numbers of CD40 and CD86 positive 
DCs, percentage positive and PCI ratio shown per Cl of blood. The fetal samples were 
analysed based on their gestational age alone into term and preterm 
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Adult 
11.92+/
9.71 
16.75+/
11.5 
53.88+/
20.6 
81.46+/
25.83 
4.83+/
3.6 
10.28+/
6.46 
14 
Term fetus 
6.29+/
6.87 
13.43+/
9.03 
33.86+/
25.37 
76.91+/
28.04 
4.88+/
2.47 
6.68+/
5.19 
7 
Preterm 
fetus 
4.98+/
4.64 
11.54+/
8.14 
32.27+/
19.36 
80.92+/
18.82 
3.58+/
1.66 
7.7+/
6.05 
14 
Fetus (term 
& preterm) 
5.44+/
5.38 
12.2+/
8.28 
32.83+/
20.99 
79.52+/
21.82 
4.04+/
2.02 
4.77+/
2.3 
21 
 
The expressions of CD40 and CD86 on the myeloid subset is shown as absolute numbers, 
percentage positive and PCI ratio 
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Absolute numbers (Figure 6.3A) and percentage positive DCs (Figure 6.3B) increased 
significantly from preterm to adult.  
On comparison between adult and fetus the absolute numbers ( 0.031) and percentage of 
positive DCs ( 0.037) showed a significant increase in the adult.  
The PCI ratio showed no significant change between preterm and term CBDCs (Figure 6.3C) and 
between adult and fetus ( 0.426).  
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Comparison of the subgroups of preterm and term did not reveal any change in numbers, 
percentage of positive DCs and PCI ratios (Figures 6.3D, 6.3E and 6.3F).  
There was no statistically significant change between adult and fetal DCs in numbers ( 0.203), 
percentage of positive DCs ( 0.403) and PCI ratios ( 0.059).  
 
Taken together the data above shows that the CD11c
+
CD45
hi
 subset significantly increased 
expression of the CD40 marker with increasing age from fetus to adult but did not change with 
advancing gestational age. The expression of CD86 showed no change with advancing age and 
gestation.   



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Multigraph with point plots and values shown. Numbers of CD40 and CD86 positive DC, 
percentage positive and PCI ratio shown per Cl of blood. The fetal samples were analysed 
based on their gestational age alone into term and preterm 
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Adult 
6.33+/
4.17 
3.46+/
2.69 
51.19+/
29.43 
35.26+/
27.48 
12.85+/
14.42 
3.12+/
2.21 
14 
Term fetus 
12.57+/
7.28 
7.51+/
6.87 
52.02+/
14.75 
32.38+/
27.86 
14.96+/
10.9 
2.76+/
1.77 
7 
Preterm 
fetus 
13.57+/
12.59 
5.7+/4 
67.44+/
24.2 
32.72+/
16.74 
8.37+/
8.02 
2.36+/
1.17 
14 
Fetus (term 
& preterm) 
13.24+/
10.92 
6.3+/
5.01 
62.3+/
22.39 
32.61+/
20.37 
10.57+/
9.36 
2.49+/
1.37 
21 
 
The expressions of CD40 and CD86 on the plasmacytoid subset is shown as absolute 
numbers, percentage positive and PCI ratio 
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There was a statistically significant decrease in the numbers of CD11c

CD45
hi
 DCs expressing 
CD40 with advancing age from fetus to adult ( 0.037). On comparison within the subgroups of 
preterm and term the reduction in numbers was significant between term CB and adult PB and 
between preterm CB and adult PB (Figure 6.4A). 
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There was no significant difference in the percentage of DCs positive for CD40 ( 0.222) and in 
the PCI ratios ( 0.750) between adult PB and CB. Comparison of the subgroups of term and 
preterm also showed no difference in the percentage positive (Figure 6.4B) and PCI ratios 
(Figure 6.4C). 
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The CD11c

CD45
hi 
CBDCs did not exhibit any change in the expression of CD86 with advancing 
age and gestation. No change was seen in absolute numbers (Figure 6.4D), percentage of DCs 
positive (Figure 6.4E) and PCI ratios (Figure 6.4F). 
 
Taken together the data above shows that the plasmacytoid CBDC subset significantly decreased 
the numbers of DCs expressing CD40 with advancing age from fetus to adult, but there was no 
significant change in CD86 expression. 
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Multigraph with point plots and  values shown. Numbers of CD40 and CD86 positive 
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DCs, percentage positive and PCI ratio shown per Cl of blood. The fetal samples were 
analysed based on their gestational age alone into term and preterm 
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Term fetus 8+/6.43 
8.14+/
4.78 
66.08+/
16.11 
76.01+/
10.14 
2.80+/
2.71 
4.23+/
3.81 
7 
Preterm 
fetus 
3.34+/
2.11 
5.21+/
3.7 
45.98+/
23.59 
62.72+/
20.82 
3.11+/
3.54 
2.24+/
1.34 
14 
 
The expressions of CD40 and CD86 on the CD11c

CD45
inm
CBDC subset is shown as 
absolute numbers, percentage positive and PCI ratio 
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A significant upregulation was seen in the absolute numbers in term CB compared with preterm 
CB (Figure 6.5A). 
The percentage of DCs positive for CD40 in term CB did not reach statistical significance when 
compared with preterm CB (Figure 6.5B). The PCI Ratios were similar in term and preterm CB 
(Figure 6.5C).  
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A statistically significant upregulation in the PCI ratio was seen in term when compared to 
preterm CB (Figure 6.5F).  
No statistically significant increase was seen in the absolute numbers (Figure 6.5D) and in the 
percentage positive DCs (Figure 6.5E).  
 
Taken together the data above indicates that the CD11c

CD45
inm 
CBDC subset significantly 
increased the numbers of DCs expressing CD40 with advancing gestational age. There was also a 
significant increase in the expression of CD86 with advancing gestational age. 

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

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
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It was postulated that increasing gestational age as well as fetal/intrauterine stressors could lead 
to increased expression of costimulatory markers. To distinguish between the upregulation 
effects of stressors and of increasing gestational age all the preterm CB samples (14) were 
analysed in two groups; samples from fetuses with (7) and without stress stimuli (7). All the 
term CB analysed did not have any exposure to stress stimuli (7).  
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Term non 
stressed 
6.29+/
6.87 
13.43+/
9.03 
33.86+/
25.37 
76.91+/
28.04 
4.88+/
2.47 
4.77+/
2.3 
7 
Preterm non 
stressed 
2.75+/
1.84 
8.17+/
3.76 
29.99+/
12.89 
88.31+/
11.36 
3.86+/
2.37 
10.24+/
7.73 
7 
Preterm 
stressed 
6.89+/
5.57 
14.43+/
9.98 
34.23+/
24.52 
74.59+/
22.35 
3.34+/
0.82 
5.53+/
3.40 
7 
 
Numbers of myeloid DC positive for CD40 and CD86 expression, percentage positive and 
PCI ratio shown per Cl of blood 
 
The myeloid subset did not change on exposure to stressors in the expressions of CD40 and 
CD86 in the numbers of positive DCs, percentage of positive DCs and PCI ratios.
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Term non 
stressed 
12.57+/
7.28 
7.51+/
6.87 
67.48+/
32.42 
32.38+/
27.86 
14.96+/
10.9 
2.76+/
1.77 
7 
Preterm non 
stressed 
9+/4.97 
3.67+/
2.05 
52.02+/
14.75 
28.34+/
16.84 
11.5+/
10.08 
2.51+/
1.47 
7 
Preterm 
stressed 
18.14+/
16.44 
7.71+/
4.5 
67.4+/
14.77 
37.11+/
16.69 
5.26+/
3.9 
2.21+/
0.88 
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Numbers of plasmacytoid DC positive for CD40 and CD86 expression, percentage positive 
and PCI ratio shown per Cl of blood 
 
The plasmacytoid subset did not change on exposure to stressors in the expressions of CD40 and 
of CD86 in the numbers of positive DCs, percentage of positive DCs and PCI ratios.  
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Multigraph with column bars and  values shown. Numbers of CD40 and CD86 positive 
DCs, percentage positive and PCI ratio of positive DCs shown per Cl of blood 
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Term non 
stressed 
8+/6.43 
8.14+/
4.78 
66.08+/
16.11 
76.01+/
10.14 
2.8+/
2.7 
4.23+/
3.81 
7 
Preterm non 
stressed 
1.83+/
0.73 
3.14+/
2.41 
40.59+/
25.02 
53.42+/
21.92 
3.78+/
4.77 
2.54+/
1.66 
7 
Preterm 
stressed 
4.86+/
1.95 
7.29+/
3.79 
51.38+/
22.62 
72.03+/
16.02 
2.44+/
1.83 
1.95+/
0.95 
7 
 
Numbers of CD11c

CD45
inm
 DC positive for CD40 and CD86 expression, percentage 
positive and PCI ratio shown per Cl of blood

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A significant stress related increase in numbers was seen in the CB of preterm fetuses with stress 
compared to the preterm fetuses without stress. An age related significant increase in numbers 
was also seen in the term CB compared with preterm non stressed CB (Figure 6.6A). 
No stress related change was seen in the percentage of DCs positive for CD40 or in the PCI 
ratios (Figures 6.6B and 6.6C). There was an age related increase in the percentage of DCs 
expressing CD40 in the term non stressed CBDCs compared to the preterm non stressed CBDCs.  
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An increase in CD86 expression was seen which was similar to the increase in CD40 expression. 
Thus a stress related as well as an age related increase was seen in the numbers of CBDCs 
positive for CD86 (Figure 6.6D).  
No stress related change was seen in the percentage of DCs positive for CD86 or in the PCI 
ratios (Figures 6.6E and 6.6F). There was an age related increase in the percentage of DCs 
expressing CD86 in the term non stressed CBDCs compared to the preterm non stressed CBDCs 
(Figure 6.6E). 
 
These findings postulate that advancing gestational age as well as exposure to stressors increased 
costimulatory marker expression in the CD11c

CD45
inm
 subset. 
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Accumulation of IL12 within freshlyisolated cells during a 4hr incubation was measured. 
No monensin controls were used to delineate the negative expression of the marker to be 
identified (Figure 6.7B). The intracellular cytokine production was determined by 
subtracting a no monensin control staining with the same cytokine antibody from staining 
with the marker (Figure 6.7A).Histogram shown with unmarked region indicating negative 
fluorescence (Figure 6.7A). Representative histograms shown from 18 experiments 
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The amount of intracellular cytokine expression was analysed using the subtraction method as 
described in Figure 6.7. Ano monensin control was used rather than an isotype control antibody 
as this avoided the potential complications from the labelling of preformed cytokine, and of the 
differences in the fluorochrome to antibody ratio on isotype controls. The given method provided 
us with an accurate assessment of the amount of IL12 produced during the time window of 4 
hours. Detailed discussion of the advantages of this method is given in  !"#$%C 







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percentage positive and PCI ratio of positive DCs shown per Cl of blood. The fetal samples 
were analysed based on their gestational age alone into term and preterm 
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4-#')5
-$,')5
,!(*!
4-#')5
-$,')5
,!(*!
4-#')5
Adult 
20.08+/
14.07 
23.69+/
18.29 
39.7+/
27.08 
30.58+/
25.58 
2.28+/
3.69 
1.48+/
0.71 
14 
Term 
fetus 
23.15+/
16.06 
29.63+/
22.43 
42.29+/
24.21 
16.95+/
17.42 
1.59+/
0.65 
1.42+/
1.01 
10 
Preterm 
fetus  
7.84+/
14.79 
17.3+/
14.76 
10.82+/
18.83 
24.48+/
20.79 
1.04+/
1.52 
0.84+/
0.52 
8 
Fetus 
(term & 
preterm) 
16.35+/
16.97 
23.83+/
19.67 
28.3+/
26.74 
20.5+/
18.87 
1.35+/
1.12 
1.14+/
0.85 
18 
 
Numbers of myeloid and plasmacytoid DC positive for IL12, percentage positive and PCI 
ratio shown per Cl of blood

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Significant increase was seen in the numbers (Figure 6.8A) and in the percentage positive DCs 
(Figure 6.8B) from preterm to term and from fetus to adult showing increased production with 
advancing gestation as well as with age. No change was seen in the PCI ratios (Figure 6.8C). 
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There was a significant increase in PCI ratios between preterm and adult (Figure 6.8F). There 
was no significant change in the numbers of positive DCs and percentage positive DCs (Figure 
6.8D and 6.8E). 
 Taken together the data above indicate that the myeloid DCs increased IL12 production with age 
on comparison between adult and preterm CB and with advancing gestational age on comparison 
between preterm and term CB. The plasmacytoid DCs increased IL12 expression with 
increasing age, but did not change with advancing gestational age. 
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 values shown. Numbers of IL12 positive DCs, 
percentage positive and PCI ratio of positive DCs shown per Cl of blood 
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Term fetus 40.75+/37.26 29.97+/23.35 1.67+/1.31 10 
Preterm fetus 12.96+/15.31 7.97+/16.27 0.82+/0.95 8 
 
Numbers of CD11c

CD45
inm
 DC positive for IL12, percentage positive and PCI ratio 
shown per Cl of blood 
 
The CD11c

CD45
inm
 CBDCs did not change IL12 production in the numbers of positive DCs 
(Figure 6.9A) and PCI ratios (Figure 6.9C).  
There was a significant increase in the percentage of IL12 positive DCs with advancing 
gestational age (Figure 6.9B). As this measure was of the percentage of positive DCs, this could 
be affected by the change in the actual numbers of DCs occurring with the change in gestation. 
And this may not be a real reflection of increased IL12 production.  
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It was postulated that increasing gestational age as well as fetal/intrauterine stressors could lead 
to increased production of IL12. To distinguish between the upregulation effects of stressors and 
of increasing gestational age all the preterm CB samples (8) were analysed in two groups; 
fetuses with (3) and without (5) stress stimuli. The term CB samples (10) were analysed in 
two groups; fetuses with stress (5) and without stress (5) stimuli. 
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Multigraph with column bars and significant  values shown. Numbers of IL12 positive 
DCs, percentage positive and PCI ratio of positive DCs shown per Cl of blood 
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Term non 
stressed 
33.46+/
16.12 
14.59+/
16.4 
39.37+/
32.12 
6.09+/
6.84 
1.4+/ 
0.32 
1.41+/
1.34 
5 
Term 
stressed 
12.85+/
7.42 
48.43+/
11.62 
45.21+/
16.3 
30.53+/
17.44 
1.77+/
0.88 
1.43+/
0.55 
5 
Preterm 
non 
stressed 
10.84+/
18.46 
9.92+/
10.96 
16.6+/
22.52 
23.69+/
24.74 
1.36+/
1.82 
0.65+/
0.6 
 
5 
Preterm 
stressed 
2.84+/
4.92 
29.59+/
12.64 
1.19+/
2.07 
25.81+/
16.89 
0.51+/
0.88 
1.14+/
0.08 
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Numbers of myeloid and plasmacytoid DC positive for IL12, percentage positive and PCI 
ratio shown per Cl of blood 
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The CD11c
+
CD45
hi 
CBDC subset significantly decreased the numbers of IL12 producing DCs 
in the term stressed group when compared to the term non stressed group. In the preterm stressed 
group the numbers did not reach statistical significance. Both the stressed groups (term and 
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preterm) were not different and hence this decrease in production was independent of the 
gestational age (Figure 6.10A).  
The above change was not reflected in the percentage of positive DCs and PCI ratios (Figures 
6.10B and 6.10C). 
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The CD11c

CD45
hi 
CBDC subset significantly increased the numbers of IL12 producing and 
percentage positive DCs in the term stressed group when compared to the term non stressed 
group. In the preterm stressed group the numbers did not reach statistical significance. Both the 
stressed groups were not different and hence this increase in production was independent of the 
gestational age (Figures 6.10D and 6.10E).  
The above change was not reflected in the PCI ratios (Figure 6.10F). 
  

Taken together the data given above shows that myeloid DCs decreased and plasmacytoid DCs 
increased IL12 production on exposure to stressors. The above changes were not reflected in the 
PCI ratios which could be the effect of the small number of samples in each group.  

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The above multigraph with column bars show the numbers, percentage positive DCs and 
PCI ratios for IL12 production. Only significant  values are shown on the graph 
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Term non stressed 12.49+/11.52 17.34+/19.28 1.84+/1.81 5 
Term stressed 76.06+/23.08 45.77+/18.97 1.44+/0.32 5 
Preterm non stressed 7.54+/11.39 11.46+/20.46 0.74+/1.07 5 
Preterm stressed 22+/19.11 2.14+/2.83 0.96+/0.89 3 

The change in CD11c

CD45
inm
 CBDCs with stressors is shown as absolute numbers, 
percentage positive DCs and PCI ratios 
 
Exposure to stressors resulted in an increase in the numbers of CD11c

CD45
inm
 CBDCs 
producing IL12 in term. The term stressed CBDCs produced significantly more IL12 than the 
term non stressed group. The preterm stressed group were not significantly different to the 
preterm non stressed group. Thus the numbers of CBDCs producing IL12 was increased on 
exposure to stressors and this increased production was seen irrespective of the gestation (Figure 
6.11A).  
The above increase was not reflected in the percentage of positive DCs, and the PCI ratios which 
could be a reflection of the small numbers of samples in each group (Figure 6.11B and 6.11C). 
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This study analysed the proinflammatory changes on CBDC populations on exposure to stressor 
stimuli. The findings confirmed increased numbers of CD40 and CD86 expressing DCs and 
increased production of IL12 by the CD11c

CD45
inm
 DC subset in response to infection or stress 
in the CB samples. Both the myeloid and the plasmacytoid CBDC subset did not alter the 
expression of costimulatory markers on exposure to stressors in the preterm subset. The myeloid 
subset decreased production of IL12 while the plasmacytoid subset increased IL12 production 
on exposure to stressors. The previous findings of change in these DC subsets with increasing 
gestation lead us to investigate whether an infectious or immunogenic stimuli has the same 
potential to trigger proinflammatory responses in the CBDC populations. 
As CBDCs have long been labelled as tolerogenic, their expression of costimulatory markers was 
assessed initially prior to analysing the change seen with stressors. The myeloid subset expressed 
more CD86 than CD40 and this finding was reversed in the plasmacytoid subset. Comparison 
showed CD40 expression to be highest in the plasmacytoid subset and CD86 expression to be 
highest in the myeloid subset. The CD11c

CD45
inm
 subset expressed equal amounts of both 
CD40 and CD86 with at least more than 50 percentage of DCs in this subset expressing the 
markers. These findings add credence to an immunogenic capacity of fetal DCs. The role and 
mechanism of action of CD40 is different from that of CD86 and as myelod DC and pDC are 
different DC types, it would be immunologically advantageous that they have different levels of 
such costimulatory markers. 
Any change in the expression of costimulatory markers with advancing gestational age was 
analysed. CBDCs regulated CD40 expression more than CD86. The myeloid CBDC subset 
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increased and the plasmacytoid CBDC subset decreased CD40 expression with advancing age to 
adult. Both subsets did not change with advancing gestational age from preterm to term. CD40 
and CD86 were upregulated with advancing gestational age from preterm to term by the CD11c

CD45
inm
 subset.  
Costimulatory marker expression of CD40 and CD86 was analysed on the CBDC subsets on 
exposure to stressors. The integration of antigenic stimuli through the costimulatory molecules is 
critical for the activation of immune responses and hence the upregulation of these molecules 
indicate an immune system which has or is being activated. A stressor related increase was seen 
in the CD11c

CD45
inm 
CBDC with preterm CBs exposed to stressors upregulating both CD40 
and CD86. Upregulation by preterm CBs exposed to stressors were similar to the non stressed 
term samples which lead to the hypothesis that exposure to stressors stimuli could be maturing 
the premature CBDCs to a gestationally mature profile in readiness for delivery. An age related 
increase was also seen between the non stressed preterm and term samples. The ability of DCs to 
express costimulatory molecules indicates the maturation of the APC (Hellstrom,  1996). 
These findings confirm the hypothesis that the CD11c

CD45
inm
 DC subset appear to be an 
immunologically immature (decreased levels of CD45), changing population, which is matured 
with increasing gestation and exposure to stressors.   
Significantly the myeloid and plasmacytoid subsets did not change on exposure to stressors in the 
expression of these costimulatory markers. Only the CD11c

CD45
inm
 subset DCs increased the 
expressions of CD40 and CD86 markers in response to stressors. This finding enhances the 
importance of this DC subset as the pivotal APC within the fetal immune system capable of 
mounting an immune response and thus the measure of the maturation of this DC subset could be 
a measure of the immunocompetence of the fetus. 
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IL12 is a proinflammatory cytokine produced by DCs on exposure to infectious stimuli, the 
analyses of which would give a lucid depiction of the immunogenic capacity of the fetal DCs. 
Hence the production of IL12 by all of the CBDC subsets was analysed. As previous findings 
have indicated that increasing gestational age alone has the potential to alter the immunogenicity 
of the CBDC, the changes with age were analysed initially. The CD11c
+
CD45
hi 
and CD11c

CD45
hi
 DC subsets increased IL12 production with advancing age. This increase of IL12 
production was consistent with a shift by the DCs towards preparation for birth and therefore 
perhaps a Th1 generating capacity. Conversely the CD11c

CD45
inm 
DCs did not change 
production of IL12 with advancing gestational age.  
Alterations of IL12 production on exposure to stressors were analysed. Exposure to stressors 
increased the production of IL12 by the CD11c

CD45
inm 
CBDCs in the term fetuses. The 
myeloid CBDC subset decreased and the plasmacytoid CBDC subset increased IL12 production 
on exposure to stressors.  
Preterm neonates born as a result of an infectious aetiology are more likely to have long term 
sequelae such as bronchopulmonary dysplasia (Yoon,  ., 1997b), PVL and an increased 
incidence of CP (Yoon, ., 1997a). The Th2 bias of the fetal immune system with its attendant 
immunodeficiency has been implicated in the increased susceptibility of neonates to infection 
(Kalinski, ., 1990; Wegmann, ., 1993; Naderi, ., 2009). Infections in a decreased 
immunocompetent environment are potentially disastrous, with long term sequelae especially 
neurologically (Yoon, ., 1997a).Identification of preterm infants who are at the greater risk 
of short and long term infectious morbidity will have an impact on further management and 
prognosis.  
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The ability of DC to alter their phenotype and function in response to microbial exposure 
suggests that changes of CBDC populations might be useful markers of intrauterine infection and 
neonatal sequelae (Kadowaki,  ., 2001).  The sensitivity of DCs to changes  	

distinguishes this APC as ideal to be used in identifying such changes. The observation that out 
of the three subsets of DCs identified in the fetus only the CD11c

CD45
inm
 subset increased the 
costimulatory markers expression is significant in understanding the importance of this DC 
subset in the modulation of the fetal immune system. This finding emphasises the sensitivity of 
this DC subset to antigenic stimuli as opposed to the other DC subsets. The implications of these 
findings in relation to the known infectious aetiology of preterm births are vital to the 
understanding of the pathophysiology of prematurity.  
The observed upregulation of costimulatory markers with infection raises the question whether 
these changes on the CD11c

CD45
inm
 DC subset have the potential to be used as biomarkers to 
identify neonates exposed to infection or stress  	
Monitoring of the phenotype and 
functional changes of the CD11c

CD45
inm
 DC subset could provide a diagnostic marker of 
infection/stress and identify the immunologically challenged fetus. Developing the technology to 
analyse the CB provides us with a sample obtained at no discomfort or pain to the baby and as it 
is the earliest possible neonatal sample available, will provide us with the earliest clue to the 
infection risk and prognosis. It would also act as a prognostic factor to predict long term 
neurological outcome as increased levels of cytokines are associated with cerebral palsy (Yoon, 
., 1997a). Flow cytometer facilities are available in most laboratories and thus this analysis 
could be a valuable aid in the management of prematurity in decreasing the infectious sequelae, 
both neonatal and maternal.  
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By the very definition the primary function of an APC is orchestrating the defence of the human 
body against infections, which the DC does so admirably. Many studies catalogue the central 
role played by the DC in infectious states, e.g.: HIV. But to date there is no evidence in 
published literature of the role of the DC in preterm labour. Research in preterm labour has so far 
focussed on the microbiological and preventative aspects. The annals of history have taught us 
that understanding the molecular pathogenesis of a disease is the key to formulating preventative 
and curative strategies. Thus as professional APCs, the DC would be fundamental to the immune 
response mounted during preterm labour and it seems logical that studying the immune 
modulation by the DC would provide us with many answers regarding the pathogenesis of 
preterm labour and delivery.  
This body of work presented has successfully identified DC populations in CB comparable to the 
populations seen in adult PB. Additionally analyses of the DC subsets in CB lead to 
identification of a hitherto unreported putative CD11c
*
CD45
inm
 DC population with phenotypic 
and functional properties conforming to the characteristics of DC in established literature. We 
have shown that the CD11c
*
CD45
inm
 CBDCs have the capacity to mount an immune response on 
exposure to intrauterine stressor stimuli by their upregulation of costimulatory markers and 
increased production of IL*12. Of the three CBDC populations, the novel CD11c
*
CD45
inm
 
population proved to be the most kinetic, changing with gestational age as well as on exposure to 
stressors. 
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As expected, phenotypic analysis of plasmacytoid markers was negative on the myeloid subset 
and positive on the plasmacytoid subsets in adult and fetus. The CD11c
*
CD45
inm
 subset was 
negative for the expression of CD123, BDCA2, CD45RA, CD33 and CD13, showing these DCs 
to be distinct from the plasmacytoid DCs and not to be of myeloid lineage. In literature to date, 
previous reports of increased CD11c
*
 DC in CB have not distinguished plasmacytoid DCs from 
the distinct CD11c
*
CD45
inm
 population described here. The phenotypic analyses show this novel 
population to be a distinct subset of CBDCs, and not a subset of or form a part of the CD11c
*
 
plasmacytoid CBDCs. 
The functional studies showed that all CBDC subsets endocytosed Dextran particles. The 
CD11c
*
CD45
inm
 subset exhibited endocytosis comparable to the myeloid DC subset in the adult. 
CBDCs stimulated MLR and the capacity was equivalent to adult DCs. It would have been 
pertinent to assess the stimulatory capacity of the various CBDC subsets separately after sorting. 
But unfortunately labelling and sorting which required handling of the cells negated the 
stimulatory capacity.  
The fetal immune system exhibit changes in all its components and function with advancing 
gestational age. Hence the effect of gestational  on the composition and maturation of these 
CBDC subsets was analysed. The myeloid and plasmacytoid CBDC subsets did not change with 
advancing gestation. The CD11c
*
CD45
inm
 subset decreased significantly with increasing 
gestational age. This subset represented 31.33% of the total number of DCs in the preterm CB, 
but represented 21.26% in the term CB samples and only 1.54% of the total number of DCs in 
adult PB. It was interesting to note that whilst the myeloid subset did not change with advancing 
gestational age from preterm to adult it predominated in the adult. Does the increase in numbers  
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occur during the neonatal or childhood periods is a question not answerable to date as no 
longitudinal comparative studies from fetus to adult have been published. 
Gestational age itself affected the total numbers of DC. There was a significant decrease seen 
from preterm CB to adult PB. Why does the fetus situated especially intrauterine and protected 
from the environment need more numbers of DCs than the adult? Are the increased numbers in 
the fetus required for immune modulation at the materno*fetal interface to protect the fetus from 
immune rejection by the mother? Additionally although the numbers are increased, fetal DCs are 
tolerogenic promoting a Th2 polarisation (Klein and Remington, 2001; Adkins, ., 2004). The 
impaired immune activity may be partly due to increased fetal production of IL*6 which exhibit 
Th2 polarising functions by inhibiting neutrophil migration to sites of infection (Marchini, ., 
2000; Schultz, ., 2002) and also leads to low levels of secretory IgA (Markel, ., 2006). 
Thus the increased numbers could be a requirement to ensure effectiveness of a Th1 response if 
necessary.  
The maturation process in the DC is associated with increased expressions of HLA*DR and 
CD45. The surface expressions of HLA*DR and CD45 on the myeloid and plasmacytoid CBDCs 
were comparable to the adult contradicting the various literature reports of immature CBDCs. 
Hunt  reported in their study that umbilical CBDCs had lower levels of ICAM*1 and MHC 
classes I and II than PB DCs from adults (Hunt, 	
1994). The CD11c
*
CD45
inm 
DCs exhibited 
lower levels of CD45 and HLA*DR indicating an immature phenotype. The immaturity of this 
novel subset could be a major factor in the immaturity of the fetal immune system as 
significantly increased numbers were seen in the preterm CB compared to the term CB. A lower 
functional capacity has been attributed to CBDCs when compared to adult DCs. They have a 
reduced ability to attain a fully mature adult phenotype and to activate CD4+ T cells to produce 
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IFN*α (Langrish,  ., 2002). Theoretically the expressions of HLA*DR and CD45 should 
increase with advancing gestational age and birth reflecting a maturing immune system, but no 
such change was identified in our study. This could be a reflection of the small sample size as the 
changes in expressions could be subtle requiring large numbers of samples in order to identify a 
significant change.  
The microenvironment in which antigen uptake occurs impacts the manner in which DCs process 
antigens and can determine whether a tolerogenic or an immunogenic response should be 
mounted. Thus maturation of DCs by an inflammatory cytokine filled milieu result in an 
immunogenic response and immature DCs in a steady state environment may present antigens 
that promote tolerance and tissue growth. Evidence to date shows that, in the fetus as both 
tolerogenic and immunogenic responses are needed, most immune responses are modulated and 
executed differently from the adult. It was of interest to ascertain the immune responses mounted 
by the fetus on exposure to stressor stimuli as this in turn would impact on the pathogenesis and 
initiation of preterm labour. Hence we decided to analyse the changes seen on the identified 
CBDC populations in response to exposure to intrauterine stressor stimuli. All CBDC subsets 
increased in numbers on exposure to stressors. This increase in numbers was reflected in the 
increase in the total numbers of CBDCs on exposure to stressors. Thus the CBDCs in our study 
exhibited capacity to mount a response to immunogenic stimuli.  
But as evidence shows this response has to be tempered with a need to mask an overt expression 
of the fetal antigens and hence the tolerogenic expressions of fetal DCs predominate. Thus 
although they increased in numbers of DCs on exposure to stressor stimuli, the myeloid and 
plasmacytoid CBDC subsets did not upregulate the costimulatory markers; CD40 and CD86 on 
exposure to stressor stimuli. This immature functioning of the DCs conforms to literature 
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evidence of immunotolerance in the fetus. Conversely the CD11c
*
CD45
inm
 CBDC subset 
upregulated the above costimulatory markers on exposure to stressor stimuli. Antigen 
presentation in the feto*maternal interface is unique and presentation on ‘non*classical’ MHC 
class I proteins, such as HLA*E and HLA*G may inhibit maternal responses to fetal antigen and 
induce a ‘tolerogenic’ state (Holt and Jones, 2000; Petty and Hunt, 1998). Thus the upregulation 
of costimulatory markers by the CD11c
*
CD45
inm
 CBDCs contrary to the established tolerogenic 
immune capacity of fetal DCs confer an important role on these DCs in the capacity of the fetus 
to mount an immune response.   
Advancing age was seen to have an impact on the expressions of the costimulatory markers. 
Holloway   has shown the percentage of CBDCs expressing CD40, CD86 and CD54 are 
lower than adults throughout gestation with a reduced capacity for costimulation and the capacity 
increases with advancing gestation (Holloway,  ., 2009). The level of expressions of the 
costimulatory markers varied between the various CBDC subsets. On comparison between the 
subsets the myeloid subset expressed the highest levels of CD86 and the plasmacytoid subset 
expressed the highest levels of CD40. This was in line with literature evidence of differences in 
the expressions of CD86 by the myeloid and plasmacytoid DCs. Myeloid DCs expressed CD86 
in basal conditions but not plasmacytoid DCs (Della Bella,  ., 2008). With advancing age 
from fetus to adult, both these subsets varied the expressions of CD40 and showed no change of 
CD86 expression. The myeloid subset increased while the plasmacytoid subset decreased CD40 
expression with age. This finding of decreasing CD40 expression by the plasmacytoid DC is in 
accordance with the tolerogenic function ascribed to plasmacytoid DCs in their immature state 
(Liu, 2005; Merad, ., 2007; Steinman and Banchereau, 2007). 
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Advancing gestational age from preterm to term increased the expressions of CD40 and CD86 on 
CD11c
*
CD45
inm
 DCs, while the myeloid and plasmacytoid subsets showed no change. The above 
finding again displays CD11c
*
CD45
inm
 DCs to be the most kinetic of all the CBDC subsets. 
A similar enhanced activity was seen on analysis of the production of the proinflammatory 
cytokine, IL*12. The plasmacytoid and the CD11c
*
CD45
inm
 subset showed increased production 
of IL*12 on exposure to stressors. Conversely, the myeloid subset decreased the IL*12 
production with stressors. Neonatal myeloid DCs are deficient in IFN*b and IL*12 synthesis in 
response to TLR triggering (Renneson,  ., 2009). Functionally neonatal increased 
susceptibility to infection has been related to their defect in synthesis of interleukins, especially 
IL*12 in response to both LPS and CD40L (Goreily, ., 2001; Aksoy, ., 2007) and this 
IL*12 defect has been hypothesised to stem from alterations in the expression of the p35 chain 
(Goreily, ., 2004). 
Advancing age affected the capacity of the CBDCs to produce IL*12. Increased production of 
IL*12 by the myeloid and plasmacytoid subsets was seen on comparison between fetus and adult. 
The CD11c
*
CD45
inm
 subset showed no change in IL*12 production with advancing gestational 
age.  
The above analyses of the response of CBDC subsets to advancing gestational age and exposure 
to stressor stimuli focussed our attention on the novel CD11c
*
CD45
inm
 subset as these DCs were 
more dynamic and changed with gestational age as well as stressor stimuli as opposed to the 
myeloid and plasmacytoid subsets.  
DCs do not function in isolation during an immune response and many cellular elements of the 
immune system interact to facilitate defence against pathogen attack. Accordingly we analysed 
the neutrophils in CB samples classified as exposed to stressor stimuli to ascertain if they 
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exhibited the established neutrophilic changes in response to exposure to infectious stimuli. We 
were able to validate the clinical classification of CB samples by showing a correlation between 
the changes on DCs and on neutrophils in response to stressor stimuli. 

		
 
We selected CB as the sample for conducting the experiments as it was freely available without 
additional procedural steps and at no risk to the mother or infant. We analysed the CB as whole 
blood as analysis of whole blood without manipulation avoids selective loss of cell population 
during mononuclear cell separation. The separation process itself can result in cell activation, 
maturation and skew cytokine production and thus invalidate the results. Whole blood analyses 
also allows for cell populations to be studied in a state mimicking the  state as much as 
possible with host serum and plasma factors present. The addition of the prenumbered bead 
solution to the cell sample has enabled accurate counts of cell numbers per Hl of blood. The 
fluorescent beads were added into the samples prior to acquisition of the cells, and thus the beads 
were acquired from an unmanipulated sample. Absolute counts distinguish between absolute loss 
and gain of cell populations with certainty. As physiological processes itself such as advancing 
gestational age can change CBDC populations, comparisons between percentage positive cells 
alone was thought to be not accurate enough.  
Adult PB samples were used as controls and labelled contemporaneously with the CB samples. 
All samples were analysed within 1*2 hours of delivery to prevent  activation of cells and 
also to reflect the  environment as closely as possible. 
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The Flow cytometer used had four channels and an additional channel was required to study the 
costimulatory marker expression and production of IL*12 by the CD11c
*
 CBDC subsets. To this 
purpose, cychrome conjugated CD11c was added to the lineage cocktail in the third channel 
which removed the CD11c
+
 DCs from the DC gate staining thus freeing up a channel. Freeing of 
one channel enabled the further delineation of CD11c* subsets with respect to their phenotype 
and function. Concurrent cell samples were stained with CD123 and CD45RA to ensure no loss 
of CD11c* DCs occurred due to the addition of CD11c to the lineage cocktail (see  !
 ").  
The methodology of the experiments was tested to check the integrity and reproducibility. DC 
sorting and labelling experiment was conducted to check the integrity of flow cytometer sorting. 
Purity of the flow cytometer sorting was confirmed by pre and post sorting labelling experiments 
(see   !   " ). Potential loss of DC populations due to the metrizamide 
separation was also checked and found not to occur (see  ! " ). 
Surface phenotyping by flow cytometry does not provide functional information and assessing of 
cytokine production by the CBDCs was felt to be necessary. ELISA measurements of cytokine 
production give limited information as it does not measure functionally active cytokine binding 
onto receptors and internalisation. Measurement of cytokine production intracellularly is a more 
accurate reflection of cytokine activity, thus intracellular detection of cytokine production by 
flow cytometry gives accurate functional data. As we have used whole blood without 
manipulation the results of the analyses may characterise  cytokine production.  
CBDCs were exposed for 4 hours to medium alone, or to the intracellular transport vesicle 
blocking agent monensin, such that active production of the cytokine within the cell in that 
window period of time could be measured. The cytokine expression of the sample without added 
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monensin was subtracted from the cytokine expression of that with monensin to determine the 
cytokine accumulation by production within the cell in the above time period. We did not use an 
intracellular isotype control for cytokine expression as a no*monensin sample was felt to provide 
more accurate results due to the following reasons. Isotype control comparison may also detect 
the cytokine stored already inside the cell and not just the amount produced in the 4 hours. 
Cytokine bound to surface receptors depends on the affinity and avidity of the antibody which 
may vary and also may not be equal to that exhibited by the anti*cytokine antibody. Additionally 
some antibodies have a high staining intensity at baseline due to a high flourochrome:antibody 
ratio and can give false positive results.  
Although we have established ongoing intracellular cytokine production, further work needs to 
be done. Experiments using excess non*specific antibodies to show non blockage of cytokine 
staining and thereby indicating the specificity of the technique for the detection of intracellular 
cytokines should be done.  
Enhanced normalised subtraction gives an accurate measurement of the staining intensity and 
was used throughout the study to derive the positive control intensity ratios. Non specific binding 
represented by the isotype staining was subtracted from the phonotype labelling using the 
WinList
TM 
programme. This calculation identifies low positive events occurring within the 
distribution of the control histogram and is more accurate than the geometric mean fluorescence 
of a gated population. 
Subtraction was not used for the CD45, HLA*DR and CD16 analyses as an isotype control 
labelled tube for these markers was not included in the experiments. For analyses of these 
markers geometric mean fluorescence of the positive population was compared with the 
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geometric mean fluorescence of the corresponding isotype. It is submitted that any error would 
be negated as the same comparisons were done within the same sample in each experiment.  
  
		

The most significant area of research described in this study was the identification of a hitherto 
unreported putative CD11c
*
CD45
inm
 DC population with phenotypic and functional properties 
conforming to the characteristics of DC in established literature. Of the three CBDC populations, 
the novel CD11c
*
CD45
inm
 population proved to be the most kinetic, changing with gestational 
age as well as on exposure to stressors. Furthermore we have highlighted the possibility that 
these identifiable changes, with further studies could lead to identification of the systemically 
compromised infant immediately post delivery.  
Spontaneous preterm labour and delivery is a syndrome caused by multiple pathologic processes 
that activate the common pathway of parturition and is a diagnostic conundrum due to the 
multifactorial aetiology (Romero, ., 1993b; Romero, ., 1994). Mechanisms of disease 
involved in the “preterm labor syndrome” include infection/inflammation (Minkoff, 1983; Gibbs, 
 ., 1992; Fidel,  ., 1994; Gomez,  ., 1995; Fidel,  ., 1998; Lamont, 1998; 
Goldenberg, ., 2000; Hirsch and Wang, 2005; Romero, ., 2007; DiGiulio, ., 2008; 
DiGiulio, ., 2010), vascular disease (Arias, ., 1993; Kim, ., 2002; Kim, ., 2003), 
uterine over distension (Manabe,  ., 1981; Manabe,  ., 1994; Many,  ., 1995; 
Leguizamon, ., 2001), abnormal allograft reaction (eg, rejection) (Kim, ., 2008;  Kim, 
., 2009;  Kim, ., 2010), an allergic*like phenomenon (Romero, ., 1991;  Romero, ., 
2010; Bytautiene,  ., 2002; Bytautiene,  ., 2004), a progesterone deficiency (Mesiano, 
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2001; Pieber, ., 2001; Mesiano, 2004; Hassan, et al., 2011) and cervical disorders (Smith, 
., 1992; Iams, ., 1995; Heath, ., 1998; Hassan, ., 2000).  
The first mechanism of disease responsible for preterm labour and delivery for which a causal 
link was well established is infection (Romero and Mazor, 1988; Fidel, ., 1994; Gravett, 
., 1994; Hirsch,  ., 1995; Hirsch and Wang, 2005; Romero,  ., 2007). Moreover, the 
mechanisms responsible for this process have been identified and involve PRRs (Elovitz, ., 
2003; Abrahams, ., 2004; Kim, ., 2004; Abrahams and Mor, 2005; Mor, et al., 2005), 
chemokines (Kelly, ., 1992; Hamill, ., 2008; Nhan*Chang, ., 2008), or inflammatory 
cytokines (Romero, ., 1989a; Romero, ., 1990). In spite of this wealth of information on 
aetiology robust tests to identify the mother and fetus at risk of preterm labour sequelae have not 
yet been formulated. The Wilson criteria for a screening test advocates specificity, sensitivity, 
acceptability to the patient, reliability, good positive and negative predictive values and should 
be subject to quality assurance (Wilson and Jungner, 1968). Acceptability to the patient and 
feasibility has always been issues in fetal tests as obtaining samples from the fetus itself are 
associated with risks. Tests using placental tissue and CB which are currently perceived as 
‘waste products’ of labour are ideal as they are available immediately post delivery and without 
additional procedures or risks. Thus the study of DCs in CB and their changes with stressor 
exposure could lead to identification of the high risk infant immediately after birth without any 
further tests on the neonate. Our work has focussed attention on the novel CBDC population 
CD11c
*
CD45
inm
,
 
as being the most kinetic and responsive to intrauterine stressors compared to 
the myeloid and plasmacytoid CBDC subsets. Analyses of this subset could offer a more 
accurate depiction of the immune status of the fetus. Additionally DC changes reflect the 
immune modulations by the fetus in response to intrauterine stressors, studying which would 
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contribute to our understanding of the pathogenesis of preterm labour and delivery. This in turn 
could lead to formulation of more effective preventative and curative strategies.  
Non invasive diagnosis using maternal or cord blood is the future direction as obtaining fetal 
samples by amniocentesis and chorionic villus sampling have an approximately 0.5*1% risk for 
fetal loss. Recent development in the field of non*invasive prenatal diagnosis through the use of 
cell*free fetal nucleic acids in maternal circulation during pregnancy is a successful example of 
the same. Thus extrapolating similar non invasive diagnostic techniques using cord blood will be 
the realistic future and should be cost neutral on comparison with invasive tests. 
 
	  #$%
 
The results discussed in this body of work may form the basis of future studies assessing the role 
of CBDC populations in spontaneous preterm labour. This body of work has raised many 
questions which could be answered by further studies especially regarding the role of the novel 
CD11c
*
CD45
inm 
DCs in the fetal immune system. What is the significance of this immature DC 
subset? Does this subset contribute to the general haemopoietic immaturity of CB which inhibits 
immune responses and maintains a tolerogenic environment? The CD11c
*
CD45
inm
 immature DC 
population appeared similar to the immature DC population identified in haemalogical 
malignancies (Panoskaltsis, Ph.D. thesis, 2008). This could be due to a common mechanism 
through which the immature DC in the fetus as well as in malignancies provide tolerogenic 
signals to facilitate growth of the ‘foreign’ tissue. Blood and bone marrow CD11c
low
 cells can 
behave as a precursor and give rise to all DC subsets. The ontogeny of this subset could be 
studied using tissue samples which would give a picture of very early development in the first 
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trimester. Tissue could be obtained after terminations of pregnancies in the first trimester and no 
data exists to date of the same. Similar techniques of immunohistochemistry, flow cytometry 
surface phenotype and intracellular cytokine labelling could be done to track the development of 
these DC subsets and their evolution. In addition to any condition leading to suspected 
intrauterine immunocompromise, adult conditions such as haematological malignancies and 
autoimmune disorders could be evaluated for this CD45
inm
 DC subset. 
The CD11c
*
CD45
inm
 DC might be a subset of DC in transition to another DC subset. The 
decreasing numbers with increasing age of the fetus indicated that this might be so. Does 
decreasing numbers with increasing age in the fetus indicate evolvement of the CD11c
*
CD45
inm 
DCs into the predominant myeloid DC subset in the adult? Longitudinal studies of CB at 
different gestations and from neonate to infant to adult should provide insight into the evolution 
of this subset. This subset expressed lower levels of CD45 and HLA*DR, but no significant 
increased in levels were seen with increasing gestation and on exposure to stressors. As 
discussed, this could be due to the small number of samples in the groups. Analyses of larger 
numbers of samples could show an increasing level of maturity on exposure to stressors thus 
adding credence to an evolving DC phenotype.   
Further work needs to be done to establish the functional characteristics of the CBDC subsets. As 
manipulation and labelling of CBDCs have been shown to negate their lymphocytic stimulatory 
capacity other methods of separating the subpopulations has to be considered. Negative selection 
using microbeads where the cells of interest are not manipulated is one of the methods which 
could be used to sort the subpopulations.   
Power calculations were not applied as practically the time limit of the project as well as the 
scarcity of samples resulted in few numbers. This does mean that results which could have been 
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statistically significant were not significant due to the small sample size. The present study could 
be considered as a feasibility/observational study of the differences in CBDCs. In future if these 
changes are to be developed as a test power calculations would need to be applied to ensure 
adequate number of samples are obtained. 
The next steps would be to analyse larger numbers of samples, especially to provide comparisons 
between stressed and non stressed fetuses at various gestational ages. In our study we were not 
able to obtain samples from term fetuses exposed to intrauterine stressors except for the analyses 
of IL*12 production. The type and efficacy of the immune response mounted by the fetal DC 
populations could vary with the gestational age and hence comparisons would be valid only 
between the same gestational age groups. Further analyses could show if these CBDC 
phenotypic changes are consistent and reliable to be used as a test for diagnosis of the 
immunocompromised fetus.  
  models of infection could be set up including culturing the CBDCs with microbial 
antigens to ascertain whether the  DC changes could be reproduced. These experiments 
may provide insight into the functioning of the innate and the establishment of the adaptive 
immune system in the fetus.  
Furthermore the clinical course of the neonates identified as having been exposed to stressors by 
the CBDC changes should be monitored. The clinical information gathered would add to the 
reliability of the DC changes in identifying the compromised fetus.  Long term follow up work 
would also establish whether the DC phenotypic changes are indicative of long term adverse 
sequelae of FIRS.  
Understanding the function and role that the DC populations play in the activation of the fetal 
immune cells is crucial to understanding the differential functioning of the fetal immune system 
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in their ability to fight infections and their immuno protective capacity or Th2 bias which leads 
to a successful pregnancy. Also a greater understanding of the characteristics and function of 
DCs, in the differential response seen in the fetal immune system will help us understand the role 
of infections in the pathophysiology of preterm birth and in turn will lead to more effective 
preventive and curative measures.  
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